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ABSTRACT 
The phenomenon of induced peroxisome proliferation in rodents has invariably been 
associated with upregulation of member(s) of the CYP4A subfamily of heme-
proteins. However, regulation of the members ofthe rat CYP4A family has not been 
fully examined at the molecular level. Despite the publication of the rat CYP4Al and 
CYP4A2 genomic sequences (Kimura eta!., 1989a), no functional ｡ｳｳｾｹｳ＠ have been 
performed to detennine the mechanism of peroxisome proliferator modulated 
transcriptional activation of these genes. The objective of this study was to isolate 
members of the rat CYP4A subfamily of genes and investigate their ｩｮ､ｵｾｩ｢ｩｬｩｴｹ＠ by 
peroxisome proliferators at the molecular level. In this thesis I present results to 
demonstrate:-
I) the isolation and partial characterisation of recombinant DNA clones 
corresponding to 3 different rat genomic sequences, showing a degree of similarity to 
the rat CYP4Al eDNA, 
2) identification, by sequencing, of one of the groups of clones (group C) to 
correspond to CYP4A2 and another (group B) to be, possibly, the genomic sequence 
of CYP4A3. The identification of the remaining group (group D) remains unknown, 
but most likely represents a novel member of the rat CYP4A subfamily, 
3) the apparent absence of a peroXIsome proliferator response element 
(PPRE) in the 5' flanking DNA sequence of the clones, as determined by hybridisation 
to the rat acyl-CoA oxidase PPRE oligonucleotide (GTOX285), 
4) a lack of a response of a -5.8kb upstream sequence of the newly-isolated 
human CYP4All gene in a co-transfection assay with the mouse PP AR and in the 
presence of the peroxisome proliferator Wy 14643 . 
The results further extend knowledge on the multiplicity of CYP4A genes in the rat 
and provide data on the transcriptional regulation of CYP4A genes in rodents and 
man. 
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CHAPTER! 
INTRODUCTION 
1.1 THE CYTOCHROME P450 GENE SUPERFAMILY 
The cytochrome P450 gene superfamily (EC 1.14.14.1) comprise a family of b-type 
haemoproteins with an identical prosthetic group and mechanism of catalysis, but 
widely different substrate specificities. 
The first cytochrome P450 was identified independently by two groups in the same 
year (Klingenberg, 1958, and Garfinkel, 1958) as a reduced pigment that had an 
absorption band with a soret maximum at 450nm after binding to carbon monoxide. 
However it was not until 1964 that the haemoprotein nature of the pigment was 
documented by Omura and Sato (classifying it as a b type) and provisionally gave it the 
name cytochrome P450. The role of cytochrome P450 in the microsomal mixed 
function monoxygenase system was also established at this time (Cooper eta/., 1965). 
Since this time it has become evident that multiple forms of cytochrome P450 exist 
with a ubiquitous distribution in nature. Cytochrome P450s are found in prokaryotes, 
unicellular eukaryotes, plants, fowl, insects, fish, invertebrates and mammals (Nelson et 
a/., 1993 and references therein). Whilst the prokaryotic enzyme cytochrome 
P450cam (CYP 101 ), is a soluble haemoprotein, those of higher organisms are 
membrane bound. Mammalian cytochrome P450s may be divided into two major 
groups based on their intracellular location and the enzyme from which they receive 
electrons (Gonzalez, 1990). The mitochondrial P450s, such as side chain cleavage 
enzyme (CYPIIAI) and steroid 11(3-hydroxylase (CYP11B1), are found in the 
mitochondria of the adrenal cortex and are involved in steroid synthesis. These 
enzymes are synthesised by cytoplasmic polyribosomes (Nabi et a/., 1983). However 
the great majority of P450s are found primarily in the endoplasmic reticulum and are 
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synthesised on membrane·bound polyribosomes (Gonzalez and Kasper, 1980). 
1.1.1 Nomenclature 
Omura and Sato (1964) had intended that the name "P450" would be provisional, until 
more knowledge about the substance had been elucidated. However as more 
cytochrome P450s were discovered, primarily through protein purification research, it 
became clear that many cytochrome P450 forms had broad overlapping substrate 
specificities which precluded establishing a nomenclature system based upon unique 
catalytic functions. However, within the last decade the isolation and sequencing of 
P450 proteins, genes and cDNAs (Table 1.1) have facilitated the development of a 
P450 classification system based on primary amino acid sequence alignment data 
(Nebert eta/., 1987). 
This system of nomenclature is constantly evolving as more P450s are isolated and 
characterised (Nebert et al., 1989a, 1991, and Nelson et al., 1993). According to this 
classification system, those cytochrome P450 proteins with 40% or greater sequence 
similarity are included in the same family (designated by an Arabic number), and those 
with greater than 55% similarity are included in the same subfamily (designated by a 
capital letter). The individual genes are arbitrarily assigned numbers in order of their 
discovery. For all P450 genes and cDNAs the italicised root symbol "CYP" for human 
("Cyp" for rr.·)use), representing "cytochrome P450," is used, ｦｯｮｾｷ･､＠ by the family 
number, subfamily letter and then the individual gene number. The mRNAs and enzymes 
in all species (including mouse) are written with all capital letters, without italics. 
1.1.2 Evolution of the Cytochrome P450 Superfamily 
Cytochrome P450 evolution is believed to have originiated with the emergence of a 
common ancestral gene 3.5 billion years ago. There are presently 221 P450 genes and 
3 
Table 1.1 Total number of cytochrome P450 genes and eDNA's 
that have been reported in the last seven years in two year 
intervals. 
YEAR NUMBER OF P450's NUMBER OF REFERENCE 
genes pseudogenes GENE FAMILIES 
1987 65 
-
10 Nebert et al., 1987 
1989 71 4 14 Nebert et al., 1989a 
1991 154 7 27 Nebert et al., 1991 
1993 221 12 36 Nelson et a/., 1993 
4 
12 putative pseudogenes that have been described in 31 eukaryotes (including 11 
mammalian and 3 plant species) and in 11 prokaryotes (Nelson eta/., 1993). Of the 36 
gene families so far described, 12 families exist in all mammals comprising 22 
subfamilies of which 17 have been mapped to the human genome. 
This wealth of sequence information has provided important insights into cytochrome 
P450 evolution (Nelson and Strobel, 1987, Gonzalez and Nebert, 1990, Nebert eta/., 
1991 ). Since all cytochrome P450 enzymes studied to date metabolise endogenous 
substrates, it is perhaps not unreasonable to assume that they originated early in 
evolution to provide the organism with oxidative and peroxidative metabolism of 
important endogenous molecules, as well as the breakdown of environmental 
chemicals utilised for energy. Subsequently, the P450 enzymes in eukaryotes probably 
diversified more recently, in response to the adverse effects . of dietary pressures, 
plant/anitnal warfare and other environmental chemicals (Gonzalez and Nebert, 1990). 
Those mammalian cytochrome P450 isozymes involved with steroid and bile acid 
synthesis are highly conserved across species and are among the oldest forms. It has 
been proposed that these earliest P450s evolved to maintain membrane integrity 
through the metabolism of lipids and steroids (Gonzalez, 1990). The highly conserved 
nature implies that any mutation in these genes proves fatal and is therefore not carried 
through evolution (Gonzalez, 1990). The majority of microsomal cytochrome P450s 
act on xenobiotics and constitute part of a detoxification system. These .xenobiotic 
metabolising enzymes, present in CYP families 1 to 3, are thought to have evolved due 
to the need to remove toxins ingested in the diet. Their diversity has been the result of 
gene duplication and mutational events which have conferred an evolutionary 
advantage on the animals concerned. 
One consequence of human cytochrome P450 gene evolution is the polymorphism of 
drug metabolism, leading to marked differences in the response of individuals to the 
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toxic and carcinogenic effects of drugs and other environmental chemicals. The 
differences between human individuals, races or ethnic groups, are either at the level of 
expression of some forms (extrahepatic CYPIAl after induction, hepatic CYPIA2, 
2B7, 2D6, 2E1), or at the absence of a particular cytochrome P450 form, as compared 
to rodents (e.g. forms CYP2A3 and 3A5), and may become clinically manifest in 
quantitative differences in the metabolism of certain drugs resulting in "poor" or 
"extensive" metabolizers eg. the 4-hydroxylation of debrisoquine by CYP2D6 
(Guengerich, 1989, Gonzalez eta/., 1991 ). 
1.1.3 Cytochrome P450 Catalysed Reactions 
As well as the widespread distribution throughout the animal and plant kingdom, one 
also finds within the mammalian population a marked tissue specificity of enzyme 
synthesis. It was initially thought that cytochrome P450s occurred only in the liver, 
however, although in mammalian species they are most abundant in this latter tissue, 
they also occur in extra-hepatic tissues, including the small intestine, colon, kidney and 
lung (DeWaziers eta/., 1990). 
Cytochrome P450s are of importance in the oxidative, peroxidative, and reductive 
metabolism of numerous endogenous compounds such as steroids, bile acids, fatty 
acids, prostaglandins, leukotrienes and biogenic amines (Gonzalez 1989, 1990). Many 
of the P450 enzymes can also metabolise a wide range of foreign chemicals 
(xenobiotics) including drugs, environmental pollutants, natural plant products and 
alcohols. By introducing a polar hydroxyl group into these xenobiotic molecules the 
P450 enzyme allows for phase II conjugation enzymes to introduce additional polar 
groups thereby facilitating the elimination of these xenobiotics from the body. 
However, in some cases the oxidation of these xenobiotics can generate biologically 
reactive electrophiles that are detrimental to the host and may cause toxicity or cancer 
(Guengerich, 1988). 
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The extensive range of reactions catalysed by cytochrome P450, including 
hydroxylation of aromatic, aliphatic and cyclic compounds, oxidation, dealk:ylation and 
deamination, is made possible by its ability to cleave molecular oxygen to active 
oxygen species, one atom of which is incorporated into the substrate and the other is 
reduced to the level of water according to the following equation (where RH 
represents the substrate). 
The essential stages of this reaction are as follows. The initial step involves substrate 
binding to the oxidised form of the iron atom in the haem group of cytochrome P450. 
The substrate-enzyme complex is then reduced by the transfer of an electron from 
NADPH, which is catalysed by NADPH-cytochrome P450 reuctase. The reduced 
enzyme-substrate complex then binds with molecular oxygen and further reduction of 
this complex occurs by the transfer of an electron either from NADPH-cytochrome 
P450 reductase or NADH via NADH-cytochrome b5 reductase and cytochrome b5. 
Finally, the substrate-enzyme-oxygen complex splits into water, ox.idised substrate and 
the oxidised form of the enzyme (for a review see Porter and Coon, 1991). 
1.1.4 Mechanisms of Induction and Regulation of the Cytochrome 
P450 Superfamily 
Consonant with the multiplicity of cytochrome P450s is the considerable diversity in 
the mechanisms of regulation of these enzymes, as depicted schematically in Figure 
1.1. Not surprisingly, the most common means of regulation is transcriptional. Post-
transcriptional mechanisms include mRNA stabilisation and protein stabilisation or 
degradation that may be mediated through changes in the phosphorylation state of the 
enzyme. Moreover, many cytochrome P450s are subject to tissue-specific patterns of 
expression, with resulting differences in isoform compositions and activities in various 
tissues eg. the CYP4A subfamily (for review see Okey, 1990). 
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GENE 
TRANSCRIPTION 
Processing 
+ 
... 
1A1 2C12 3A6 1A2 
1A2 209 4A1 
281 2E1 11A1 
282 2H1 1181 
2C7 2H2 17 
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mRNA 
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2C12 3A6 
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N 
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3A1/2 
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Fig 1.1 Multiplicity in the regulation of cytochrome P-450 
expression. P-450 designations (shown at the bottom of the 
figure) are as described in Nebert eta/. (1991) and are based 
on selected examples from various mammalian species. 
(Taken from Porter and Coon, 1991). 
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1.1.4.1 Transcriptional Regulation 
All eukaryotic genes are under control of transcription factors that bind to DNA 
sequences in their 5' flanking regions, which act as promoters, enhancers and 
suppressors. These transcription factors are contained within four families of DNA-
binding proteins that are characterised by the presence of various sequence motifs 
including zinc fingers, leucine zippers and homeodomains (Mitchell and Tjian, 1989, 
Schwabe and Rhodes, 1991 ). Cis-regulatory elements can also occur downstream 
of the promoter eg introns. 
The most extensively characterised cytochrome P450 with regard to regulation is 
CYP JAJ (Nebert and Jones, 1989). The CYP JAJ gene is transcriptionally activated by 
a number of chemicals including benzo(a)pyrene and 2,3, 7,8-tetrachlorodibenzo-p-
dioxin (TCDD) that exert their effect by binding to the Ah receptor and converting it 
into a form capable of interacting with the cis-acting elements (variously referred to as 
drug regulatory elements, DRE, xenobiotic regulatory elements, XRE, and Ah 
regulatory elements, AhRE) located upstream of the CYP JA 1 coding gene. From 
three to five AhREs are found in the mouse, rat and human CYP JAJ genes. The gene 
and eDNA encoding a second protein, named the Ah receptor nuclear translocator 
(Arnt) have been cloned (Hoffman eta/., 1991), and identified as being necessary for 
Ah receptor function, the two proteins forming a heterodimeric structure (Hankinson, 
1993). It should be noted, however, that the complete functional Ah receptor activity 
has not been reconstituted from eDNA-expressed subunits. Another factor involved in 
CYP JAJ regulation is the presence of a negative regulatory element that inhibits 
transcription. A repressor protein has been identified and appears to associate with the 
Ah receptor inhibiting its binding to the AhRE (Watson eta/., 1992). The heterodimer 
motif seems to be a reoccurring theme in the control of transcription as demonstrated 
by the steroid hormone receptors and the proto-oncogenes fos and jun (Green, 1992a). 
A number of other P450s are transcriptionally activated by xenobiotics (i.e. induced). 
For example, phenobarbital induces a number of cytochrome P450s in the CYP2B, 
9 
CYP2C and CYP3A subfamilies (reviewed in Waxman and Azaroff, 1992). 
Many xenobiotic-metabolising cytochrome P450s are constitutively expressed in the 
absence of inducers. Two P450 genes, CYP2El and CYP2C6, have been studied and 
found to be under the control of known hepatocyte-enriched transcription factors. The 
factor HNF-la (Hepatocyte Nuclear Factor) was found to control in vitro expression 
of the CYP 2El gene by binding to an upstream cis-acting element (Ueno and 
Gonzalez, 1990). The hepatic CYP2C6 gene becomes maximally transcriptionally 
activated when male and female rats reach puberty. The timing of this activation is 
coincident with expression of a protein designated DBP (albumin gene D region 
Binding Protein), and a DBP response element upstream from the CYP2C6 
transcription start has been found, which activates its transcription (Yano eta/., 1992). 
In rodents, but less so in man, the expression of a number of cytochrome P450s is 
sexually determined, by neonatal imprinting and by hormonal regulation in mature 
animals. The CYP2CJJ is a male specific P450 wheras CYP2Cl2 is a female specific 
P450, both expressed in rat liver under the influence of pituitary-dependent hormones 
(Waxman, 1988). The effect of sex hormone exposure appears to be related to the 
subsequent pattern of growth hormone secretions which is pulsatile in male and 
constant in female rats. 
The bovine CYP 11 A, CYP 11 B, CYP 17 and CYP21 A 1 genes have been shown to be 
transcriptionally activated in cultured adrenocortical cells by ACTH which acts via 
cyclic AMP (John et a/., 1986). It has been postulated that cAMP does not stimulate 
transcription directly but rather that cAMP activates a gene encoding a hypothetical 
steroid hydroxylase inducing protein (SHIP) (Nebert and Gonzalez, 1987), although 
this SHIP protein remains to be isolated and fully characterised. 
10 
···--------------------------
1.1.4.2 mRNA Processing and Stabilisation 
Another point of control in cytochrome P450 regulation is the efficiency of removing 
introns from the pre-mRNA and the subsequent splicing of exons to form a mature 
mRNA. Aberrant splicing (due to a G to A base pair transition at the intron 3/exon 4 
boundary) is one of the mechanisms (others being frame shift mutations and deletions) 
which underlies the observed polymorphism in the human CYP2D subfamily (Gough et 
a!., 1990). Alternative mRNA splicing has also been observed for CYP2A3, which 
results in the production of both functional and non-functional enzyme (Okino et a/., 
1987). 
Messenger RNA stabilisation as a mechanism of induction is demonstrated by several 
cytochrome P450s, including rat CYP3Al which is up-regulated as a result of 
administering the macrolide antibiotic triacetyloeandomycin (TAO) (Watkins et a!., 
1986), and CYP2E I which is elevated I 0-fold as a consequence of diabetes (Song et 
a!., 1987). It is interesting to note that a 10-fold increase in CYP2El mRNA is also 
seen following fasting. This, however, results from an increase in gene transcription 
(Johansson eta!., 1990). 
1.1.4.3 Enzyme Stabilisation and Protein Phosphorylation 
In addition to the post-transcriptional effects described above, cytochromes P450 have 
also been shown to be controlled at post-translational levels. Obviously the availability 
of the haem prosthetic group is an important factor as described by Padmanaban et a!. 
( 1989), but more specific mechanisms of post-translational control have been 
demonstrated to be the protection of CYP2E 1 apoprotein by ethanol, acetone or 
pyrazole (Song et a!., 1989) and the protection of CYP3A apoproteins by TAO 
against degradation (Watkins eta/., 1986). The role of phosphorylation by cAMP 
dependent protein kinases in the regulation of cytochrome P450 ｡｣ｴｩｾＮｲｩｴｹ＠ is less clear 
but appears to lead to inactivation of several forms, namely CYP2B 1, CYP2C2 and 
CYP2E1 (Goldfarb, 1990). 
11 
1.2 CYTOCHROME P450 FAMILY 4 (CYP4) 
The first member of the CYP4 family to be identified was a clofibrate inducible, lauric 
acid ro-hydroxylase, first purified tcr electrophoretic homogeneity in 1982 (Gibson et 
a/., 1982). This new form of cytochrome P450 had a characteristic absorbance 
maximum at 452nm and was therefore named P452 (Tamburini et a/., 1984). Since 
this time, a number of complementary DNAs of the CYP4 family have been isolated 
from eDNA libraries made from liver, kidney, prostate and lung of various species 
including the rat, mouse, guinea pig, rabbit, human and insects (Nelson eta/., 1993), 
Table 1.2. To date there are 22 gene members of the CYP4 family, arranged into 6 
subfamilies (A-F). 
The CYP4 gene family encodes a group of cytochrome P450 enzymes that hydroxylate 
the terminal co carbon and, to a lesser extent, the ro-1 position of saturated and 
unsaturated fatty acids (Bjorkhem and Hamberg, 1971 ). ro-Hydroxylation is an 
important step in the metabolism of saturated fatty acids, arachidonic acid, and the 
pharmacologically active eicosanoids, prostaglandins (PG), hydroxyeicosatetraenoic 
acid (HETE), and leukotrienes (LT) (Ellin eta/., 1972, Powell, 1984, Sumimoto eta/., 
1984). For straight-chain fatty acids, ro-oxidation is a minor pathway except during 
ketotic states such as starvation and diabetes. ro-Hydroxylation represents a major 
pathway for the metabolism of branched-chain or substituted fatty acids (Yamakawa, 
1950). These hydroxylated fatty acids are further oxidised to dicarboxylic acids by 
alcohol and aldehyde dehydrogenase, subsequently shortened by ｾＭｯｸｩ､｡ｴｩｯｮＬ＠ and 
excreted as C6-C 1 o dicarboxylic acids. 
The eDNA for the first isozyme identified in the CYP4A family, P452, was cloned and 
characterised from the livers of clofibrate-treated rats (Hardwick et a/., 1987, 
Earnshaw eta/., 1988) and was designated CYP4Al in accordance with the system of 
nomenclature (Nelson et a!., 1993). The genomic clone of CYP4Al has 
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since been identified along with a closely related gene, designated CYP4A2, as well as 
the eDNA of a third member of this rat CYP4A family, CYP4A3 (Kimura et a/., 
1989a, 1989b). The mRNAs for these three genes have been shown to be coordinately 
regulated in the liver by hypolipidemic drugs (Kimura et al., 1989a, 1989b ). CYP4A2 
is a constitutive isozyme in the kidney which is weakly induced by clofibrate, whereas 
both CYP4AJ and CYP4A3 are dramatically induced in the kidney at a lower dosage 
of clofibrate than CYP4A2 (Kimura eta/., 1989b). 
A prostaglandin co-hydroxylase has been isolated from lungs of pregnant rabbits 
(Williams eta/., 1984) and rabbits treated with progesterone (Yamamoto eta/., 1984). 
The eDNA for this enzyme, designated CYP4A4 (formerly P450p-2), has been 
isolated and sequenced (Matsubara eta/., 1987) and more recently the genomic clone 
of CYP4A4 has been isolated (Palmer et a/., 1993a). A similar or possibly identical 
protein to CYP4A4 has also been isolated from the livers of pregnant rabbits (Kikuta 
eta/., 1989). The observation that preparations of CYP4A4 exhibited negligible lauric 
acid co-hydroxylase activity (Yamamoto et al., 1984) suggested that members of the 
CYP4A subfamily, distinct from CYP4A4, may be expressed in the rabbit. Using 
CYP4A 4 as a hybridisation probe, two different groups have isolated cDNAs for 
CYP4A4 -related forms from rabbit kidney eDNA libraries. Yokatani et a/. (1989) 
have reported the isolation of two different cDNAs encoding lauric acid co-
hydroxylases. P450ka-1 mRNA was expressed in liver and kidney and was induced by 
the treatment of rabbits with clofibrate, while P450ka-2 mRNA was constitutively 
expressed in liver, kidney and small intestine, but only induced in the liver by clofibrate. 
Johnson et a!. (1990) have isolated cDNAs for three rabbit kidney lauric acid co-
hydroxylases denoted CYP4A5-7. CYP4A6 and CYP4A7 are identical to P450ka-1 
and P450ka-2, respectively. More recently the genomic sequence for CYP4A6 has 
been isolated (Muerhoff eta/., 1992a). 
A fourth member of the rat CYP4A family was isolated from a rat prostate eDNA 
16 
library and shares 76% amino acid similarity with CYP4Al (Stromstedt eta/., 1990). 
This cytochrome P450 isoform, designated CYP4A8, was found to have high 
constitutive expression in the kidney, but no detectable signal was obtained with RNA 
from liver. This finding led to the isolation of a rat kidney eDNA, differing from 
CYP 4A8 in only three nucleotide positions. 
The first report of a human member of the CYP4A subfamily (designated CYP4A9) was 
in 1991, in the form of a personal communication by Hardwick et al. (Nebert eta/., 
1991 ). However, details of this human liver P450 isoform have yet to be published. 
The first murine member of the CYP 4A subfamily was identified by Henderson et a/. 
(1992) and was designated Cyp4a-10. This isoform shared 92% sequence similarity 
with the rat CYP4A 1 and Western Blot analysis revealed three and four mRNA species 
present in m0use liver and kidney respectively. 
A 52kDa protein, which exhibits lauric acid co-hydroxylase activity, has been isolated 
from human kidney microsomes (Kawashima et al., 1992). Amino acid sequencing of 
the NH2 terminal end of the protein showed it to possess between 75-80% similarity 
with other members of the CYP4A family. Subsequently, the use of the eDNA for 
CYP4A4 as a hybridisation probe, identified a full length eDNA (designated 
CYP4All) from a human kidney eDNA library, (Palmer et al., 1993b) that may or may 
not correspond to the 52kda protein identified by Kawashima et a/. (1992). The 
CYP4A1 1 eDNA was expressed in E. coli, and a solubilised preparation of the enzyme 
reconstituted with cytochrome P450 reductase was shown to catalyse the co-
hydroxylation of lauric acid, palmitic acid and arachidonic acid. CYP4All was found 
to be expressed at high levels in the kidney, with the liver showing the next highest 
abundance. Concurrently, results in our laboratory demonstrated the presence of a 
fatty acid co-hydroxylase activity in human liver microsomes(Chinje, personal 
communication), confirming the existence of an in vivo expressed human member of 
17 
the CYP4A subfamily. The genomic clone of CYP4All has recently been isolated and 
partially sequenced in our laboratory (Hood eta/., 1992). The exons so far sequenced, 
1, 8, 9 and 10 have identical DNA sequence to the CYP4All eDNA, and exhibit 80% 
amino acid similarity to the four rabbit genes (CYP4A4-7) and 73% amino acid 
similarity to the three rat genes (CYP4Al-3). 
More recently a second member of the murine Cyp4a family was identified and 
designated Cyp4a-12 (Bell et a/., 1993). This isoform shows the highest degree of 
similarity to the rat CYP4A8 gene (93% amino acid similarity). Unlike the rat 
CYP4A8, this isoform shows high constitutive expression in both male kidney and liver 
(as oppossed to just kidney), however low expression of Cyp4a-12 in female kidney 
and liver was observed, although this could be greatly induced in both organs by 
methylclofenapate. The sex specific regulation of the rat CYP4A8 gene has not been 
investigated. This same group (Bell eta/., 1993) identified the first guinea pig CYP4A 
gene and designated it CYP4Al3. This isoform was found to be expressed in liver, but 
was not inducible by the administration of methylclofenapate confirming the earlier 
findings in this laboratory (Gibson, 1989). The guinea pig CYP4Al3 gene is most 
similar to the rat CYP4Al, sharing 83% amino acid similarity. 
The CYP4B subfamily has three orthologous eDNA members isolated from rat and 
rabbit (Gasser and Philpot, 1989), and from man (Nhamburo et a!., 1989). The 
CYP4B subfamily proteins mediate mainly the pulmonary N-oxidation of aromatic 
amines such as the promutagen 2-aminofluorene. Unlike the orthologous rabbit form, 
human CYP4B 1 was unable to metabolise this latter compound despite the presence of 
CYP4B 1 mRNA in three out of four lungs analysed (Nhamburo et a/., 1989). In 
contrast to its expression in lung, CYP4B 1 mRNA was undetectable in livers obtained 
from 14 individuals, including those from which the lungs were derived. Similarly, 
CYP4B 1-related mRNA was also expressed in rat lung but was undetected in 
untreated rat liver. Expression of CYP4B I in rabbit but not rat or human liver 
18 
suggests an interesting species difference in tissue-specific expression of this gene. 
The gene for human CYP4Bl has also been isolated (Yokotani et al., 1990). 
In 1991, a new gene member of the CYP 4 family, sharing 3 5% sequence similarity 
with CYP4Al, was identified in the cockroach (Blaberus discoidalis) (Bradfield et al., 
1991 ). Despite this gene not satisfying the 40% rule for classification into an existing 
family, the gene was found to contain a 13 base-pair sequence characteristic of the 
CYP4 family (Nhamburo et a!., 1989) and was therefore designated CYP4CJ. The 
physiological role for CYP4C 1 is highly speculative, but the mRNA level is known to 
be elevated by both the hypertrehalosemic hormone (HTH) and starvation. A principal 
function of HTH is stimulation of fat body glycogen to trehalose, the main circulating 
carbohydrate in insects. Bradfield and co-workers (1991) concluded from their studies 
that CYP4C 1 may be hormonally regulated in association with energy substrate 
mobilisation. However, the protein catalytic activity and regulation of the 
corresponding CYP4CJ gene by HTH still remains to be ascertained. CYP4 genes 
have also been identified in Drosophi 1/a melanogaster and have been designated 
CYP4Dl and CYP4El (Gandhi eta/., 1992, Nelson et al., 1993). 
The last subfamily to be identified (to date), as a member of the CYP4 family, has been 
designated CYP4F. Chen and Hardwick (1992) constructed a eDNA library from a 2-
acetylaminofluorene-induced transplantable rat hepatic tumour and screened it with a 
CYP4 family probe. A eDNA was isolated which exhibited 44-45% amino acid 
identity to rat CYP4A members, 43% to human CYP4Bl, and 35 and 32% to insect 
CYP4CJ and CYP4Dl, respectively. This new P450 was thus named CYP4Fl. This 
form is expressed at a high level in hepatic tumours which is in contrast to other rat 
CYP4A members whose expression is reduced in most cases, thus implying that the 
CYP4A and CYP4F 1 genes are differentially regulated (Chen and Hardwick, 1992). 
19 
1.2.1 Regulation of Expression of the CYP4A Subfamily 
CYP4AJ, CYP4A2 and CYP4A3 have been shown to be coordinately induced in the 
rat liver by hypolipidemic drugs (Kimura et a/., 1989a,b ). CYP4A2 is a constitutive 
isozyme in the kidney where it is weakly induced by clofibrate, whereas both CYP4AJ 
and CYP4A3 are dramatically induced in the kidney at a lower dosage of clofibrate 
than CYP4A2. The CYP4Al, CYP4A2 and CYP4A3 genes are coordinately regulated 
by clofibrate in the liver and are induced transcriptionally by clofibrate, starvation and 
drug-induced diabetes (Kimura eta/., 1989b, Kusunose eta/., 1981 ). 
CYP4A expression has been shown to be controlled at the level of transcription 
(Hardwick eta/., 1987) and it is also thought that mRNA processing or stabilisation 
may play a part in the control ofthese genes (Earnshaw eta/., 1988). As well as being 
transcriptionally activated by peroxisome proliferators, hepatic CYP4A mRNA has 
also been shown to be suppressed by 49% from a maximally induced level, by the 
administration of polyinosinic acid. polycytidylic acid (poly IC), an alpha/beta interferon 
inducer (Knickle eta/., 1992, D. Bulsara, personnal communication). How interferon 
(IFN) mediates this suppression is unknown. Protein kinase C (PKC) has been shown 
to be involved in the signal transduction pathway induced by IFNa (Reich and Pfeffe, 
1990). It could be that phosphorylation of a transcription factor(s) (such as members 
ofthe steroid hormone receptor superfamily), involved in maintaining the basal level of 
the CYP4A genes or upregulating them, would cause the factor to be inactivated, 
therby causing downregulation of the CYP4A genes. Alternatively phosphorylation by 
PKC might cause the activation of an unidentified negative transcriptional regulation 
factor. This activated factor might compete directly with the peroxisome proliferator 
activated transcription factor for its DNA binding site, or compete indirectly by binding 
to the factor itself preventing it from binding to the DNA and enhancing the 
transcription of the CYP4A genes. 
Sex differences have been observed in the responsiveness of rat liver to several 
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peroxisome proliferators. Female rats are less susceptible to clofibrate-induced 
peroxisome proliferation than males (Reddy and Kumar, 1979, Kawashima et a/., 
1989). Sundseth and Waxman (1992) demonstrated by Northern blot analysis that in 
the liver, CYP4A1 and CYP4A3 mRNAs were induced to a much greater extent in 
male as compared to female rats following clofibrate treatment, whereas CYP4A2 
mRNA was absent from female rat liver. They also observed male-specific expression 
of CYP4A2 in the kidney. If indeed, CYP4A induction is an early and perhaps 
obligatory step in the peroxisome proliferation pathway, then sex differences in the 
constitutive expression and/or inducibility of these genes might contribute to the sex-
dependent effects of clofibrate on peroxisome proliferation, however the underlying 
mechanistic basis for the lower responsiveness of female rats to clofibrate-inducible 
CYP4A expression is unknown. 
The CYP4Al and CYP4A2 genes have been isolated and sequenced and found to 
possess 13 and 12 exons respectively (Kimura et a!., 1989a). Interestingly the 
CYP4AJ and CYP4A2 genes lack the TATA box upstream of the transcriptional start 
site. Genes that lack the TAT A box are believed to have multiple transcriptional start 
sites, however, both the CYP4Al and CYP4A2 have a single start site. 
The CYP4A6 gene has been isolated and sequenced and found to contain 12 exons 
(Muerhoff eta/., 1992a). Intronlexon junctions within the coding region of CYP4A6 
are conserved relative to the rat CYP4Al and CYP4A2 genes and primer extension 
analysis indicates the presence of a single transcriptional start site. The CYP4A6 
promoter region, like that of the rat CYP4Al and CYP4A2 genes, does not contain a 
consensus TAT A box. 
The other CYP4A gene that has been sequenced is that of CYP4A4 (Palmer et a/., 
1993a). This gene is not induced by clofibrate but is elevated in the lung, liver and 
kidney during pregnancy. Treatment of male rabbits with dexamethasone also 
21 
increases the levels of CYP4A4 m.RNA in the lung and liver, but the levels are 
eightfold less than those seen for pregnant rabbits. The intron/exon structure is highly 
conserved in relation to the clofibrate inducible genes rat CYP4AJ, CYP4A2 and rabbit 
CYP4A6 and like these genes the CYP4A4 promoter does not contain a TATA 
consensus sequence. 
The mechanism of regulation of CYP4A has been studied intensely by this laboratory 
and others. The proposed role of the PP AR receptor in this regulation is discussed in 
detail in section 1.5.2. 
1.2.2 The Physiological Role of the CYP4A Subfamily 
The CYP4A gene subfamily encodes a group of cytochrome P450 enzymes that 
hydroxylate the terminal ro carbon and, to a lesser extent, the ro-1 position of saturated 
and unsaturated fatty acids. ro-Hydroxylation is an important step in the metabolism of 
saturated fatty acids, ·arachidonic acid, and the pharmacologically active eicosanoids, 
prostaglandins (PG), hydroxyeicosatetraenoic acid (HETE), and leukotrienes (LT) 
(Ellin et a!., 1972, Powell, 1984, Sumimoto et a/., 1984). For straight-chain fatty 
acids, ro-oxidation is a minor pathway except during ketotic states such as starvation 
and diabetes (Orton and Parker, 1982). It has been proposed that the ( ro-1 )-
hydroxylating activity is catalysed by several cytochrome P450 isoenzymes and is 
therefore non-specific. By contrast the ro-hydroxylase is highly specific for fatty acids 
(Kufper, 1982) and represents a major pathway for the metabolism of branched-chain 
or substituted fatty acids. These hydroxylated fatty acids are further oxidised to 
dicarboxylic acids by alcohol and aldehyde dehydrogenase, subsequently shortened 
from both ends by ｾＭｯｸｩ､｡ｴｩｯｮＬ＠ and excreted as C6-C10 dicarboxylic acids. 
The substrate specificites of the members of the CYP4A subfamily can be seen in Table 
1.2. CYP4Al, CYP4A3, CYP4A5, CYP4A6 and CYP4A7 actively catalyse the ro-
hydroxylation of fatty acids and have low or negligable prostaglandin ro-hydroxylase 
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activity, whereas the reverse substrate specificity has been reported for CYP4A4. 
Although the specific substrate for CYP4A2 has not been determined, work in 
spontaneous hypertensive rats by Iwai and Inagami (1991) strongly suggests that 
CYP4A2 has some role in water and electrolyte metabolism in the kidney. These 
workers demonstrated that expression of CYP4A2 mRNA in the kidney was positively 
modulated by low sodium chloride diet feeding, indicating that this enzyme may have 
some role in reducing sodium excretion from the kidney. 
The use of oligonucleotide probes, specific for CYP4A1, CYP4A2 and CYP4A3, in in 
situ hybridisation (Hardwick, 1991 ), has demonstrated that in untreated rats, CYP4A 1 
and CYP4A3 mRNA's are distributed throughout the liver, however most of the 
mRNA is found in the periportal region. In kidney, CYP4A1 and CYP4A3 mRNA's 
are localised within the proximal tubule cell, whereas CYP4A2 is found within the 
reno medullary region. When rats are administered clofibrate, the level of CYP4A1 and 
CYP4A3 mRNA increases in the proximal tubules, whereas CYP4A2 remains 
unchanged in the cells of the renomedullary region (Hardwick, 1991 ). 
Arachidonic acid serves as an excellent substrate for the clofibrate-induced CYP4A 
hydroxylase system in the rat liver and kidney (Bains eta/., 1985, Sharma eta/., 1989). 
Pretreatment of rats with ciprofibrate resulted in an 8-fold stimulation of ro- and ro-1 
oxidation of arachidonic acid with a simultaneous net decrease in the formation of the 
other oxygenated metabolites (Capdevila eta/., 1984). 
The major metabolite in both rat hepatic and renal arachidonate metabolism is the 20-
hydroxyarachidonic acid (20 HETE), however, in both control and clofibrate-induced 
states, the kidney remains more efficient at metabolising arachidonic acid to the 20-
hydroxy metabolite (Sharma eta/., 1989). It has been demonstrated that ro- and ro-1 
metabolites of 20-HETE are a potent vasoconstrictor in rat aortic rings and a 
stimulator of the Na+, K+-ATPase pump respectively (Escalante et a/., 1989, 
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Schwartzman et al., 1989}. Ma and co-workers (1993) have demonstrated that 20-
HETE constricted canine renal arcurate arteries and was associated with a significant 
depolarization of vascular smooth muscle cells. In contrast, these workers found that 
19(R)-HETE was a vasodilator in renal arteries. These results are consistent with 
previous findings indicating that myogenic activation of renal arteries is potentiated by 
arachidonic acid and attenuated by inhibitors of cytochrome P450 (Kauser et a!., 
1991). 
Arachidonic acid is also metabolised in the kidney by a cytochrome P450 epoxygenase 
located in the thick ascending loop of Henle (TALH). This cytochrome P450-
dependent epoxygenase produces epoxyeicosatrienoic acid (BET) which inhibits the 
Na+, I<+-ATPase pump, resulting in increased hypertension (Schwartzman et a!., 
1986). As mentioned above, specific ro- and ro-1-HETE products produced by the 
kidney prove to be potent vasoconstrictors and a stimulator of the Na+, K+ -ATPase 
pump respectively. Since the CYP4Al and CYP4A3 enzymes are localised in the 
proximal tubules of the kidney, induction of these enzymes would increase the 
conversion of arachidonic acid to ro/ro-1 products and therefore prevent the oxidation 
of arachidonic acid by the P450 epoxygenase in the T ALH cells. 
1.3 PLEIOTROPIC RESPONSE TO THE ADMINISTRATION OF 
PEROXISOME PROLIFERA TORS 
The CYP4A gene family is unique in that its members are induced by a group of 
structurally diverse compounds including hypolipidaemic drugs, phthalate esters, and 
halogenated hydrocarbon solvents. Administration of these compounds to susceptible 
species such as rodents and more particularly the mouse and rat, induces the 
proliferation of peroxisomes in hepatocytes (Gibson et al., 1982) and hence such 
compounds are called peroxisome proliferators. These compounds have been 
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extensively studied and the results have been surveyed by the European Chemical 
Industry Ecology and Toxicology Centre (ECETOC, 1992). The degree of 
peroxisome proliferation varies markedly depending upon the substance inducing the 
change. Examples of some peroxisome proliferators are shown in Figure 1.2. The 
proliferation may be accompanied by changes in the morphology of the peroxisomes, 
and also results in characteristic changes in the morphology and biochemistry of the 
liver. Peroxisome proliferators have been used clinically, in man, to lower the risk 
of heart disease. 
1.3.1 Peroxisomes 
Peroxisomes are cytoplasmic organelles widely distributed in animal and plant cells 
(DeDuve, 1969) and are particularly abundant in cells which are involved in lipid 
metabolism and they are often associated with lipid droplets within the cell (Gorgas, 
1987). Peroxisomes are single membrane bound organelles that stain positive for 
peroxidase activity (due to the presence of catalase). Their shape and size varies 
greatly depending on the cell type investigated. In general, they appear to be round 
and contain an electron-dense crystalloid core, which contains the enzyme urate 
oxidase. Human hepatic peroxisomes are generally smaller than their rodent 
counterparts and lack the crystalloid core. 
Peroxisomes contain a large number of enzymes many of which are intimately involved 
in lipid metabolism, e.g. breakdown of lipid (i.e. the fatty acid f3-oxidation system), the 
synthesis of plasmologens (ether lipids), the synthesis of cholesterol and of long chain 
fatty esters which are found in waxes and pheromones. Most of these functions are 
also performed by other subcellular organelles, e.g. microsomes or mitochondria, and 
it is often difficult to assess the contribution of the peroxisomal enzymes to the total 
cellular reactions. 
Although the reactions involved during peroxisomal f3-oxidation are very similar to 
those of mitochondrial f3-oxidation, the enzymes differ from their mitochondrial 
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Figure 1.2 Examples of peroxisome proliferators and some of their uses 
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counterparts with respect to their catalytic and molecular properties. It has been 
shown that unlike the carnitine-dependent, cyanide-sensitive mitochondrial system, 
peroxisomal ｾＭｯｸｩ､｡ｴｩｯｮ＠ enzymes are cyanide-insensitive in vitro and do not require 
carnitine (Lazarow, 1982). Peroxisomal 13-oxidation generates reduced FAD which is 
reoxidised by molecular oxygen (Figure 1.3). NADII/lrt produced by the oxidation of 
beta-hydroxy-fatty acyl CoA's is reoxidised by glycerol-3-phosphate dehydrogenase in 
a peroxisomal shunt for NADHIH+. The first enzyme in the peroxisomal P-oxidation 
pathway, acyl CoA oxidase, is rate limiting and results in the generation of FADH2. 
The reduced flavin units are not available for ATP generation via the mitochondrial 
electron transport chain, but are oxidised by molecular oxygen with the resultant 
formation of hydrogen peroxide. This results in an overall waste of energy in 
comparison to the mitochondrial beta-oxidation pathway. The hydrogen peroxide can 
also be generated within the peroxisome via urate oxidase, D-amino acid oxidase and 
glycolate oxidase (Lock et al., 1989, Reddy and Lalwani, 1983). 
Many theories of peroxisomal biogenesis have been proposed. The classical model 
suggests that peroxisomal proteins are synthesised within the lumen of the endoplasmic 
reticulum and then form vesicles which detach from the endoplasmic reticulum to form 
peroxisomes (De Duve and Baudhuin, 1966). However, the polypeptide composition 
of the ｰ･ｲｯｸｩｾｯｭ｡ｬ＠ membrane and the endoplasmic reticulum have been shown to be 
markedly dissimilar (Fujiki et a/., 1982). The current model of peroxisome biogenesis 
suggests that peroxisomes are formed by fission from pre-existing organelles 
(Yamamoto and Fahimi, 1987, Fujiki eta/., 1984) and that the peroxisomal enzymes, 
synthesised on free polysomes, enter these organelles. Lazarow et a/, {1982), showed 
that peroxisomal proteins are made as mature proteins i.e. are not processed during 
uptake into pre-existing peroxisomes. 
A great deal of speculation as to the metabolic role of the peroxisomes has been made. 
In the case of fatty acid 13-oxidation it would appear that very long fatty acids which 
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are poorly oxidised by the mitochondrial system are good substrates for the 
peroxisomal system so in this manner the two systems may complement each other 
(Boeck et a/, 1980, Fahimi and Sies, 1987). In this respect it is of interest that children 
suffering from Zellweger's syndrome (a hereditary disease characterised by a lack of 
peroxisomes ), or adrenoleukodystrophy (a disorder characterised by defective 
transport of enzymes into peroxisomes ), show accumulation of very long chain fatty 
acids (C2s and C26) in adrenals as well as the central nervous system (Singh et al., 
1981). 
1.3.2 Hepatomegaly 
Within a few days of administration of peroxisome proliferators to rats or mice, a 
marked hepatomegaly is observed (Hess et a/., 1965), measured as an increase in liver 
to body weight ratio, which is characterised by hyperplasia (increase in cell number and 
content of DNA) and hypertrophy (increase in cell size). The increased number of 
peroxisomes and the hepatomegaly start to appear within 24 hours of the first dose and 
this initial growth period lasts 3-4 days. The earliest observable change is an 
accumulation of small lipid droplets similar to those found in hyperphagia which are 
possibly associated with alterations in fatty acid metabolism (Mitchell et a/, 1986). 
However, within a few hours an increase in messenger RNAs for c-myc, c-fos, 
CYP4A1 and for the peroxisomal enzymes can be observed (Bentley et a/., 1987, 
Milton et a/., 1990). This is accompanied by increased hepatocyte 3H-thymidine 
incorporation (a measurement of DNA synthesis) reaching a peak at the third day 
which subsequently reverts to normal levels for most, but not all, peroxisome 
proliferators. Liver growth continues and reaches a steady state within 14 days of 
treatment and is sustained as long as the agent is administered. Rao and Reddy (1987) 
reported continuation of this steady state level up to 25 months of treatment with 
ciprofibrate. Peroxisomal number may increase 5-7 fold as, for example, after 
treatment with high doses of clofibrate and ciprofibrate (Cohen and Grasso, 1981 ). 
Liver cells revert to a normal phenotype between 2-3 weeks following the withdrawal 
29 
of the peroxisome proliferator (Svoboda and Azarnoff, 1966). However, if 
administration is continued, the liver remains enlarged (Mitchell et a!., 1985b) and 
other aspects of the peroxisome proliferation phenomenon become apparent. These 
include the deposition of lipofuscin and eventually the formation of pre-neoplastic foci, 
liver nodules and ultimately tumours (Rao and Reddy, 1987). The interval between the 
early changes and the eventual appearance of tumours is measured in terms of several 
months. The rates of appearance of liver nodules and tumours are related and differ 
from compound to compound (reviewed in ECETOC, 1992). 
1.3.3 Peroxisomal and Mitochondrial Changes 
Peroxisomes produced after the administration of peroxisome proliferators to rats are 
heterogeneous, some may contain fibrillar striations, cavitations and double walled 
tubules, while others may be devoid of their crystalloid cores (Schulte-Hermann, 
1979). The increase in peroxisomal number is accompanied by a very marked increase 
in the 'marker' enzymes for this organelle. The ｾＭｯｸｩ､｡ｴｩｯｮ＠ enzymes are induced up to 
30-fold, as measured by cyanide-insensitive palmitoyl CoA oxidation (Lazarow and De 
Duve, 1976, Osumi and Hashimoto, 1976). The activity of enoyl CoA hydratase is 
increased 30-50 fold and the 80kD peroxisome proliferation-associated polypeptide 
(PP A-80) which is identical to the multi-functional peroxisome protein, is selectively 
induced by peroxisome proliferators. In contrast, catalase activity is only slightly 
induced, often not more than 2-fold (Chattetjee eta/., 1983). 
Other peroxisomal enzymes are also induced. Short chain carnitine acyl-CoA 
transferase, which is important for the removal of acetyl CoA from the peroxisome, is 
induced 20 to 160 fold in parallel to peroxisome proliferation (Stott, 1988). Likewise, 
carnitine octanoyltransferase can be induced over 40-fold by DEHP (Miyazawa eta!., 
1983). 
Increases in the activity of acyl-CoA synthetase, carnitine acetyltransferase, carnitine 
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palmitoyltransferase and acyi-CoA hydrolase have been observed in hepatic 
mitochondria isolated from rats treated with peroxisome proliferators (Leighton et al., 
I 982, Berge et a/., I 983). A slight induction in the mitochondrial (3-oxidation of 
short-chain acyl-carnitines has been demonstrated in clofibrate-treated rats 
(Christiansen et a/., I 978). Clofibrate administration has also been shown to inhibit 
branched-chain amino acid metabolism in the mitochondria (Wagenmakers et a/., 
1985). 
The administration of peroxisome proliferators to rats also induces certain cytosolic 
proteins, namely palmitoyi-CoA hydrolase, cytosolic epoxide hydrolase and fatty-acid 
binding protein (Berge eta/., 1987, Moody eta/., 1991). The proportion of catalase in 
rat liver cytosol is also increased and may reflect an altered fluidity of the peroxisomal 
membrane (Crane et a/., 1985). Inhibition of cytosolic glutathione peroxidase, 
glutathione transferase and superoxide dismutase have also been observed when rats 
have been treated with a number of peroxisome proliferators for a period of 30 days or 
more (Lake eta/., 1987, 1989). 
The smooth endoplasmic reticulum proliferation seemingly parallels the proliferation of 
peroxisomes i.e. it is apparent by 2-3 days and persists at 14 and 30 days. 
Immunochemical methods have shown an increase in CYP4Al from its constitutive 
levels of 5% of the total cytochrome P450 population, to 45% after clofibrate 
treatment in the rat (Sharma eta/., 1988). CYP4Al induction precedes peroxisome 
proliferation, and a close correlation between this induction and peroxisomal P-
oxidation has been observed (Sharma eta/., 1988). 
Peroxisome proliferation appears to be a tissue and species specific phenomenon. In 
rats the liver is the most susceptible organ, though the kidney, heart, intestinal mucosa 
and skeletal muscle all respond depending on the dose and duration of exposure to 
peroxisome proliferators (Stott, 1988). The induction of mitochondrial and 
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peroxisomal enzymes involved in the f3-oxidation of fatty acids and the induction of 
phase II metabolising enzymes such as the microsomal UDP-glucoronosyl transferase 
(Fournel eta/., 1985), in conjunction with other known cellular responses, points to a 
common mechanism involved in their hypolipidaemic effect. 
1.4 SPECIES DIFFERENCES IN RESPONSE TO PEROXISOME 
PROLIFERA TORS 
It is now well established that in rats and mice hypolipidaemic agents and other 
chemicals such as DEHP induce hepatic peroxisome proliferation and peroxisomal and 
CYP4A enzyme induction (Hawkins et al., 1987). Hamster liver is also responsive to 
these compounds, although to a lesser extent (Reddy et al., 1982, Lake et al., 1984, 
Orton et a/., 1984). Other species that have been examined for their response after 
challenge by numerous peroxisome proliferators, include various rat strains, dogs, 
rhesus monkeys, guinea pigs, mice. ferrets, rabbits, marmosets and humans (Grey and 
De La Iglesia, 1984, Orton et a/., 1984, Reddy et al., 1984a, Gariot eta!., 1983, 
Watanabe et al., 1989, Makowska eta/., 1991). The results obtained have so far 
revealed that higher mammalian species are considerably less sensitive than rats and 
mice, or totaHy insensitive to the effects of known peroxisome proliferative agents at 
tolerated or therapeutic doses. For instance, Lake et a/. (1989) demonstrated the 
insensitivity of marmosets to nafenopin, only a small (2-fold) increase in f3-oxidation 
being seen after 250mg!kg!day for 3 weeks. A clear no effect level of 50mg!kg!day in 
the marmoset was noted; in contrast, this dose given to rats, resulted in a 1 0-fold 
increase in peroxisomal f3-oxidation. -Similar differences between rats, mice and higher 
mammalian species have been reported for DEHP and trichloroacetic acid (Elcombe et 
a/., 1985, Elcombe and Mitchell, 1986). 
A number of studies have been conducted on patients who had been treated with 
hypolipidaemic agents for several months to several years, in an attempt to elucidate 
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the effect, if any, of peroxisome proliferators in the human liver. The only substantial 
report of a chemically induced increase in the number of peroxisomes in humans was 
made by Hanefeld eta!. (1983). They compared the number of peroxisomes found in 
biopsy specimens from 16 patients on hypolipidaemic therapy before and after 
receiving treatment with clofibrate for three to four months, and found that there was a 
50% increase in the mean number of peroxisomes but that the volume density was 
increased by only 23%. Statistically, the mean increase in the number of organelles 
was significant whereas the increase in volume density was not. In contrast Gariot et 
a!. (1987) compared liver biopsies from 12 hypolipidaemic patients receiving a mean 
daily dose of 317mg fenofibrate and from 15 patients receiving a low fat diet. There 
was no difference in the volume density or in the number of peroxisomes between test 
and control groups. In another earlier study by De La Iglesia et a/. (1982), liver 
biopsies from 9 patients on long term (17-25 months) treatment with gemfibrozil were 
examined. It was found that the content of hepatic peroxisomes in the treated patients 
varied widely from cell to cell according to the location in the hepatic lobule but 
peroxisome proliferation as observed in rodents does not occur. A study on the 
prolonged use of clofibrate (the average length of the trial was 5.8 years) on 15,745 
males was carried out by WHO (Oliver et a/., 1978). However, the results were 
inconclusive and have since restricted the use of clofibrate, reflecting doubts about the 
effectiveness of its therapeutic action and the possibility of latent side-effects, probably 
unrelated to the phenomenon of peroxisome proliferation. 
Studies designed to evaluate species differences in vivo are frequently confounded by 
variations in administered dose, target organ dose, or differences in routes and rates of 
biotransformation. Hence several laboratories have attempted to eliminate these 
confounding factors by using in vitro hepatocyte culture systems (Gray et al., 1982, 
1983, Mitchell et al., 1984, Foxworthy eta/., 1986), and cultured hepatocytes from a 
number of species have been used to assess their response to peroxisome proliferators 
(Mitchell et a!., 1985a, Elcombe and Styles, 1989, Foxworthy et a/., 1990). These 
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latter studies have shown a marked species difference in response to the proximate 
peroxisome proliferators: mouse and rat hepatocytes respond, while cultured guinea 
pig, and human hepatocytes revealed little effect upon peroxisomes or related enzyme 
activities, such as peroxisomal f3-oxidation or microsomal co-hydroxylation of lauric 
acid. 
In general, the sensitivity of species to peroxisome proliferators follows the trend: rats, 
mice>> hamster> rabbit> guinea pig> dog, primates (including man). On the basis 
of limited studies in humans, it has been argued by some researchers that humans are at 
a limited risk from the carcinogenic effects of peroxisome proliferators. This may be a 
reasonable argument, but to be convincing, peroxisome proliferation must be proven as 
the cause of the carcinogenic response. 
1.5 MECHANISMS OF PEROXISOME PROLIFERATION 
The exact underlying cellular mechanism responsible for the induction of peroxisome 
proliferation and associated enzyme activities, remains to be fully ascertained. Two 
mechanisms have been proposed which remain to be fully explored. 
1.5.1 Perturbation of Lipid Metabolism, Substrate Overload 
Mechanism 
The ability of structurally diverse chemicals to elicit peroxisome proliferation has led to 
the proposal that perturbation in lipid metabolism is the event which initiates the 
process (Bremmer and Norman, 1982, Elcombe and Mitchell, 1986, Berge et a/., 
1987). This concept has gained support from the observation that high fat diets induce 
an increase in peroxisomal J3-oxidation (Osmundsen, 1982) and in the microsomal 
cytochrome P-450 hydroxylase system (Ishii et a/., 1980); however, the exact way in 
which this occurs is still not clear. 
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The accumulation of hepatic lipid can occur in a number of ways, and the structurally 
diverse chemicals that produce peroxisome proliferation may act at many different loci 
to perturb lipid metabolism. In the substrate overload theory (Sharma et a/., 1988), it 
is thought that the hypolipidaemic agent or peroxisome proliferator is taken up by the 
hepatocyte followed by, initially, inhibition of fatty acid oxidation by the dual 
mechanism of inhibition of carnitine acyl transferase in the mitochondrion (Lock et al., 
1989) or sequestration of essential CoA by the peroxisome proliferator itself 
(Bronfman et al., 1989). Inhibition of mitochondrial f3-oxidation due to sequestration 
of CoA would lead to the accumulation of medium (C6-C1o) and long chain (C12· 
C2o) fatty acids or their CoA esters in the cell. Induction of CYP4A synthesis then 
occurs as an early event along with peroxisome proliferation in order to maintain lipid 
homeostasis (Figure 1.4). 
In support of this hypothesis, it has been shown that medium chain (C6-C8) fatty acids 
induce CYP4A in cultured hepatocytes. It is also known that CYP4A preferentially 
metabolises long chain fatty acids (Orton and McCormick, 1982). Hence, the 
accumulated long chain fatty acids could be converted to long chain dicarboxylic acids 
(Robbins, 1968) by the newly induced CYP4A followed by the action of cytosolic 
alcohol and aldehyde dehydrogenases. It is then proposed that these dicarboxylic acids 
are then taken up by the peroxisome, thus presenting the organelle with a substrate 
overload of one of its preferred substrates (Singh et a/., 1984). These long chain 
dicarboxylic acids are also able to stimulate 3H-thymidine incorporation into DNA in 
isolated rat hepatocytes in culture (Lock et al., 1989) thus contributing to the 
hyperplasia seen following the administration of peroxisome proliferators in vivo. 
The proposed mechanism in Figure 1.4 requires the induction of CYP4A prior to the 
induction of peroxisomal enzymes such as acyl Co A oxidase. Several studies (Bell et 
al., 1991, Bell and Elcombe, 1991 and Bieri et a/., 1991) suggest that CYP4A is 
indeed induced prior to acyl CoA oxidase, both in vivo and in primary rat hepatocyte 
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cultures. Furthermore, inhibition of protein synthesis by cyclohexamide did not 
prevent the transcription of CYP4A mRNA but inhibited the transcription of acyl CoA 
oxidase mRNA (Milton eta/., 1990, Bieri eta/., 1991). This suggests the requirement 
of a protein, possibly CYP4A, for the subsequent induction of acyl CoA oxidase. 
It may well be possible that the above sequential mechanism put forward by Sharma 
and co-workers, may not be dependent on CYP4A induction of peroxisomal f3-
oxidation indicating a casual relationship between the two phenomena. An alternative 
mechanism is possible, whereby the commonality is related to structurally similar 
regulatory elements in the 5' upstream flanking regions of the CYP4A and f3-oxidation 
genes. This would imply the peroxisome proliferator may directly interact with the 
common regulatory sequences or indirectly modulate gene expression by lipids derived 
as a direct result of inhibition of mitochondrial fatty acid f3-oxidation described above, 
or from lipids displaced from fatty acid binding proteins (Cannon and Eacho, 1991 ). 
This alternative mechanism may provide an explanation as to why several structurally 
diverse inducers of CYP4A and the peroxisomal f3-oxidation enzymes exist, in that the 
peroxisome proliferators may not all directly interact with the inducible genes but 
indirectly act by influencing lipid disposition or a common perturbation of lipid 
biotransformation. 
1.5.2 Receptor Mediated Mechanism 
Lalwani eta! (1983) described a saturable pool of binding sites for nafenopin in the 
cytosol of rat liver. This demonstration of a reversible, specific, albeit weak binding of 
nafenopin to a cytosolic protein, led to the proposal by Reddy and co-workers (Reddy 
and Lalwani, 1983, Rao and Reddy, 1987), that peroxisome proliferators evoke their 
action possibly by a receptor-mediated mechanism. There is a good deal of evidence 
to support this suggestion including: (a) the tissue-specific biological response in 
transplanted hepatocytes (Reddy eta/., 1984b, Rao eta!., 1986); (b) the inducibility of 
peroxisome proliferation in hepatocytes in primary culture (Gray et a/., 1982, Mitchell 
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et a/., 1984 ); (c) the induction of a similar changes in protein composition in the livers 
of rats exposed to structurally dissimilar peroxisome proliferators (Sharma et a!., 
1988); and (d) the rapid and significant increase in the rate of synthesis of mRNAs for 
peroxisomal J3-oxidation and microsomal co-hydroxylation enzymes (CYP4A) in liver 
(Reddy et a/, 1986, Hardwick et a/., 1987) and the rapidity of the transcriptional 
response of these genes. 
A 70kD protein that binds 3H-nafenopin has been isolated from rat liver and partially 
characterised (Lalwani eta/., 1987). When clofibric acid and ciprofibrate were used as 
affinity ligands, the same 70kD protein was isolated. However, other workers have 
failed to detect any specific binding of 3H-nafenopin or 3H-ciprofibrate to hepatic 
microsomal or cytosolic fractions (Milton et a!., 1988) thereby raising doubts about 
the existence of such a receptor, as described by Reddy (Reddy and Lalwani, 1983). 
More recent]y, Alvares et a/. (1990) have further characterised this postulated 
receptor, and have been able to show that the protein is homologous with the 'Heat 
shock' protein HS P70 family. Additional work is required to ascertain if binding 
occurs in vivo and if this plays a role in transcriptional activation. 
The diverse nature of the chemical structures producing peroxisome proliferation 
suggested that agents do not interact with a single type of binding protein with a single 
recognition site. Hence it was suggested (Reddy and Rao, 1986) that a binding protein 
with multiple recognition sites exists or, alternatively, that several binding proteins 
with different ligand binding properties are involved. Issemann and Green (1990) have 
reported the cloning and characterisation (from a mouse liver eDNA library) of a 
member of the nuclear hormone receptor family that can be activated by structually 
diverse peroxisome proliferators, and hence, have called it the 'Peroxisome Proliferator 
Activated Receptor' (PP AR). These workers constructed chimeric receptors 
containing the putative ligand binding domain of PP AR and the N-terminal sequence 
and DNA binding domains of both the human oestrogen and human glucocorticoid 
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receptors. They demonstrated that these chimeric receptors were able to activate an 
oestrogen/glucocorticoid responsive gene in the presence of peroxisome proliferators. 
However, they were unable to demonstrate ligand binding. When the oestrogen 
chimeric receptor was tested using several different peroxisome proliferators (Wy-
14,643, nafenopin, f\.ffiHP, clofibrate, and trichloroacetic acid) a good correlation was 
observed between their ability to activate the chimeric receptor and their potency either 
as peroxisome proliferators or as rat liver carcinogens. The pattern of expression of 
PP AR mirrors the tissue specific effects of peroxisome proliferators, being highly 
expressed in liver, kidney and heart and to a lesser extent in brain, brown adipose 
tissue and testis. 
The data above suggests that PP AR mediates some of the biological effects of 
peroxisome proliferators. The classical scheme of steroid hormone receptor action is 
shown in Figure 1.5. The receptor-ligand complex is thought to translocate to the 
nucleus and bind to response elements in target genes causing an increase or decrease 
in their transcription. In 1991, Osumi et a/., identified an activating and inhibitory 
cis-acting regulatory sequence upstream of the rat Acyl Co A-oxidase gene. Tugwood 
eta!. (1992) demonstrated that PPAR could bind to a region in the 5' sequence of rat 
acyl Co A-oxidase gene and could activate transcription of a CAT reporter construct in 
the presence of the peroxisome proliferator, Wy-14,643. This region was identical to 
the activatiou region identified previously (Osumi et a/ 1991 ). The sequence that 
PP AR binds to is termed a 'Peroxisome Proliferator Response Element' (PPRE), and 
can be seen below: 
-572bp -556bp 
5'-ACG TGACCT T TGTCCT GG-3' Rat Acyl CoA-oxidase PPRE 
PPRE's have since been identified in rat 3-ketoacyl CoA-thiolase (Kliewer et a/., 
1992b ), rat enoyl CoA hydratase/3-hydroxyacyl CoA dehydrogenase (Zhang et a!., 
1992a), rat fatty acid binding protein (Issemann eta/., 1992) and in the rabbit CYP4A6 
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gene (Muerhoff et a/., 1992b ). Other PPRE's will undoubtedly be discovered, but to 
date none have been identified in the rat CYP4A gene family. It will be important to 
determine whether all of the effects of peroxisome proliferators are receptor-mediated. 
Despite the apparent conflict between the receptor hypothesis and the substrate 
overload hypothesis of peroxisome proliferation the two mechanisms are not 
necessarily mutually exclusive. It has been demonstrated by a number of groups 
(Gottlicher eta/., 1992, Issemannn eta/., 1992 and Keller et al., 1993) that long chain 
polyunsaturated fatty acids can activate PP AR, and thus may serve as the endogenous 
ligand for PP AR, although no direct ligand binding has been shown. Figure 1. 6 shows 
a possible strategy for the induction of peroxisome proliferation. 
1.6 THE PEROXISOME PROLIFERATOR ACTIVATED 
RECEPTOR (PPAR) 
The PP AR is a member of the nuclear receptor superfamily and is structually related to 
the subfamily of receptors that includes the thyroid hormone receptor (TR), retinoic 
acid receptor (RAR) and vitamin D3 receptor (VDR). The steroid hormone receptors 
are intracellular proteins that bind their cognate ligand with high affinity and 
specificity. Additionally they are DNA binding proteins that recognise short DNA 
motifs generally termed Hormone Response Elements (HR.Es). Such HR.Es are usually 
located upstream of the target genes and behave as transcriptional enhancers or in 
some cases as transcriptional silencers, which appears to be dependent upon the 
context of the HRE within the promoter of each target gene 
The cloning of the cDNAs for the steroid hormone receptors has revealed that they all 
share a common primary organisation with a highly conserved DNA and ligand binding 
domain. Indeed, it was the fact that the DNA binding domain of these receptors is so 
highly conserved that was utilised by Issemann and Green (1990) in the isolation of the 
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Inhibition of Fatty 
Acid Oxidation, 
High Fat Diets etc 
Metabolic 
Perturbation 
-stimulation 
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Intermediate 
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CoA Derivative 
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/ 
Genome I 
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Activated/ 
Dimerised 
Receptor ( s) 
Fig 1.6 Possible unifying receptor-mediated mechanism for 
peroxisome proliferation. (Taken from ECETOC, 1992). 
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mouse PPAR (mPPAR). 
Since the isolation of the mPP AR, a number of other PP ARs have been isolated and 
characterised from different species including Xenopus laevis PP AR (xPP AR) a, ｾ＠ and 
y , sharing 77o/o, 55% and 50% amino acid similarity to mPP AR, respectively (Dreyer 
et a/., 1992), rat PPAR (rPPAR) sharing 97% amino acid similarity to mPPAR 
(Gottlicher eta/., 1992), and more recently human PPAR (hPPAR) sharing 91% amino 
acid similarity to mPP AR (Sher et a/., 1993). A PP AR-like receptor isolated from a 
human osteoblastoma cell line termed NUC-1 has been isolated and found to have a 
64% amino acid similarity to mPP AR (Schmidt et a/., 1992). This may indicate the 
presence of another family of related PP AR receptors. 
The PP ARs have been shown to be activated in vitro by peroxisome proliferators 
(lssemann and Green, 1990) and by fatty acids (Gottlicher eta/., 1992, lssemann et al., 
1992 and Keller et a/., 1993), but, as of yet no direct ligand binding has been 
demonstrated. 
The known peroxisome proliferator response elements (PPREs), found in rat acyl-CoA 
oxidase (Tugwood et a/., 19912), rat 3-ketothiolase (Kliewer et a/., 1992b ), rat enoyl 
CoA hydratase/3-hydroxyacyl CoA dehydrogenase (Zhang et a/., 1992a), rabbit 
CYP4A6 (Muerhoff et a/., 1992a) and rat liver fatty acid binding protein (Issemann et 
a/., 1992), contain a DNA binding motif consisting of a direct repeat (DR) of a 
hexanucleotide sequence [5' - TGA (A/C/T) CT -3'] separated by a single nucleotide 
(DRI). This kind of DR sequence is also found in a number of other nuclear receptor 
response elements, eg., the TR, RAR, VDR, COUP (chicken ovalbumin upstream 
promoter) transcription factor and retinoid X receptor (RXR.). Although these 
receptors can all recognise the same half-site motif, they discriminate between target 
elements through the arrangement and spacing of the half-site motifs. 
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Recently, it has been demonstrated that receptors such as the Drosophila ecdysone 
receptor (EcR), RAR, TR and VDR do not efficiently bind to their cognate response 
elements as homodimers, but rather require additional factors present in cell nuclear 
extracts to achieve high affinity DNA binding. This additional factor has been 
identified as the RXR (Yao et al., 1992, Leid et al., 1992, Zhang et al., 1992b, 
Kliewer eta/., 1992a, and Carlberg et al., 1993). 
The observation that the acyl-CoA oxidase gene could be induced by retinoic acid in 
cultured rat hepatocytes (Yu et al., 1991 and Hertz and Bar-Tana, 1992) and that 
heterodimerisation of RXR occured with other members of the nuclear hormone 
receptor superfamily, indicated a possible coupling between PP ARs and RXR.s. This 
has since ·been demonstrated by a number of groups (Kliewer et al., 1992b, Issemann 
eta!., 1993, Gearing eta!., 1993 and Keller eta!., 1993), who showed that PPAR and 
RXR formed a heterodimer that activated the rat acyl-CoA oxidase PPRE in response 
to either peroxisome proliferators or the RXR ligand, 9-cis retinoic acid; simultaneous 
exposure to both activators resulted in a synergistic induction of gene expression. The 
implications of these results in relation to the possible involvement of PP AR in the 
regulation of the rat and human CYP4A genes will be discussed in more detail in 
Chapter 7. 
1.7 MECHANISMS OF HEPATOCARCINOGENICITY OF 
PEROXISOME PROLIFERA TORS 
Several studies have now unequivocally established the hepatocarcinogenicity of 
peroxisome proliferators in rats and mice (Reddy et a/., 1980). A strong correlation 
exists between the incidence of liver cancer and the effectiveness of the administered 
dose in inducing peroxisomes (Reddy and Lalwani, 1983). However, the basic 
mechanism(s) by which peroxisome proliferators induce tumours in rodents is 
unknown. 
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The development of cancer is generally accepted to be a multistage process. 
Operationally, these stages have been defined as initiation, promotion, progression and 
metastasis (Figure 1. 7). Initiation appears to represent damage to key genes involved 
in the regulation of cell growth. By definition, genotoxic chemicals produce DNA 
damage and therefore are believed to contribute to initiation. The clonal expansion of 
these initiated cells requires cellular hyperplasia and both growth factors and hormones 
could contribute to promotion. Numerous studies have indicated that peroxisome 
proliferators ( or their metabolites) are not mutagenic and do not interact directly with 
nor damage DNA (Butterworth et al., 1984, Glauert et al., 1984, Warren et al., 1980), 
i.e. they are non-genotoxic or epigenetic agents. Since cellular hyperplasia is a 
common feature associated with the action of many non-genotoxic carcinogens then 
these may act as tumour promoters. 
A variety of peroxisome proliferators have given negative results m the Ames 
Salmonella typhimurium reversion assay, DNA repair assays and also the 32p 
postlabelling assay (Gupta eta!., 1985). The findings from such experiments strongly 
suggest that direct DNA damage is not a prerequisite for the carcinogenicity of 
peroxisome proliferators. The observation that many carcinogenic peroxisome 
proliferators were not mutagenic led Reddy et a/. (1980) to postulate that such 
compounds formed a unique class of carcinogens and that there was a causal link 
between peroxisome proliferation and carcinogenicity. Various mechanisms have been 
suggested to explain this phenomenon as described below and as depicted in Figure 
1.8. 
1.7.1 Oxidative Stress Hypothesis 
This hypothesis was proposed (Reddy et a/., 1980) based on the finding that the 
enzyme pattern in induced peroxisomes differed from that of control peroxisomes. 
Certain oxidases, in particular fatty acyl Co A oxidase (the first step of peroxisomal P-
oxidation) are markedly induced whilst catalase activity is generally only slightly 
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Initiation Promotion Progression Metastasis 
DNA damage Hyperplasia Genetic Invasion 
Instability 
___ ......... ｾ＠ ... 
Genotoxic-
chemicals 
Radiation/UV 
Viruses 
Error-prone-
DNA synthesis 
Growth factors 
Hormones 
Non-genotoxic-
chemicals 
Gene amplification 
Loss of 'normal' oncogene allele 
Suppressor gene loss 
Chromosomal rearrangements 
Additional mutations 
Fig 1. 7 Multi-stage carcinogenesis. Listed are some of the factors 
associated with the development of cancer at each of the different stages. 
(Taken from Green, 1991 ). 
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Nodular Hyperplasia, 
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Treatment Dependent Cells 
Peroxisome Proliferator 
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Transformation to Autocrtne ＱＭＭＭＱＱｾ＠
Growth 
Lipid Peroxldatlon 
Figure 1.8 Mechanisms of tumour induction by peroxisome proliferators 
(taken from ECETOC, 1992) 
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increased or even repressed (Reddy and Lalwani, 1983, Hawkins et al., 1987, Lake et 
a/., 1989, Nemali et a/., 1989). Reddy eta!. (1980) postulated that this imbalance 
between hydrogen peroxide production (fatty acyl CoA oxidase) and degradation 
(catalase, glutathione peroxidase) could lead to increased formation of oxygen radicals 
which could eventually lead to oxidative DNA damage. 
This model has gained support from a number of observations. Conway eta!. (1989) 
demonstrated a correlation between the potency of weak (DEHP) and potent (Wy 
14,643) carcinogens and the level of accumulated hepatic lipofuscin used as an 
indicator of oxidative damage. Fahl et a/. (1984) have shown that, in the presence of 
palmitoyl CoA, peroxisomes from ciprofibrate-pretreated animals catalysed the 
formation of single strand breaks in SV-40 DNA in vitro. The authors suggested that 
hydrogen peroxide production formed by the induced peroxisomes was inducing the 
DNA damage. Oxidative damage may also be assessed by the presence of oxidised 
DNA bases, particularly 8-hydrox:ydeox:yguanosine and thymidine glycol (Kasai eta/., 
1986). Kasai et a/. (1989) have investigated the formation of 8-
hydroxydeoxyguanosine in liver DNA during treatment of rats with ciprofibrate for up 
to 40 weeks. A persistent increase in the formation of 8-hydrox:ydeox:yguanosine was 
observed for 16 to 20 weeks. Takagi et a/. ( 1990) showed a small (less than 2-fold, 
but statistically significant) increase in the level of 8-hydroxydeox:yguanosine in rats 
treated with DHEP and DHEA for I and 2 weeks respectively. However, at present, 
too little is known about variations in endogenous 8-hydrox:ydeoxyguanosine levels to 
decide whether a 2-fold increase above the control level is biologically significant. 
1. 7.2 Promotion of Spontaneous Preneoplastic Lesions 
Schulte-Hermann et al. (1981, 1983) have proposed that selective promotion of 
.. spontaneously .. initiated cells may explain the production of tumours following long 
term exposure of rats to non-genotoxic compounds. This was supported by the 
observations that nafenopin will stimulate DNA synthesis preferentially in spontaneous 
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and nitrosamine induced enzyme-altered foci and will also stimulate tumour formation 
in old rats much more rapidly than in young rats (Kraup-Grasl, 1990). 
The increase in size of preneoplastic lesions is a reflection of the difference between 
the rates of cell division and cell death. Tumour promoters, e.g. phenobarbitone, 
inhibit programmed cell death ( apoptosis) in a manner which is at present poorly 
understood (ECETOC, 1992). Cessation of promoter treatment results in a rapid 
increase in the number of apoptotic bodies within the liver and reapplication of the 
promoter during the regression inhibits this process. Peroxisome proliferators have 
also been shown to inhibit apoptosis (Bursch eta/., 1984). Consequently, peroxisome 
proliferators may both stimulate the growth of preneoplastic lesions and inhibit cell 
turnover (apoptosis) in these lesions. 
1. 7.3 Sustained Growth Stimulation 
As discussed above, most peroxisome proliferators will also induce DNA synthesis and 
mitotic activity within the liver with subsequent liver enlargement. The induction of 
DNA synthesis can be reproduced in vitro in primary cultures of adult rat hepatocytes 
and is, therefore, a direct property of the compounds (Bieri et al., 1984, 1990, 
Butterworth eta!., 1987). 
The actual mechanism by which peroxisome proliferators induce cell growth is unclear. 
Thompson et al. (1986) have shown that liver regeneration is controlled by the ordered 
sequential expression of hepatic cellular protooncogenes. Bentley et a/. (1987) also 
showed that upon nafenopin administration, induction of the c-jos and c-myc nuclear 
oncogenes occurred within a few hours of initiation of treatment and continued 
throughout the treatment. These findings suggest that the mechanism which control 
cell growth induced by peroxisome proliferators and normal regenerative cell division 
are the same. 
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Preliminary observations (Ochsner et al., 1990) indicate that one of the earliest events 
after addition of nafenopin to hepatocyte suspensions is an increase in the cytoplasmic 
calcium concentration. Indeed, several recent papers have suggested a role for calcium 
in peroxisome proliferation. The first reports indicated that the dihydropyridine 
calcium antagonists, nicardipine, nifedipine and diltiazem suppress peroxisome 
proliferation and CYP4A induction (Watanabe et al., 1988, 1991, Itoga et al., 1990). 
These authors suggested that peroxisome proliferators increase intracellular calcium 
concentrations by opening plasma membrane calcium channels. Ochsner et al. (1990) 
have shown that nafenopin, clofibrate and ciprofibrate increase intracellular calcium 
concentrations in rat hepatocytes and suggested that this increase was due to release of 
calcium from the endoplasmic reticulum. Bennett et al. ( 1992) have found that 
ciprofibrate inhibited the endoplasmic reticulum Ca2+.ATPase and this resulted in 
impaired sequestration of calcium in microsomes, which could lead to an increase in 
cytoplasmic calcium as the calcium diffuses out of the endoplasmic reticulum. 
There is no doubt that peroxisome proliferators modulate calcium homeostasis; 
however the mechanism by which this occurs and its consequences are not clear. The 
importance of cell signalling in peroxisome proliferation is beginning to become 
apparent. Protein kinase C (Ca2+ -activated, phospholipid-dependent protein kinase) 
has been implicated in tumorigenesis by the observation that this protein represents the 
major cellular receptor for tumour-promoting phorbol esters (Nishizuka, 1984). It has 
been suggested that the carcinogenic effects of many peroxisome proliferators may be 
due to their corresponding Co A thioesters and that the latter (but not the free acids) 
are able to stimulate protein kinase C (possibly by increasing intracellular calcium, 
since protein kinase C activity depends on the presence of calcium), which may result 
in the phosphorylation of regulatory proteins (Bronfinan et al., 1986, 1989). 
However, the significance of this process is not known. 
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1.8 OBJECTIVES OF THE PRESENT INVESTIGATION 
The use of hypolipdaemic drugs and various industrial chemicals which have been 
shown to induce peroxisome proliferation in rodents has caused growing concern with 
respect to the long term exposure of man to these chemicals. This concern is based on 
the large amount of evidence that these compounds constitute a class of hepatic non-
genotoxic carcinogens, in rodents at least. Since only limited biochemical data is 
available for human or primates, it is important to understand the molecular basis of 
peroxisome proliferation and hepatocarcinogenesis in the rodent at the molecular level 
in order to compare and explain the observed species differences. 
The phenomenon of peroxisome proliferation has invariably been associated with 
induction of members of the cytochrome P450 4A subfamily of proteins, a relationship 
which is not well characterised at present. At the start of my PhD I set out to isolate 
the regulatory 5' flanking DNA sequences of members of the rat CYP4A gene 
subfamily by screening a rat genomic library using the 2.1kb full length eDNA 
encoding rat CYP4Al (Earnshaw et a/., 1988), the only published member of the 
CYP4A family at that time. During the characterisation of the genomic clones I had 
isolated, Kimura eta!., (1989a and b) published the genomic sequences of CYP4Al, 
CYP4A2 and the eDNA for CYP4A3. It was therefore possible to compare my DNA 
sequences with those published, to search for familiar regulatory sequences, and, using 
functional in vitro assays to investigate the possible role of the recently identified 
PP AR in the regulation of those members of the rat CYP4A genes I had isolated and 
also that of the recently isolated human CYP4All gene (Hood eta/., 1992). 
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2.1 MATERIALS 
2.1.1 Chemicals 
CHAPTER2 
MATERIALS AND METHODS 
All chemicals purchased were of the highest purity available and unless otherwise 
stated were supplied by BDH Chemicals Ltd 
Bacto-Agar : Difco Laboratories. 
N,N,N',N'-tetramethylethylenediamine (Temed), T4 DNA ligase, agarose, low melting 
point (LMP) agarose, 5-Bromo-4-chloro-3-indolyl-(3-D-galactosidase (X-gal), urea 
and all mammalian cell culture media: Gibco BRL. 
2% N,N'Methylene bisacrylamide solution and 30% acrylamide solution: National 
Diagnostics. 
Bacto-tryptone and yeast extract: Oxoid Ltd. 
Citric acid (trisodium salt), sodium chloride, EDTA, ethidium bromide, bromophenol 
blue, xylene cyanol, spermidine trihydrochloride, activated charcoal, acetyl co-enzyme 
A, ｯＭｮｩｴｲｯｰｨ･ｮｯｬＭｾＭｄＭｧ｡ｬ｡｣ｴｯｳｩ､｡ｳ･Ｌ＠ polyvinylpyrolidone, lysozyme, ampicillin, 
DMSO (ACS reagent), bovine serum albumin (BSA) fraction V and ｩｳｯｰｲｯｰｹｬＭｾＭｄﾭ
thiogalactosidase (IPTG): Sigma Chemical Company. 
Calf intestinal alkaline phosphatase (ClAP), Klenow fragment of DNA polymerase, 
T4 polynucleotide kinase, deoxynucleotide triphosphates and Taq polymerase: 
Prom ega. 
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DMSO (Analar reagent): Fisons. 
Ficoll 400 and dextran T70: Pharmacia. 
Proteinase K, DNase I and RNase A: Boehringer Mannheim. 
The sources for other materials and kits are given in the text. 
2.1.2 Radiochemicals 
i) Deoxycytidine 5'-[a32p] triphosphate, triethylammonium salt. Specific activity 
approximately 3,000Ci/mmol. lOmCi/ml. (JCN Flow). 
ii) Deoxyadenosine 5'-[a35s] thiotriphosphate, triethylammonium salt. Specific 
activity I ,200Cilmmol. (Amersham ). 
iii) Adenosine 5'-[y32p] triphosphate, triethylammonium salt. Specific activity 
approximately 5,000Ci/mmol. (Amersham). 
iv) [I4c] Chloramphenicol in 0.25M, pH 7.5 tris.HCI buffer. Specific activity 50-
60mCilmmol. (Amersham) . 
2.1.3 Mammalian cells, Bacteria, Bacteriophage and Plasmids 
' 
i) Mammalian cell lines 
Hepa 1 c 1 c7: Mouse hepatoma cell line, obtained from Stephen Green, ICI. 
ii) Bacterial strains, Bacteriophage and Plasm ids 
The E. coli strains used in this work are listed in Table 2.1 along with their genotype 
and use. The source of bacteriophage libraries and plasmid vectors are given in the 
text. Figures 2.1, 2.2 and 2.3 show the bacteriophage vector A.Ch4A and the plasmid 
vectors pGEM7Zf(+) and pG.CAT respectively. 
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Figure 2.1 Charon 4A bacteriophage vector (taken from Sambrook eta!., 
1989, Molecular Cloning, a Laboratory Manual, second edition). 
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T7 ! 
1 start 
Apal 14 
Aat II 20 
Sphl 26 
Xbal 31 
Xhol 37 
pGEM®-7Zf(+) EcoR I 43 Kpnl 53 
plasmid Smal 56 
(3000bp) Csp45 I 61 Cia I 67 
Hind Ill 72 
BamH I 78 
Sac I 91 
BstX I 100 
Nsi I 109 
T SP6 123 
Figure 2.2 pGEM7Zf(+) vector circle map (taken from Promega 
protocols and applications guide, 1991, second edition). 
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pEMBL8+ 
Bam HI 
pG.CAT 
ｾＵＮＵｫ｢＠
Eco Rl Smal 
Bg/11 
CAT 
SV40 3' 
Figure 2.3 pG.CAT vector circle map. G represents the rabbit 
pglobin promoter, CAT represents the coding sequence for chloramphenicol 
acetyl transferase, SV40 3' represents the SV40 slplice acceptor site and 
polyadenylation signals and pEMBLB+ represents the plasmid vector 
backbone (lssemann and Green, 1990). 
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2.2 GENERAL NUCLEIC ACID PROCEDURES 
For all nucleic acid procedures, solutions, glassware and plasticware were sterilised 
for 20min at 120°C in a Rodwell series 32, automatic autoclave to destroy nucleases. 
2.2.1 Extraction of Solutions of Nucleic Acid with Phenol-chloroform 
Phenol was redistilled prior to use to remove impurities. Phenol-chloroform was 
prepared as a 1:1 (v:v) mixture, saturated with TE (lOmM Tris.HCl pH 8.0, lmM 
EDT A). An equal volume of phenol-chloroform was added to the aqueous solution 
containing nucleic acid and emulsified by mixing. The aqueous and organic phases 
were separated by centrifugation at 2,500g (lOmin) and the aqueous phase was 
transferred to a fresh tube. The extraction procedure was repeated until the interface 
between the phases became clear. A final extraction was performed using an equal 
volume of chloroform to remove residual phenol. 
2.2.2 Ethanol Precipitation of Nucleic Acid 
Nucleic acids were precipitated from aqueous solution using one of the following 
methods: 
Method A: Addition ofO.l volume of 3M sodium acetate pH 5.2 followed by 2.5-3.0 
volumes of 100% ethanol. 
Method B: Addition of0.5 volume of7.5M ammonium acetate followed by 2.5-3.0 
volumes of 100% ethanol. 
After the addition of ethanol the solutions were mixed and were placed at -70°C for 
15min or -20°C for 30min or longer. The precipitated nucleic acids were pelleted by 
centrifugation at 12,000g (4°C, 15min) and then washed in 70% (v/v) ethanol and 
dried under vacuum (Univap centrifugal evaporator, Uniscience Ltd.) prior to 
resuspension in an appropriate volume of water or TE. 
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2.2.3 Quantitation of Nucleic Acids in Aqueous Solution 
The concentration and purity of nucleic acids in aqueous solution was estimated by 
measuring the UV absorbance of the solution over the wavelength range of 220-
300nm. Pure solutions of DNA and RNA have an absorbance peak at 260nm, and a 
260nm/280nm ratio of 2.0 and 1.8 respectively (Sambrook et al., 1989). The 
concentration of nucleic acid was calculated using an absorbance value of 1 at 260nm 
to be equivalent to SOJ..Lg/ml for double stranded DNA and 40J..Lg/ml for single 
stranded nucleic acid. When estimating the concentration of oligonucleotides 
synthesised in the Applied Biosystems DNA synthesiser (section 2. 7.6), a value of 33 
jlg/ml per absorbance unit was used to calculate DNA concentration as recommended 
by the manufacturers. Before the UV absorbance for the nucleic acids was 
determined the spectrophotometer was automatically set to zero with the use of an 
appropriate blank, namely TE buffer. 
2.2.4 Agarose Gel Electrophoresis of DNA 
The standard protocol as described by Maniatis et al., (1982) was used routinely. 
Gels were electrophoresed at 150mA for a time which depended on the gel 
dimensions and the agarose concentration at room temperature. Preparative I. 0% 
(w/v) low melting point (LMP) agarose gels were run in the cold room at 100mA. 
Gels were cast and run in lx TAE (40mM Tris.acetate, lm.M EDTA pH 8.0) with 
samples loaded in lx loading buffer (0.25% (w/v) bromophenol blue, 0.25% (w/v) 
xylene cyanol in 40% (w/v) sucrose). After electrophoresis, gels were stained with 
ethidium bromide (O.SJ..Lg/ml) for 20-30min, destained in water for 10min and the 
nucleic acid bands visualised by UV-irradiation (Sharp et al., 1973). 300nm 
irradiation absorbed by the bound dye is re-emitted at 590nm in the red/orange region 
of the visible spectrum. 
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2.2.5 Photography and Autoradiography 
A permanent record of ethidium bromide stained gels was made by photographing the 
UV -irradiated gel with a polaroid land speed MP-4 camera and type 665 
positive/negative film. The film was exposed for approximately 14 sec with an 
aperture off4.5 and an orange filter. 
Autoradiography was used to visualise radioactive molecules hybridised to nylon 
filters, present in gels and attached to thin layer chromatography (TLC) plates. For all 
procedures Kodak X-Omat ARS high speed film was used. For Southern blots where 
32p was the incorporated radionucleotide, filters were wrapped in Saran wrap and 
placed in cassettes containing Cronex lightening plus intensifying screens. The films 
were exposed at -70°C and developed automatically in a Fuji RGII Medical Film 
Processor. The RG developer and RG fixer were purchased from Wardray products 
Ltd. For 35s sequencing gels and TLC plates containing 14c no intensifying screen 
was used and the film exposed overnight at room temperature. 
2.2.6 Purification of DNA Fragments from Agarose Gels 
Agarose gel electrophoresis was performed on restriction enzyme digested DNA and 
the gel stained with ethidium bromide as described in section 2.2.4. The fragment(s) 
of interest were recovered from the gels by one of two methods depending on the 
intended use of the DNA. DNA to be used as a radiolabelled probe was purified 
using the Geneclean ™ II (Stratech Scientific) method, whereas DNA to be used in 
ligations was purified by cold phenol extraction. 
2.2.6.1 Geneclean ™Purification 
The method is based on that of Vogelstein and Gillespie (1979}. The DNA sample 
was electrophoresed through T AE agarose gels as previously described and a gel slice 
containing the required DNA fragment was excised from the gel and weighed. 
Sodium iodide (2-3 volumes) was added and then incubated at 55°C until the agarose 
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gel slice had melted. "Glassmilk" suspension was then added to the DNA solution (5 
J..Ll per 5J..Lg DNA), mixed thoroughly and incubated on ice for 5 minutes to allow 
binding of the DNA to the silica matrix. The silica matrix was pelleted by 
centrifugation (1 OOOOg, 5 seconds) and the sodium iodide supernatant discarded. The 
pellet was washed by resuspension in 400fll ice cold "NEW" buffer and the silica 
matrix sedimented by centrifugation (10000g, 5 seconds). The supernatant was 
discarded and the washing procedure repeated twice more before resuspending the 
pellet in 5-lOJ..Ll ofTE buffer. The suspension was incubated at 55°C for 3-4 minutes 
and pelleted by centrifugation (lOOOOg, 10 seconds). The supernatant containing the 
DNA was recovered. The recovered DNA was stored at -20°C. 
2.2.6.2 Cold Phenol Extraction 
DNJ\ was electrophoresed as described in section 2.2.4 in low melting point (Ll\AP) 
agarose, after which the gel was stained with ethidium bromide and the DNA bands of 
interest excised under UV light. The agarose was placed in a preweighed Falcon 
tube, its weight determined and an equal volume of water was added. The gel was 
melted at 90°C in the minimum amount of time and allowed to cool to 3 7°C. The 
DNA was extracted by the addition of ice cold phenol and phases separated as 
described in section 2.2 1. Extraction was repeated 2-3 times before ethanol 
precipitation of the DNA (section 2.2.2 method A). The volume was reduced to 
approximately 1 OOJ..ll by butan-2-ol extraction as described by Maniatis et al., (1982). 
2.2. 7 In Vitro Enzyme Reactions 
2.2.7.1 Restriction Enzyme Digestion of DNA 
Restriction enzymes were obtained from BRL and NBL and digests performed 
according to the manufacturer's instructions. Small scale analysis was performed using 
approximately 1 J..lg of DNA and 1-5 units of enzyme in a volume of 1 0-20fll. When 
analysing small DNA fragments, RNase A (0.1 mglml) was included in the digestion 
buffer. 
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2.2.7.2 Dephosphorylation of DNA 5' Ends 
Dephosphorylation of vector DNA was performed using calf intestinal alkaline 
phosphatase (ClAP) and was performed after vector DNA had been digested with a 
single restriction enzyme. The reaction was carried out at 3 7°C for 60min in the 
presence of lx ClAP buffer (50mM Tris-HCI, pH 9.0, lmM MgCl2, O.lmM ZnCI2, 
1 mM spermidine) and with the addition of 1 Unit of enzyme per nmol of 5' ends. The 
reaction was stopped with the addition ofEDTA (lmM final concentration) and the 
ClAP extracted using phenoVchloroform (section 2.2.1). The dephosphorylated 
vector was then recovered by ethanol precipitation (section 2.2.2, method B). 
2.2.7.3 Filling 3' Recessed Ends of Double Stranded DNA 
The 3' ｲｾ｣･ｳｳ･､＠ ends of restriction enzyme digested DNA were filled in using Klenow 
fragment of DNA polymerase. The DNA was incubated at room temperature for 
45min with 2mM dNTPs and 6U of enzyme in lx Klenow buffer (40mM Tris-HCI, 
pH 7.2, lOmM MgS04, O.lmM DTT). The DNA was then purified by 
phenoVchloroform extraction (section 2.2.1) followed by ethanol precipitation 
(section 2.2.2, method A). 
2.2. 7.4 Phosphorylation of DNA 
The following reaction was set up in a total volume of 40J.1l:-
dephosphorylated DNA 
4J.ll kinase buffer, 1 Ox (700mM Tris-HCI, pH 7.6, lOOmM MgCI2, SOmM DTT) 
2J.1l ATP (2mM) 
lJ.ll T4 polynucleotide kinase (IOU) 
The reaction was incubated at 3 7°C for 60min and then stopped by the addition of 
0.5M EDTA (2J.ll). The DNA was extracted with phenoVchloroform (section 2.2.1} 
and precipitated with ethanol (section 2.2.2, method A). 
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2.3 PROCEDURES WITH BACTERIOPHAGE RECOMBINANTS 
There are two distinct life cycles in the growth of lambda phage, lytic and lysogenic. 
Briefly, lysogenic growth is established when A repressor (CI gene product) binds the 
operators (OLand OR) which control the two early promoters PL and PR and the 
phage DNA is inserted into the host genome. In the absence of this repression the 
phage enters the lytic cycle in which it reproduces until approximately 100 progeny 
are formed and the host cell is lysed. A phage vectors used in recombinant DNA 
procedures are defective in lysogeny and can only perform the lytic cycle. 
2.3.1 Preparation of Host Cells 
An individual colony of a freshly grown host was picked from an LB agar plate ( 1 Og 
tryptone, Sg NaCl, Sg yeast extract and 15g bacto agar per litre of H20, pH 7.0) and 
used to inoculate 50ml LB media (1 Og tryptone, 5gNaCI, 5g yeast extract per litre of 
H20, pH 7.0, supplemented with 0.2% (w/v) maltose and lOmM MgS04). The 
culture was grown overnight and the cells collected by centrifugation (3000g, 4°C, 
IOmin). The cells were resuspended in lOmM MgS04 (approximately 15ml) to an 
optical density (OD) at 600nrn of0.5 and placed on ice. 
2.3.2 Titration of Lambda Phage (Libraries and Recombinants) 
Phage was titred by making serial dilutions in SM buffer (O.IM NaCI, O.lM 
MgS04.1H20, O.OSM Tris.HCl pH 7.5, 0.01% (v/v) gelatin). lOml of each dilution 
was incubated for 15-30min at 37°C with 200f.d of phage plating cells (section 2.3.1) 
and plated on prewarmed (37°C) LB-agar plates (petri dish, 90mm diameter) by 
adding 4ml of top agarose (7g/L agarose in LB media, kept at 47°C) containing 
1 OmM MgS04. The plates were allowed to harden at room temperature for 1 Omin 
and then incubated, inverted, at 3 7°C overnight. The titre was calculated by counting 
the plaques and expressed as plaque forming units per ml (pfu/ml) of the undiluted 
phage suspension. 
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2.3.3 Plating Out of The Recombinant Library 
The library was plated on LB-agar plates (20cm x 20cm) using the appropriate 
number of phage to give 200,000 plaques per plate. The procedure was essentially a 
large scale method (xlO) of that used to titrate the library (section 2.3.2). In total 
1 x 1 o6 recombinant phage were screened per experiment. 
2.3.4 Plaque Lifts 
Plates were incubated at 4°C for 2hr, to harden the agarose top layer, before replica 
filters of plaques were obtained by direct contact with the plate surface. The first 
nylon filter (Hybond-NTM, Amersham) was placed in contact with the plate for 2min 
and its position marked by making pin-holes into the agarose with a syringe dipped in 
bromophenol blue solution. The filter was carefully removed, inverted, and the 
attached phage lysed by placing on a pad of Whatman 3M:M: filter paper soaked in 
O.lM NaOH for lmin. The released phage DNA was denatured by transferring the 
filter to a fresh pad soaked in l.SM NaCl for lmin. Filters were neutralised by 
treatment with 0.2M Tris.HCI for Smin and 2x SSPE (17.5g NaCl, 2.7g 
NaH2P04.H20, 0. 7g EDT A per litre of H20 pH 7.4) for Smin as before. The filters 
were blotted dry and the DNA fixed by UV crosslinking for 3min. The second filter 
was treated in the same way except it was left in contact with the agar plate for Smin. 
2.3.5 Plaque Purification 
Positive plaques were identified following hybridisation of the replica filters (section 
2.6.2) and excised from the plate by removing a plug of agar in the region of the 
positive signal using the wide end of a sterile pasteur pipette. The plug was placed in 
1 ml of SM buffer containing 1 drop of chloroform and left overnight at 4 °C to enable 
the phage to diffuse from the agar. The phage from this stock was then replated at 
lower density, rescreened, and positive plaques picked. Further purification was 
achieved by repeated rounds of replating and rescreening until individual positive 
plaques could be picked. 
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2.3.6 Isolation of Recombinant Phage DNA 
Recombinant phage DNA was prepared in bulk using a method adapted from that of 
Kaslow, (1986). A cleared lysate of phage was prepared by mixing 10ml of an 
overnight culture of the appropriate strain of E. coli (section 2.1. 3) with 1 OOJ.I.l of high 
(108 pfu/ml) titre phage at 37°C for lOmin. This was added to 450ml of LB 
(containing lOmM MgS04) and the culture was incubated with shaking at 42°C for 
4-7hr (until lysis had occurred). A few drops of chloroform were added to kill any 
remaining bacteria and the culture was cooled on ice for Smin. Debris was removed 
by centrifugation at lO,OOOg for lOmin. DNase I was added to the supernatant, to a 
final concentration of lOJlg/ml and incubated at 37°C for 30min, to degrade bacterial 
chromosomal DNA. 150ml of 1.5% (w/v) SDS, 0.3M Tris.HCl pH 9.0, 0.15M EDTA 
was then added and the mixture heated to 70°C to dissociate the phage particles and 
inactivate the DNase I. E.coli debris and phage proteins, E.coli DNA fragments, 
and SDS were precipitated from this mixture after addition of 11 Oml of 8M potassium 
acetate and incubation on ice (15-JOmin). The precipitate was removed by 
centrifugation at 6000g for 15rnin at 4 °C, and phage DNA precipitated from the 
supernatant by addition of a 0.6 volume of isopropanol. After standing for 15min at 
room temperature the DNA was pelleted by centrifugation at 13,800g for 20min, and 
then resuspended in 1-2ml of sterile water. RNase A was added to a concentration of 
SOJ.lg/ml, and the mixture was incubated at 37°C for 30min to degrade any residual 
bacterial RNA. This was followed by incubation with Proteinase K (200Jlg/ml) under 
the same conditions as above. Phenol extraction was then performed from the 
aqueous phase (section 2.2.1) and the DNA precipitated with ethanol (section 2.2.2, 
method A). The final DNA pellet was resusupended in 200Jll of water and its 
concentration determined (section 2.2.3). 
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2.4 SUBCLONING INTO PLASMID VECTORS 
2.4.1 Small Scale Plasmid DNA Preparation 
A simple extraction of plasmid DNA from bacterial cells was used in a rapid 
procedure to screen recombinant subclones. The protocol applied was based on the 
original procedure of Holmes and Quigley (1981). 1.4ml of a IOml overnight culture 
grown in LB/ AMP (LB medium containing 150Jlg/ml ampicillin) was 
microcentrifuged at I 0, OOOg for 15-30sec. The supernatant was discarded and the 
cell pellet resuspended in lOOJ.!l of STET (O.lM sucrose, lOmM Tris.HCl pH 8.0, 
lmM EDTA pH 8.0, 5% (v/v) Triton X-100). IOJ.!l of freshly prepared lysozyme 
solution (I Omglml) was added to this and the tube left on ice for 1 Omin. The tube was 
then boiled (90sec) and centrifuged at 1 OOOOg for IS min at 4 °C in a microfuge. The 
supernatant (50-I OOJJ.l) was carefully removed and the plasmid DNA purified using 
Geneclean (section 2.2.6.1 ). (Geneclean was preferred over phenol in this case since 
the DNA was obtained free of contaminating RNA and salt). 
2.4.2 Large Scale Plasmid DNA Preparation 
2.4.2.1 Ethidium Bromide/Cesium Chloride Density Gradient DNA Purification 
This method was adapted from that reported by Maniatis eta/., (1982). 500ml of the 
appropriate medium plus antibiotic was inoculated with lml of a fresh overnight 
culture of the cells containing the plasmid required. The culture was incubated, 
shaking overnight at 3 7°C and the cells harvested by centrifugation for 1 Omin at 
2,500g at 4°C for 30min. The supernatant was discarded and the cells resuspended in 
17ml of Tris-sucrose solution (25% (w/v) sucrose in O.OSM Tris.HCI, pH 8.0). The 
suspension was transferred to two 50ml centrifuge tubes and 1.3ml of freshly 
prepared lysozyme solution (20mglml in 0.25M EDTA, pH 8.0) was added to each. 
The tubes were kept on ice and the solution swirled intermittently for 5min, followed 
by the addition of8.6ml of0.25M EDTA (pH 8.0) to each and a further 5min swirling 
on tee. 13ml of Brij/Doc solution (1% (w/v) Brij 58, 0.4% (w/v) sodium 
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deoxycholate in TE buffer (10mM Tris.HCI, lmM EDTA), pH 8.0) was added 
rapidly and mixed. After a further 30min of incubation on ice, the cell debris and 
most of the chromosomal DNA was pelleted by centrifugation for 45min, 12,500g, 
4°C. The supernatant was decanted, taking care not to disturb the pellet, and 0.2ml 
of20mg/ml ethidium bromide added. Cesium chloride was added to 0.95g/ml and the 
concentration confirmed by measurement of the refractive index (1.38-1.39). The 
solution was transferred to Beckman polyallomer quickseal tubes, balanced to within 
0.05g and sealed. The tubes were centrifuged for 60hr at 40,000rpm, at l8°C (60Ti 
rotor for 35ml tubes, 70Ti rotor for 14ml tubes, Beckman L7-65 Ultracentrifuge). 
The upper plasmid band was extracted by side puncture and the ethidium bromide 
removed by extraction with equal volumes of cesium chloride saturated isopropanol 
(1: 1 mixture of isopropanol and 0.95g/ml cesium chloride in TE buffer) until the top 
layer remained clear. The DNA was then precipitated by the addition of0.25 volume 
of3M sodium acetate, 1.25 volume of distilled water and 2.5 volumes ofisopropanol. 
This mixture was left at room temperature for 30min and the DNA pelleted by 
centrifugation at 12,500g for 15min, at 4°C. The pellet was dried under vacuum, 
resuspended in 300ml of distilled water, and the concentration determined 
spectrophotometrically (section 2.2.3). 
2.4.2.2 Qiagen Column DNA Purification 
Plasmid DNA was prepared in bulk using a QiagenTM plasmid kit (Hybaid Ltd.). A 
150ml bacterial culture was routinely grown in LB media (containing SOJ.Lg/ml 
ampicillin) overnight at 37°C. The cells were harvested at 4000g and the bacterial 
pellet was resuspended in 4ml of buffer PI (IOOJ.Lg/ml RNase A, 50mM Tris-HCI, 
lOmM EDTA, pH 8.0). To this 4ml of buffer P2 (200mM NaOH, 1% (w/v) SDS) 
was added, mixed gently, and incubated at room temperature for Smin, after which 
time 4ml of buffer P3 (2.55M potassium acetate, pH 4.8) was added, mixed and 
centrifuged at 15000g, 4°C, for 30min. The supernatant was removed promptly and 
centrifuged again at 15000g, 4 °C, for 1 Omin to obtain a particle-free clear lysate. A 
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Qiagen-tip 100 (an anion-exchange silica gel column) was equilibrated with 3ml of 
buffer QBT (750mM NaCl, 50mM MOPS, 15% (v/v) ethanol, pH 7.0, 0.15% (v/v) 
Triton X-1 00) and allowed to empty by gravity flow. The particle-free clear lysate 
was then applied to the column and allowed to enter by gravity flow. The column was 
then washed with 10ml of buffer QC (l.OM NaCl, 50mM MOPS, 15% (v/v) ethanol, 
pH 7.0) and the DNA eluted with 5ml of buffer QF (1.25M NaCI, SOmM MOPS, 
15% (v/v) ethanol, pH 8.2). The DNA was precipitated with 0.7 volumes of 
isopropanol, previously equilibrated to room temperature, allowed to stand at room 
temperature for 30min and then centrifuged at 12,000g for 30min. The DNA pellet 
was washed with 70% (v/v) ethanol, dried, and resuspended in 100fJ.l of sterile water. 
2.4.2.3 pZ523 Column DNA Purification 
A 500ml bacterial culture was routinely grown in LB media (containing 50fJ.g/ml 
ampicillin) overnight at 37°C. The cells were harvested at 4,000g, 4°C, and the 
bacterial pellet resuspended in lOml of solution A (50mM glucose, 25mM Tris.HCl, 
pH 8.0, lmM EDTA, pH 8.0, l.OM NaCl) containing 5mg/ml lysozyme. The 
solution was incubated at room temperature for 15min. After this time, 20ml of 
solution B (0.2N NaOH, 1% (w/v) SDS) was added, mixed gently, incubated on ice 
for lOmin and then 15ml of ice-cold solution C (3.5M potassium acetate, pH 4.8) 
added. This was mixed and incubated on ice for a further I Omin and then centrifuged 
at 16,000g for 60min at 4°C. The supernatant was recovered and 0.6 volumes of 
isopropanol added. The solution was mixed gently by inversion, incubated for 3 Omin 
at room temperature, and centrifuged at 16,000g for 30min at 20°C. The pellet was 
washed with 20ml of cold 70o/o (v/v) ethanol, centrifuged at 16,000g for 5min, and 
then briefly air dried. The pellet was then resuspended in 5ml of TE buffer, pH 8.0 
and incubated with DNase-free RNase A (1 OfJ.g/ml final concentration) for 60min at 
3 7°C. The DNA was extracted from the solution using an equal volume of 
phenoVchloroform (section 2.2.1 ). The aqueous phase was recovered and the DNA 
precipitated by the addition of I OM ammonium acetate to a final concentartion of 
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2.0M and 0.6 volume of isopropanol. The solution was mixed and incubated for 
30min at room temperature and the DNA collected by centrifugation at 16,000g, 
30min at 20°C. The pellet was washed with 70% (v/v) ethanol, briefly air-dried and 
then resuspended in 1.8ml of buffer D (lOmM Tris.HCI, lmM EDT A, l.OM NaCl, 
pH 8.0). The sample was loaded onto a pZ523 column (NBL Ltd) that had been 
previously centrifuged for I min at 11 OOg in a swinging bucket rotor. The column 
was centrifuged for 12min at 11 OOg in a swinging bucket rotor and the eftluent 
collected. 0.6 volume of isopropanol was added to the plasmid eflluent, mixed and 
incubated at room temperature for 30min. The plasmid DNA was collected by 
centrifugation at 12,000g for 30min at 20°C and the pellet washed in 70% (v/v) 
ethanol. The pellet was then briefly air-dried, resuspended in 1 OOJ!l of distilled water 
and the DNA concentration determined spectrophotometrically (section 2.2.3). 
2.4.2.4 NACS Column DNA Purification 
1 Oml of a bacterial culture was grown overnight in LB media (containing 50J.1g/ml) at 
3 7°C with constant shaking. The cells were harvested by centrifugation at 9,000g for 
15min and the bacterial pellet resuspended in O.lml of 25mM Tris.HCl (pH 8.0), 
SOmM Na2 EDT A, 1% (w/v) glucose. 0.2ml of 0.2M NaOH, 1% (w/v) SDS was 
added, mixed gently and incubated for lOmin at 4°C. 0.15ml of cold (4°C) SM 
potassium acetate, pH 4. 8, was added, mixed gently and then incubated for 5min at 
4°C. The bacterial debris was removed by centrifugation at 12,500g for 30min and 
the supernatant collected. 2 volumes of cold (-20°C) 95% (v/v) ethanol was added, 
incubated for 20min at 4 °C and centrifuged at 12,500g for 15min. The pellet was 
resuspended in 0.2ml ofTE buffer, O.lml cold (4°C) 7.5M ammonium acetate added 
and incubated for 20min at 4°C. The solution was then centrifuged at 12,500g for 
15min and the supernatant recovered to a fresh tube. 0.6ml of cold (-20°C) 95% 
(v/v) ethanol was added to the supernatant, incubated at 4°C for 20min, centrifuged 
at 12,500g for 15min and the resulting pellet was briefly air-dried. The pellet was 
resuspended in 0.4ml 0.05M NaCl in TE buffer. 20 units ofRNAse Tt was added to 
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the solution and incubated at 37°C for 15min. 0.12ml of 2M NaCI in TE buffer was 
added, and this was loaded onto a PREP AC NACS column (BRL Ltd) previously 
equilibriated in 0.5M NaCl in TE buffer. The bound plasmid DNA was washed with 
lOml of 0.5M NaCl in TE buffer to remove small RNA molecules, any remaining 
proteins and other contaminating molecules. The bound plasmid DNA was eluted 
twice with 0.25ml of 0.7M NaCl in TE buffer, and the DNA precipitated by the 
addition of l.Oml cold (-20°C) 95% (v/v) ethanol and incubated at -70°C for IOmin. 
The DNA was collected by centrifugation at 12,500g for 15min and the pellet briefly 
air-dried. The pellet was resuspended in 25Jll of TE buffer and the DNA 
concentration determined spectrophotometrically (section 2.2.3). 
2.4.3 Subcloning of DNA Fragments 
The plasmid cloning vector ｰｇｅｍＷｚｾＫＩ＠ (figure 2.2) was chosen for subcloning 
because it contains a large number of restriction enzyme sites in the multiple cloning 
site and transformants are selectable by ampicillin resistance. An additional advantage 
is that the cloning site is situated within the plasmid ｾＭｧ｡ｬ｡｣ｴｯｳｩ､｡ｳ･＠ gene. Thus ｾＭｧ｡ｬﾭ
E. coli transformed with native plasmid give blue, ｾＭｧ｡ｴＫＬ＠ colonies on X-gal plates, 
whereas recombinant plasmids give white, ｾＭｧ｡ｴﾷＬ＠ colonies. In addition sequencing 
can be performed directly in pOEM from both ends of the DNA insert, as the SP6 and 
T7 primer-binding regions are present at either side of the multiple cloning site. 
2.4.3.1 Isolation of DNA inserts 
To subclone phage DNA inserts the recombinant bacteriophage were cut with the 
appropriate restriction enzymes (see section 2.2.7.1). This released rat DNA 
fragments of various size and the two arms of the bacteriophage. The mixture was 
separated on a I% (w/v) low melting point gel, and the rat DNA fragments recovered 
by phenol/chloroform extraction as described in section 2.2. I. 
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2.4.3.2 Preparation of the Plasmid Vector 
DNA from the plasmid vector pGEM7Zf{ +) was prepared as described in section 
2.4.2. SJlg of the DNA was routinely digested with an appropriate restriction 
enzyme to linearise. This was confirmed by electrophoresis of a 1 OOng sample on a 
1% agarose gel. The 5' ends of the plasmid DNA were then dephosphorylated with 
calf intestinal alkaline phosphatase as described in section 2.2. 7.2. 
2.4.3.3 Ligation of Rat DNA into Plasmid Vectors 
DNA ligations were performed using T4 DNA ligase according to the manufacturer's 
instructions. Generally, ligations were carried out using 1 OOng of a dephosphorylated 
vector and an insert:vector molar ends ratio of 1: 1 and 3: 1. Cohesive end ligations 
were incubated at l6°C and blunt end ligations at 1 0°C overnight. Ligation products 
were either diluted or used directly to transform competent cells. 
2.4.4 Transformation of Host Bacteria with Recombinant Plasmids 
2.4.4.1 Preparation of Competent Cells 
Sml of an overnight culture of bacteria was diluted 1: 100 in prewarmed LB media and 
grown with vigourous shaking at 3 7°C until the optical density of the culture at 
600nm reached 0.45-0.55. The cells were cooled on ice water for 2 hours prior to 
centrifugation (2500g, 4°C, 20min) in a precooled rotor. The cells were resuspended 
in 20ml of ice-cold tituration buffer (1 OOmM CaCl2, 70mM MgCl2, 40rnM sodium 
acetate, pH 5.5, filter sterilised) and then diluted to 500ml with the same solution. 
The cells were incubated on ice for 45rnin, collected by centrifugation (1800g, 10min, 
4 °C) and gently resuspended in 50ml of ice-cold tituration buffer. To this suspension 
80% glycerol was added dropwise with gentle swirling to give a final concentration of 
15% (v/v) glycerol. The cell suspension was divided into lrnl portions, frozen on dry 
ice, and stored at -70°C. 
72 
2.4.4.2 Transformation of Competent Cells 
Plasmid DNA (10-20ng) in lOf.d of water was added to 0.2ml of thawed competent 
cells in the presence of31J.l ofDMSO and incubated on ice for 30min. The cells were 
then heat shocked at 42°C for 90 seconds and then returned to ice for lmin. 2ml of 
LB medium was added and the cells were shaken at 3 7°C for 60min before dilutions 
of the transformation mix were spread on LB agar plates containing ampicillin (1 OOIJ. 
g/ml). When the blue/white screening was used, IPTG (O.SmM) and X-gal (40J.Lg/ml) 
were also included in the agar. The plates were incubated at 37°C overnight. 
2.4.4.3 Selection of Transformed Cells 
Blue/White Colour Screening: The plasmid pGEM7ZF{ +) contains a sequence coding 
for the a-peptide of ｾＭｧ｡ｬ｡｣ｴｯｳｩ､｡ｳ･Ｌ＠ interrupted by a multiple cloning site. Non-
recombinant plasmids produce a functional ex-peptide which complements the 
defective product of the host cell lacZLlM15 gene and results in the appearance of 
functional J3-galactosidase activity. Bacterial colonies harbouring the lacZAM15 gene 
on an F' episome and also containing the plasmid pGEM7ZF( +) produce a blue colour 
when plated on indicator media containing IPTG and X-gal. However, when the lac 
a-peptide is disrupted by cloning of a DNA fragment into the pGEM7ZF(+) multiple 
cloning region complementation does not occur and no J3-galactosidase activity is 
produced. Therefore bacterial colonies harbouring recombinant pGEM7Z vector 
constructs are white on IPTG and X-gal plates. 
Ampici11in Selection: Detection of bacteria transformed by plasmids which did not 
contain the J3-galactosidase gene was performed by selection on ampicillin plates. To 
screen ampicillin resistant colonies for those containing recombinants, it was 
necessary to estimate the size of the plasmid DNA using the rapid cracking 
procedure. 
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Cracking Procedure: Individual bacterial colonies were picked from plates using 
sterile toothpicks and smeared near the bottom of a microfuge tube containing 50J.1l of 
lOmM EDTA, pH 8.0. 50J.1l of freshly prepared 2x cracking buffer (200mM NaOH, 
0.5% (w/v) SDS, 200g/l sucrose) was added and the cells resuspended by vortexing. 
The sample was incubated at 70°C for Smin, allowed to cool to room temperature 
and then l.5Jll of 4M KCl and 0.5Jll of0.4% (w/v) bromophenol blue were added and 
mixed. The sample was placed on ice for 5min, microfuged for 3min at 4°C and 30J.1.l 
of the supernatant was run on a 0.7% agarose gel alongside a sample of the 
supercoiled plasmid used as a marker. Recombinant plasmid DNA migrated more 
slowly in the gel and could be readily identified. 
2.5 STORAGE OF RECOMBINANT BACTERIOPHAGE AND 
TRANSFORMED BACTERIA 
2.5.1 Storage of Bacteriophage 
A single plaque was picked from an LB agar plate into sterile SM buffer using a 
sterile glass pasteur pipette. Phage were stored, over chloroform, at 4 °C. 
2.5.2 Preparation of Bacterial Stocks 
Bacterial cultures were maintained on LB-agar plates, with antibiotics if ｾｰｰｲｯｰｲｩ｡ｴ･Ｌ＠
and restreaked every 6 to 8 weeks. For long term storage, bacteria were frozen at 
-70°C in LB-broth containing 15% (v/v) glycerol. 
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2.6 HYBRIDISATION PROTOCOLS 
All hybridisation experiments were performed using Hybond-N™ nylon membrane 
(Amersham). 
2.6.1 Southern Transfer of DNA 
Southern transfer was performed according to the method of Southern, (1975), as 
described in Sambrook et al., (1989). DNA agarose gel electrophoresis (section 2.2.4) 
was followed by shaking the gel gently in 0.25M Hel for lOmin, to depurinate the 
DNA (to aid transfer of large DNA fragments), soaking the gel (2 x 20min) in several 
volumes of denaturing solution (1. SM Nael, 0. SM NaOH) and in neutralising solution 
(3M NaCl, O.SM Tris-Hel pH 7.5) for 30min. The DNA was transferred from the gel 
to the membrane by capillary action using 20 X sse (3M Nael, 300mM sodium 
citrate) and blotted overnight. After blotting the membrane was dried briefly (2-3min) 
in an 80°e oven and then UV crosslinked for 3min. 
2.6.2 DNA Hybridisation 
Hybridisations (and prehybridisations) were carried out in Hybaid™ bottles at 42°e. 
Prehybridisations were performed in hybridisation solution (50% (v/v) ·deionised 
formamide, 5 X sse, 5 X Denhardts [lg Ficoll, lg polyvinylpyrolidone, lg bovine 
serum albumin fraction V per lOOml], 2.5mM sodium phosphate and just prior to use, 
sonicated salmon sperm DNA to give a final concentration of 1 OOJ.1g/ml) at 42°e for a 
minimum of 6 hours. After prehybridisation, denatured, radiolabelled probe DNA 
(section 2.6.4) was added directly .to the hybridisation solution and hybridisation 
continued at 42°e for 16-24 hours. The membranes were washed in SSe, in the 
presence of 0.1% (w/v) SDS, with the concentration of SSe and the washing 
temperature depending on the specificity of the probe DNA for its target. After 
washing, the membrane was wrapped in Saran-wrap ™ and autoradiographed as 
described in section 2.2.5. 
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2.6.3 Oligonucleotide Hybridisation 
Oligonucleotide prehybridisations and hybridisations were carried out as described in 
section 2.6.2 except that, the hybridisation solution contained 6 X sse, 5 X Denhardts 
solution, 1% (w/v) SDS and 0.1mg/ml sonicated salmon sperm DNA only, and the 
temperature of hybridisation was calculated from the formula 2(A+T) + 4(G+C) = 
TM, where TM is the melting temperature of the DNA and A, T, G and C are the 
number of adenine, thymine, guanine and cytosine bases present in the DNA (Itakura 
eta/., 1984). Hybridisations were carried out at 5-l0°C below TM. 
2.6.4 Preparation of 32p labelled DNA Probes 
2.6.4.1 Multiprime Labelling of DNA 
Radio labelling of DNA probes was carried out using an Amersham Multi prime DNA 
labelling system, based on the method ofFeinberg and Vogelstein (1983). Probe DNA 
was isolated from agarose gels using GenecleanTM (section 2.2.6.1). The amount of 
DNA used per labelling reaction was estimated by visual inspection after gel 
electrophoresis and ethidium bromide staining. Single stranded template was prepared 
by boiling the probe for 5min followed by rapid cooling on ice. The denatured DNA 
was used directly in the labelling reaction as described by the manufacturers, the label 
used being [ a-32P]-dCTP (section 2.1.2). Unincorporated nucleotides were removed 
using NICKTM columns (Pharmacia LKB) according to the manufacturer's 
instructions. 
2.6.4.2 5' End Labelling of DNA 
Oligonucleotide probes were 5' end labelled according to the method of Maxam and 
Gilbert, (1980), whereby free 5' hydroxyl groups in DNA are phosphorylated with 
3 2p by T 4 polynucleotide kinase, using -y-3 2p ATP. The following reaction mix was 
set up in a total volume of25J..Ll: 
15 pmoles oligonucleotide 
2.5J..Ll lOx kinase buffer (SOOmM Tris-HCI, pH 8.0, lOOmM MgCl2, lmM 
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EDT A, 50mM DTT, 1mM spermidine) 
5. OJ.1l y-3 2p A TP ( 50J.1Ci) 
l.OJ.Ll T4 polynucleotide kinase (10 units) 
The reaction mixture was incubated at 37°C for 45min and then stopped by heating to 
65°C for lOmin. 
2.6.5 Stripping of Probes from Filters 
Radiolabelled DNA probes were removed from filters by agitating in a boiling 
solution of 0.1% (w/v) SDS for 2 X 15min followed by rinsing in 2 X sse. The filters 
were autoradiographed before reprobing. 
2. 7 SEQUENCING OF DNA 
Inserts were sequenced using a modification of the dideoxy sequencing strategy of 
Sanger eta/. (1977) as described by Chen and Seeburg, (1985). The Sequenase™ 
version 2.0 sequenase kit (United States Biochemical Corporation) contains all the 
buffers, solutions and enzyme required for the addition of deoxynucleotides (and their 
dideoxy derivatives) to the 3' end of a growing DNA chain and was used according to 
the manufacturers instructions. 
2.7.1 Apparatus 
The sequencing apparatus for gel electrophoresis was manufactured in the 
departmental workshop at the University of Surrey and routinely accommodated glass 
plates with the dimensions of 58 x 20 x 0.5cm. The plates were cleaned with Decon™ 
and hot water, rinsed with distilled water and allowed to dry. After every 4-5 runs, 
the gel side of the front plate was resiliconised with 1 Oml of dimethyl dichlorosilane. 
The gel spacers (0.4mm) were put in place and the plates sealed using SYGLAS™ 
waterproof tape. 
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2. 7.2 Template Preparation 
Plasmid DNA, prepared as described in section 2.4.2, was denatured by alkali 
essentially as described by Zhang eta/., (1988). 2-3J.tg of DNA was denatured for 
Smin at room temperature with 0.2M NaOH and 0.2mM EDT A, in a total volume of 
20J.tl. The mixture was neutralised by the addition of 2J..1l of 2M ammonium acetate 
(pH 4.6) and the DNA precipitated with ethanol as described in section 2.2.2, method 
A. 
2. 7.3 Electrophoresis 
Urea (31.5g) was dissolved with acrylamide (11.25ml of40% (w/v) acrylamide (19:1] 
bisacrylamide) and lOx TBE (7.5ml of 0.89M Tris-HCI, 0.89M Borate, 0.02M 
EDTA) in a total volume of75ml to give a 6% (w/v) polyacrylamide gel. Ammonium 
persulphate (420J..1l, 10% (w/v)) and TEMED (75J..1l) were then added and the gel ｷ｡ｾ＠
mixed before pouring between the glass plates. When not used immediately, the 
polymerised gels were wrapped in Cling film and stored at 4 °C overnight. The gel 
was pre-electrophoresed for 30min and run at SOW constant power in 1x TBE. Just 
prior to loading the samples (3J.tl) on to the gel, they were heated to 75°C for 2min. 
Sharkstooth combs with 5. 7mm point to point spacing (BRL Ltd) were routinely used 
and the samples were loaded with a Drummond sequencing pipette (Drummond 
Scientific Co.). 
2. 7.4 Autoradiography 
After electrophoresis, the DNA was fixed in the gel by immersion in 10% (v/v) 
methanol, 10% (v/v) glacial acetic acid for 20min, and then rinsed in water for Smin 
to remove the urea. The gel was peeled off the glass plate onto a wet piece of 
Whatman 31\1M paper and dried at 80°C for 60min in a gel dryer (slab gel dryer, 
Biorad, model4823). Autoradiography was performed as described in section 2.2.5. 
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2.7.5 Oligonucleotide Synthesis 
Oligonucleotides were chemically synthesized using an "Applied Biosystems" DNA 
synthesizer model 3 81 A, according to the manufacturer's instructions. The 
oligonucleotides were extracted from their column supports using 18M ammonium 
hydroxide, and deprotected at 55°C for 12 hours in 18M ammonium hydroxide. The 
oligonucleotides were ethanol precipitated (section 2.2.2, method B), resuspended in 
TE buffer and their concentration determined spectrophotometrically using the 
equation A260 1 =3 3 J.lg/ml. 
2.8 POLYMERASE CHAIN REACTION (PCR) 
DNA (300ng) was amplified using Taq polymerase (2.5U) by cycling through 15 
rounds of denaturing at 94°C (I min), annealing at 55°C (2min) and extending at 72°C 
(3min), the final cycle concluding with an additional 4min at 72°C, in 50mM KCI, 
1 OmM Tris-HCl pH 8.3, 1.5M MgCl2, 0.01% (w/v) gelatine and 1.25mM dNTPS in 
a total volume of SOJ..Ll. The specific oligonucleotides used to prime amplification were 
added before denaturation. The reaction was carried out under a layer of paraffin oil 
to prevent evaporation of the reaction mix. The products of the PCR reaction were 
then electrophoresed on an agarose gel as described (section 2.2.4). 
2.9 ANIMAL CELL CULTURE TECHNIQUES 
2.9.1 Cell Culture 
Hepalclc7 cells were grown as monolayers in tissue culture flasks in phenol red-free 
Dulbecco's Modified Eagles Medium (DMEM) supplemented with 10% (v/v) foetal 
calf serum (FCS) at 37°C (5% (v/v) C02). Cells were subcultured when the growth 
was confluent by treating with trypsin and diluting the cells to a suitable density. The 
media was aspirated off and the cells were washed with sterile PBS (Sg NaCI, 0.2g 
KCl, 1.44g Na2HP04, 0.24g KH2P04, per litre of H20, pH 7.4). The cells were 
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then incubated with trypsin /EDT A solution at 3 7°C until the cells had detached from 
the surface. The cells were then diluted in pre-warmed media and seeded into 90mm 
Petri dishes to give 3 X 1 o5 cells. 
2.9.2 Frozen Cell Stocks 
Growing anchorage dependent cells were trypsinised, centrifuged at 80g, Smin, and 
resuspended in growth medium containing 20% FCS (v/v) and 10% DMSO (v/v) to a 
final concentration of 1 x 10 7 cells. The cells were dispensed into 1 ml aliquots and 
frozen overnight at -70°C before removing to liquid nitrogen for storage. To recover 
cells from liquid nitrogen storage, an aliquot was thawed at 3 7°C and the cells were 
diluted with I Oml growth medium. Cells were sedimented by centrifugation (80g, 
Smin) and the supernatant discarded. The cell pellet was resuspended in 1 Oml of fresh 
growth medium (containing 10% (v/v) FCS), transferred to a tissue culture flask, and 
incubated at 37°C with an overlay atmosphere of 5% (v/v) C02. 
2.9.3 Cell Counting and Viability 
Cell counts were determined by diluting aliquots of cells in culture medium, adding 
trypan blue (0.4% (w/v) in saline) and counting using a Hawksley cristalite Neubauer 
haemocytometer. Exclusion of the dye by those cells with an intact cell membrane 
indicated viablity. Those cells with a 'leaky' cell membrane incorporated the dye and 
were considered to be non-viable. The % viability was calculated from the following 
equation: 
%Viability= (V/T) x 100 
where V = viable cells/ml 
T = total cells/ml 
Cells of greater than 98% viability were used. 
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2.10 TRANSIENT COTRANSFECTION ASSAY 
Hepalclc7 cells (3 x lOS) were seeded into 9cm Petri dishes (section 2.9.1) in phenol 
red-free D:MEM supplemented with 10% (v/v) FCS three days prior to transfection. 
Cells were then washed in serum-free medium and transfected by mixing 10J.1g of 
Qiagen prepared plasmid DNA (section 2.4.2.2) with 100J.1g N·[l-(2,3-
dioleyloxy)propyl]-N,N,N-trimethylammonium chloride (DOTMA) and Sml serum-
free medium which was applied to the cells. Unless otherwise stated, each plate was 
transfected with lJ!g CAT (chloramphenicol acetyl transferase) reporter plasmid, lfJ.g 
expression vector (pSGS or pSGS .PP AR), 3 J.lg of the ｾＭｧ｡ｬ｡｣ｯｴｯｳｩ､｡ｳ･＠ expression 
vector, pCHllO (Pharmacia), and SJ.Lg pBluescript (Stratagene) as carrier. Each 
transfection was performed in triplicate. After Shr, Sml DMEM containing 20% (w/v) 
dextran coated charcoal (DCC) treated FCS was added, along with either dimethyl 
sulphoxide (DMSO) or ligand (eg. Wy 14643, Chemsyn Science Laboratories, 
Lenexa, KS) prepared in DMSO. After 20 hours the medium was replaced with fresh 
D:MEM containing 10% (w/v) DCC-FCS and ligand where appropriate. After 48 
hours the cells were harvested and cytosol extracts (300Jll in 0.2SM Tris-HCI, pH 
7. 8) prepared by three cycles of freeze-thawing and assayed for f3-galactosidase 
activity, used to normalise the CAT assay. 
2.1 0.1 (3-Galactosidase Assay 
Extracts were normalized for J3-galactosidase activity by incubating I OOJll of extract 
with 0.28mg ｯＭｮｩｴｲｯｰｨ･ｮｹｬＭｾＭｄＭｧ｡ｬ｡｣ｴｯｳｩ､｡ｳ･＠ (ONPG) in 50mM phosphate buffer pH 
7.0, lOmM KCI, lmM MgCl2 for 1 hour at 37°C. The reaction was stopped by the 
addition of 400Jll of IM Na2C03. The absorbance was then read at 420nm and the 
following equation used to determine ｾＭｧ｡ｬ｡｣ｴｯｳｩ､｡ｳ･＠ activity: 
IU/Jll.h = 1000 x OD420nm 
ml cytosol extract x hours of incubation at 3 7°C 
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2.10.2 CAT Assay 
After normalization for J3-galactosidase activity, CAT enzyme activity was determined 
by co-incubation of cell extracts with 0.1 J!Ci [14c]chloramphenicol (Amersham) and 
20mM acetyl coenzyme A (Sigma) for 1 hour at 37°C. Radiolabelled products were 
extracted with ethyl acetate and separated by TLC using 95% (v/v) chloroform/ 5% 
(v/v) methanol as the solvent. The TLC plate was autoradiographed as described in 
section 2.2.5 and quantification of the CAT assay data was performed by scanning the 
TLC plates directly, using the Berthold LB2842 scanning TLC linear analyser. 
2.11 SAFE HANDLING OF HAZARDOUS CHEMICALS 
All chemicals were handled, and procedures carried out according to COSH 
regulations. 
Ethidium Bromide: when handling this substance, gloves were worn at all times. The 
solid was weighed in a class 3 cabnet and the stock solution (IOmg/ml) was kept in a 
double walled container. Gels were stained in a designated ethidium bromide area, 
and once photographed, the gel was disposed of in a biohazard bag. The liquid 
ethidium bromide waste was kept in a contained area and disposed of according to 
Maniatis. 
Dichlorosilane: when coating the sequencing plates with this chemical gloves were 
worn and this procedure was carried out in the fume hood. The plates were only 
removed from the fume hood once dry. 
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CHAPTER3 
ISOLATION AND PRELIMINARY ANALYSIS OF 
RAT CYP4A GENES 
3.1 INTRODUCTION 
The following results detail experiments to isolate rat genomic DNA fragments with 
sequence similarity to the rat CYP4AJ eDNA from a recombinant phage library in A. 
Ch4A (a kind gift from Dr. J. Bonner). In particular, the objective was to isolate the 5' 
end of this gene, so that its regulation could be investigated. 
3.2 PREPARATION OF CYP4Al eDNA FOR USE AS A 
HYBRIDISATION PROBE 
The eDNA probe used for screening the rat recombinant phage library in A.Ch4A was 
the rat full length 2.1Kb eDNA coding for CYP4Al, previously isolated in this 
laboratory (Earnshaw et.al., 1988). The 2.1Kb eDNA had been inserted into the Eco 
RI site of the plasmid pUC9 (Figure 3.1). A large scale preparation of plasmid DNA 
was performed according to the method in section 2.4.2.1 and the 2.1Kb eDNA insert 
was excised using the restriction enzyme Eco RI. This large scale digest of the 
plasmid was electrophoresed on a 1% low melting point agarose gel (Figure 3.2). The 
2.1Kb eDNA fragment was excised from the gel and the DNA purified by the cold 
phenol method (section 2.2.6.2). 
In order to identify later which clones contained possible 5' sequences, it was decided 
to digest the 2.1Kb CYP4Al eDNA with Eco RI and Bgl I to produce a 600bp 
fragment containing the first 5 exons of the eDNA (Figure 3.1 ). The 600bp fragment 
was prepared in the same way as the full length eDNA probe. Figure 3.3 shows the 
low melting point agarose gel, the 600bp fragment being indicated. 20ng of each 
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Figure 3.1 Restriction map of the plasmid pUC9 containing the full 
length, 2.1Kb eDNA coding for CYP4Al. The restriction sites for Eco RI 
and Bgl I are shown and the position of the 600bp probe indicated. 
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2·1 Kb 
Figure 3.2 Low melting point agarose gel (1%) ofpUC9 containing the 2.1Kb eDNA 
coding for CYP4Al digested with the restriction enzyme Eco Rl. The marker lane 
contains a Hind III digest of A phage ｄｎｾ＠ the sizes of which can be seen in Figure 
3.3 . 
SIZE(Kb) 
23 
9·4 
6 · 5 
4·4 
2·3 
2 ·0 
. 0·6 600probe 
Figure 3.3 Low melting point agarose gel (1%) ofpUC9 containing the 2.1Kb eDNA 
coding for CYP4Al digested with the restriction enzymes Eco RI and Bgl I. The 
marker lane is as Figure 3 .2. 
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pure probe was electrophoresed on a 1% agarose gel to confirm that they were of the 
appropriate size (Figure 3.4). 
3.3 EVALUATION OF COLUMN METHODS IN THE 
PREPARATION OF PLASMID DNA 
New methods for purifying plasmid DNA from bacterial host cell DNA are being 
developed constantly as although the ethidium bromide/cesium chloride ultraspin 
preparation (section 2.4.2.1) is very effective, it is quite dangerous in respect to the 
chemicals used in the process and takes a long time to prepare (3 days). The three 
column methods evaluated were; Qiagen columns (Hybaid Ltd), pZ523 column (NBL 
Ltd), and NACS column (BRL Ltd). The Qiagen columns are available in three 
different sizes according to the starting volume of bacterial culture. The plasmid to be 
purified was pUC9 containing the rat full length 2.1kb eDNA encoding CYP4Al 
grown in the host E. coli strain TB 1 in LB media containing ampicillin (1501J.g/ml). 
Each column was tested with the manufacturer's recommended starting volume and 
the bacterial cell number in this volume assessed from the absorbance at 600nm: 
1 OD6oO = 8 x 1 os cells 
The concentration of the DNA from each column was determined 
spectrophotometrically (section 2.2.3) and is shown with the DNA yield in Table 3.1. 
It can be seen that the QSOO column gave the highest DNA concentration, however 
the yield of DNA per cell, in order of greatest yield was as follows:-
Q20 > QlOO > QSOO > pZ523 > NACS 
87 
Figure 3.4 Agarose gel (1 %) of the purified 2.1Kb and 600bp probes. 
Lane 1&4: A Hind III markers (see Fig. 3.3 for sizes) 
Lane 2: 2.1Kb DNA 
Lane 3: 600bp DNA 
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No DNA was recovered from the NACS column and this was confirmed by the UV 
scan performed in the region of200-300nm, Figure 3.5 (a). The DNA prepared from 
each pZ523 column and the Qiagen column appeared to be of good quality as assessed 
by the 260/280 ratio (section 2.2.3) and by the symmetrical peak around 260nm as 
seen in Figure 3.5 (band c respectively). To assess the quality and purity of the DNA 
further, lflg of DNA from each column was digested with the restriction enzyme Eco 
RI and electrophoresed on a 1% agarose gel. The DNA prepared from all the Qiagen 
columns could be digested to produce the 2.1Kb insert band and the 2. 7Kb pUC9 
band. However the DNA prepared from the pZ523 column did not digest, indicating 
that the DNA needed further purification. 
The pZ523 method was very long and laborious and although it seemed to produce 
DNA of a high concentration (1.81Jlg/ml) and a good 260/280 ratio (1.71), this did 
not digest with the restriction enzyme Eco Rl indicating that something was interfering 
with the enzyme. The preparation could have been purified further with the use of 
ethanol precipitation but this was not done since the Qiagen columns produced DNA 
of suitable quantity and quality. Also Qiagen DNA had the advantage that it was 
simple to use and required only one day as compared with the three days required to 
carry out the ethidium bromide/cesium chloride method and it used safe materials. 
Subsequent to this study, Qiagen columns have been the method of choice for 
preparing plasmid DNA for use in sequencing and transfection experiments, 
confirming that the DNA produced is of high quality. 
3.4 ISOLATION OF RECOMBINANT CLONES HYBRIDISING 
TO THE RAT FULL LENGTH 2.1Kb eDNA ENCODING CYP4Al 
A rat genomic library in A.Ch4A was screened by Dr. C. McGeoch, using the 2.1Kb 
eDNA for CYP4Al labelled with a32PdCTP as a probe. From this screen eight 
positive clones were isolated, which were purified by a further three rounds of 
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screening. A stock of these eight recombinant phage clones was prepared (section 
2.5.1) and stored at 4°C. 
3.4.1 Determination of Sizes of the Genomic DNA Inserts in the 
Recombinant Phage 
Initially, DNA was prepared from the eight recombinant lambda phage using a scaled 
down version ofthe method in section 2.3.6. From the map ofA.Ch4A (Figure 2.1) it 
can be seen that the recombinant DNA inserts can be excised using the restriction 
enzyme Eco RI. This enzyme was used to digest approximately 4Jlg of DNA from the 
eight phage clones and the resulting fragments were electrophoresed through a 1% 
agarose gel. After staining with ethidium bromide the results showed that the DNA 
had been digested by the restriction enzyme, since the 19.5Kb and 11Kb arms of the 
phage could be seen, releasing Insert fragments of various sizes (Figure 3.6 (A)). To 
determine the molecular weight of the individual insert fragments, a graph was plotted 
of the migration of the ').J/ind III digested DNA fragments from the origin, against 
ｾ＠
their known molecular weight (Figure 3.7). The sizes of the inserts were then 
extrapolated from this standard graph and the results are tabulated in Table 3 .2. It can 
be seen that clones AL4, AR5 and AR6 give the same insert digestion pattern of 8.5, 
5.5 and 2.3Kb. 
3.4.2 Characterisation of Recombinant Phage Clones 
The DNA from both gels in Figure 3.6 (A) were transferred to nylon filters by the 
method of Southern (section 2.6.1). These filters were hybridised with the rat Eco 
RI/Bgl I CYP4Al eDNA 600bp probe which had been labelled with 50J.1.Ci a32PdCTP 
using Multiprime™ (section 2.6.4.1). The unincorporated radiolabelled nucleotides 
were removed using a NICK ™ column and the probe was then denatured and added to 
20ml of hybridisation buffer (section 2.6.2). The filters were probed overnight at 42°C 
and then washed under fairly stringent conditions: two 20min washes of 2 X sse I 
0.1% (w/v) SDS at room temperature, two 20min washes of0.1 X sse I 0.1% (w/v) 
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 
B. Gel 1 
LANE 1 2 3 4 5 6 1 s 9 10 11 12 13 14 
Gel 2 
LANE 1 2 3 4 5 6 7 s 9 10 11 12 13 14 
SIZE (Kb) 
- 23 
- 9 ·4 
- 6 ·5 
- 4 ·4 
- 2 ·3 
- 2 ·0 
- 0 ·6 
SIZE (Kbl 
23 
9 ·4 
6 ·5 
4 · 4 
2 ·3 
2 ·0 
<> ·6 
Figure 3.6 A) Agarose gels of the 8 recombinant phage clones isolated from the 
2.1Kb screen. B) Autoradiographs of the above gels hybridised to the 600bp probe 
.Gd.l .Gd.l 
Lane 1&14: J... Hind ill markers Lane 1&14: J... Hind ill markers 
2&13: pUC9 Eco RI digested 2&13: pUC9 Eco RI digested 
3:- 3:-
4: AR4 Eco RI digested 
5: AR4 uncut 
6: AL 7 Eco RI digested 
7: AL7 uncut 
8: AL4 Eco RI digested 
9: AL4 uncut 
10: AL2 Eco RI digested 
11: AL2 uncut 
12: -
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4: AR9 Eco RI digested 
5: AR9 uncut 
6: AR7 Eco RI digested 
7: AR7 uncut 
8: AR6 Eco RI digested 
9: AR6 uncut 
10: AR5 Eco RI digested 
11 : AR5 uncut 
12:-
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Figure 3. 7 Semi-log plot of the distance travelled by the A Hind III DNA 
fragments, from the origin (seen in Figure 3.6), against their known 
molecular weight. 
CLONE FRAGMENT SIZES _(Kb) 
AL2 8.5, 7.0* 
AL4 8.5*, 5.5, 2.3 
AL7 6.7*, 3.4*, 2.3 
AR4 4.8, 3.4*, 2.5, 1.7, 1.0* 
AR5 8.5*, 5.5, 2.3 
AR6 8.5*, 5.5, 2.3 
AR7 15.5, 8.5 
AR9 8.5, 5.5, 3.5 
Table 3.2 Sizes of fragments produced by Eco RI digestion of 
recombinant phage clone DNA, isolated from the 2.1Kb screen. 
* indicates those fragments sharing sequence similarity with the 
Eco Rl/Bgl I 600bp CYP4Al probe (Figure 3.6, B). 
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SDS at 55°C and a final rinse in 5xSSC for 20min at room temperature. The filters 
were then wrapped in Saranwrap™ and exposed to Kodak X-OMAT™ AR5 film at-
70°C for 24 hr. Figure 3.6 (B) show the autoradiogram of the two gels. The dark 
bands indicate those fragments that have a degree of sequence identity with the 600bp 
probe and which might lie towards the 5' end of their gene. Each clone contained 
fragments that gave positive hybridisation signals to the 600bp probe (Table 3 .2), 
except for clones AR 7 and AR9. These two clones were investigated further and 
continued to produce no hybridisation signal when probed with either the 2.1Kb or the 
600bp probe and therefore were dropped from any further investigation. 
3.5 ISOLATION OF RECOMBINANT CLONES HYBRIDISING 
TO THE Eco RI I Bgl I 600bp FRAGMENT OF RAT CYP4Al 
The same rat genomic library in A.Ch4A was screened again using the Eco Rl/Bgl I 
600bp fragment ofCYP4Al, to try to obtain more recombinant clones with a stronger 
bias to the 5' end. One million plaques were plated and transferred to duplicate 
Hybond N™ nylon filters (section 2.3.4). The filters were hybridised with the 600bp 
probe which had been end labelled with a32p dCTP using Multiprime™ and exposed 
to X-ray film at -70°C for four days. Thirteen positive clones were identified in the 
first round of screening but this was reduced to ten positives in the second round as 
three colonies proved to be false positives. The remaining ten were purified by two 
further rounds of screening. The filters at each round, after probing with the 600bp 
fragments were washed at fairly high stringency: two 20min washes of 2 X sse I 0.1% 
(w/v) SDS at room temperature, two 20min washes of 0.1 x SSC I O.I% (w/v) SDS 
at 55 °C, and a final rinse in 5 x S SC at room temperature. Typical results from the 
further rounds of screening are shown in Figure 3.8. A stock of recombinant phage 
clones which hybridised to the rat 600bp probe was prepared (section 2.5.1) and 
stored at 4 °C. 
\ 95 
2nd 
round 
4th 
round 
Figure 3.8 Autoradiograph of filters from the second (2 plaques positive) 
and fourth round (all plaques positive) of screening of the A. Ch 4 A rat 
genomic library, using the 600bp probe, showing positive hybridisation 
signals produced by recombinant phage clone RG4. 
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3.5.1 Determination of Sizes of the Genomic DNA Inserts in the 
Recombinant Phage 
DNA from each of the ten phage clones was prepared (section 2.3.6), digested with 
the restriction enzyme Eco RI and the resulting fragments were separated by 
electrophoresis through a 1% agarose gel (Figure 3.9). Table 3.3 shows the fragment 
sizes for each clone as determined by comparison to the A. Hind III markers. It can be 
seen that clones RGl, 2 and 10 have the same insert Eco RI digestion pattern of 6.7, 
3.4 and 2.3Kb. It was suspected that RG7, RG6 and RG 11 would give the same 
results, so the Eco RI digestion was repeated and the DNA's electrophoresed 
alongside one another (data not shown). This confirmed that RG7 and RG6 produced 
the same Eco RI restriction pattern as RG 1, 2 and 10, but that RG 11 produced a 
different one, namely, 6.7, 3.8 and 2.1Kb. Clones RG3, 4, 8 and 9 also give the same 
pattern of fragment sizes 7.8 and 6.7Kb. The clone AL7, isolated from the 2.1Kb 
library screen, also had the same fragment pattern as that ofRG1, 2, 6, 7 and 10. 
3.6 CHARACTERISATION OF PHAGE CLONES BY SOUTHERN 
BLOT 
Figure 3. 1 0 is a schematic diagram summarising the two library screens and the 
subsequent grouping of the clones according to their Eco RI restriction pattern. 
Figure 3.11 (A) shows a gel of representative recombinant phage clone DNA from 
each group digested with Eco RI and electrophoresed alongside one another. This 
shows quite clearly that each group is different. Because so much DNA had been used 
(10-15Jlg) per digestion, the DNA had become slightly retarded in the gel as compared 
to the 'A Hind III markers, and hence the sizes appear different to those seen before, 
but the patterns remain the same. This gel was Southern blotted and hybridised to 
radiolabelled 2.1Kb CYP4Al eDNA. The filter was washed under stringent conditions: 
two 20min washes in 2 X sse I 0.1% (wlv) SDS at 42°C, two 20min washes in 0.1 X 
sse I 0.1% (wlv) SDS at 65°e and then a final rinse in 5 X sse at room temperature 
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23Kb 
9·4 
6·5 
4·4 
2·3 
2·0 
Figure 3.9 Agarose gels of the 10 recombinant phage clones isolated from the 600bp 
screen. 
.Gdl 
Lane 1&14: A. Hind Ill markers 
2&13: pUC9 Eco RI digested 
3:-
4: RG7 Eco RI digested 
5: RG7 uncut 
6: RG3 Eco RI digested 
7: RG3 uncut 
8: RG2 Eco RI digested 
9: RG2 uncut 
10: RG 1 Eco RI digested 
11: RG1 uncut 
12: 600bp DNA 
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.Gd.Z 
Lane 1&14: A. Hind Ill markers 
2: RG 11 Eco RI digested 
3: RGll uncut 
4: RG10 Eco RI digested 
5: RG10 uncut 
6: RG9 Eco RI digested 
7: RG9 uncut 
8: RG8 Eco RI digested 
9: RG8 uncut 
10: RG6 Eco RI digested 
11 : RG6 uncut 
12: RG4 Eco RI digested 
13: RG4 uncut 
CLONE FRAGMENT SIZES (Kb) 
RG7 6.7 
RG3 7.8, 6.7 
RG2 6.7, 3.4, 2.3 
RGI 6.7, 3.4, 2.3 
RGll 6.7 
RGIO 6.7, 3.4, 2.3 
RG9 7.8, 6.7 
RG8 7.8, 6.7 
RG6 6.7 
RG4 7.8, 6.7 
Table 3.3 Sizes of insert fragments produced by Eco RI digestion of 
recombinant phage DNA, isolated from the 600bp screen. 
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CHARON 4A RAT LIVER 
GENOMIC LIBRARY 
2.1 eDNA 
SCREEN 
8 POSITIVE CLONES 
2.1 eDNA k_ 
SCREEN l 2False Positives 
AR7 
2.1 eDNA I 
SCREEN f 
2.1 eDNA I 
SCREEN f 
1. AL2 
2.AL4 
3. AL7 
Group A 
AL 2 
AR9 
4. AR4 
5. ARS 
6. AR6 
Group B 
AL 4 
AR 5 
AR 6 
Group C 
AL 7 RG 6 
RG 1 RG 10 
RG 2 
RG 7 
600bp 
SCREEN 
1 3 POSITIVE CLONES 
3 False ｐｯｳｩｴｾ＠
RGS 
RG12 
RG13 
1. RGl 
2. RG2 
3. RG3 
4. RG4 
5. RG6 
600bp 
SCREEN 
600bp 
SCREEN 
600bp 
SCREEN 
6. RG7 
7 . RG8 
8. RG9 
9. RGl 0 
10. RG11 
DNA Prep and Restriction 
Enzyme Digest 
Group D 
AR 4 
GroupE 
RG 4 
RG 3 
RG 8 
RG 9 
Gr9up F 
RG 11 
Figure 3.10 Schematic diagram, summarising the two library screens 
and the subsequent grouping of recombinant phage clones, based on their 
Eco RI digestion pattern. 
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A. 
LANE 1 2 3 4 5 6 7 
B. 600 C. 2·1 
LANE 1 2 3 4 5 6 7 12 3 45 6 7 
SIZE(Kb) 
- 23 -
ｾ Ｍ Ｍ ＭＭ Ｙ ﾷ Ｔ Ｍ
- 6.5 -
-4·-
- 2·3 -
- 2·0 -
- 0 · 6 -
Figure 3.11 A) Agarose gel of a representative recombinant phage clone 
digested with Eco RI, B) Southern blot of above gel hybridised to the 
600bp probe, C) Southern blot of above gel hybridised to the 2.1Kb 
probe. 
Lane 1 : A Hind III markers 
2: Group F {RGll) 
3: GroupE (RG4) 
4: Group D (AR4) 
5: Group C (AL7) 
6: Group B (AL4) 
7: Group A (AL2) 
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After autoradiography, the filters were stripped of their probe (section 2.6.5), re-
probed with the 600bp probe under the same conditions and washed under the same 
stringent conditions. From the results seen in Figure 3.11 (B) and (C) it was possible 
to draw up a preliminary restriction map of the orientation of Eco RI fragments within 
each group (Figure 3.12), since those fragments hybridising to both the 600bp and the 
2.1Kb probe would be 5' to those fragments hybridising to the 2.1Kb probe only. 
3.7 DISCUSSION 
At the beginning of this work, only two members of the CYP 4 family had been isolated 
as eDNA's (CYP4AJ and CYP4Bl). CYP4Al was isolated from a A.gt11 expression 
library constructed from liver mRNA isolated from rats given the peroxisome 
proliferator clofibrate (Hardwick et al., 1987). CYP4BJ was isolated from a rabbit 
lung eDNA library (Matsubara et al., 1987). From a Southern blot analysis of rat 
genomic DNA, Hardwick eta/., (1987) deduced that two or three genes existed in the 
rat CYP4 family. Figure 3.11 (A) is in agreement with this data since six different 
genomic clones were isolated, however some of these groups may represent 
overlapping clones. The total size of each recombinant phage clone was found to 
range from 12.4Kb, group C (Table 3.2, AL7) to 16.3Kb, group B (Table 3.2, AL4). 
Of those genomic sequences published for other members of the cytochrome P450 
superfamily (at the time of this work), CYP21Al was found to possess the greatest 
number of exons (10) and was 3.4kb in size (Higashi eta/., 1986) and CYPJAJ was 
the largest in size (6.7kb) and had 7 exons (Gonzalez et a/., 1985). It therefore 
seemed likely that all of the gene for CYP4Al and the other members of the CYP4 
family would be present within the clones isolated. 
Figure 3.12 shows the preliminary maps for each clone based on their Eco RI 
fragments hybridisation to the 600bp and 2.1Kb probes. It can be seen that there is 
more than one possible orientation for each group since it is impossible to tell whether 
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those fragments that are negative with both probes lie to the 3' or 5' end of the other 
fragments (groups A, B, D, E and F) and in which orientation (group D). It is also 
interesting to note that when the clone AR4 (group D) was hybridised to the 600bp 
probe for the first time (Figure 3.6 (B), gell, lane 4) two Eco RI fragments 3.4Kb and 
1. OKb gave a positive signal. However when this experiment was repeated, Figure 
3.11 (B), lane 4, no signal was seen. The preliminary maps for both results can be 
seen in Figure 3. 12. 
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CHAPTER4 
CHARACTERISATION OF RAT CYP4A GENE SEQUENCES 
4.1 INTRODUCTION 
During this work, the full sequence for the rat CYP4Al gene was published along 
with the DNA sequence for a closely related gene, CYP4A2 (Kimura et al., 1989a). l 
The restriction map of these genes can be seen in Figure 4.19 (Kimura et al., 1989a). The 
_eDNA for a third member of this family, designated CYP4A3, was also published at 
this time (Kimura et a/., 1989b ). A number of other sequences of members of this 
expanding family, isolated from different species, were published during this work, 
including three rabbit cDNAs, CYP4A5, CYP4A6 and CYP4A7 (Johnson eta/., 1990) 
and three orthologous cDNAs of the CYP4B subfamily, designated CYP4BJ (human 
CYP4BJ, Nhamburo eta/., 1989; rabbit and rat CYP4Bl, Gasser and Philpot, 1989). 
The CYP4B sequences represent a different subfamily since they are :s; 59% identical to 
the CYP4A genes at the nucleotide level (Nebert eta/., 1989). The full list of CYP4 
genes published up until December 1993 can be seen in Table 1.2, Chapter 1. It was 
decided to further characterise the genes that I had isolated, to establish their identity 
within the CYP4 family. The Eco RI fragment inserts from representatives of each 
group were subcloned into the Eco RI site of the plasmid pGEM7Z (for restriction 
map see Figure 2.2). This plasmid is easily prepared and purified facilitating the 
isolation of large quantities of insert DNA for analysis. 
4.2 PREPARATION OF THE PLASMID pGEM7Z FOR USE IN 
SUBCLONING 
A large scale preparation of pGEM7Z plasmid DNA was carried out (section 2.4.2.2). 
5 J.Lg of pGEM7Z DNA was digested with the restriction enzyme Eco RI and 1 OOng of 
this electrophoresed on a 1% agarose gel to check that it had been linearised. The 
enzyme was removed from the remainder of the digest by phenoVchloroform 
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extraction (section 2.2.1) and the linear plasmid recovered by ethanol precipitation 
(section 2.2.2, method A). This was resuspended in distilled water to give a final 
concentration of 1 OOng/tJ.l Eco RI cut pGEM7Z. 
4.3 PREP.A.RATION OF INSERT DNA FROM RECOMBINANT 
PHAGE FOR SUBCLONING 
Initially a shotgun approach to cloning of insert DNA into pGEM7Z was tried. 
Shotgun cloning is where the whole preparation of Eco RI digested phage DNA was 
included in the ligations. In this approach only the insert fragments should be 
incorporated into the circular plasmid, as the two arms of the phage have only one 
"sticky end" each. Recombinant DNA from each group (A-F) was prepared on a large 
scale (section 2.3.6). Approximately 20f.lg of DNA from each group was digested 
with Eco RI and ltioth of the digest electrophoresed on a 0.8% agarose gel in order to 
check that the DNA had been digested to completion. The enzyme was removed from 
the remaining digest with phenol/chloroform (section 2.2.1) and the DNA ethanol 
precipitated (section 2.2.2, method A). The digested DNA was resuspended in 
distilled water to give a final concentration of 1 ｏｏｮｧＯｾＱＮ＠
The use of the shotgun approach did not always work in the subcloning of all of the 
Eco RI insert fragments from each group. In such cases a second approach was taken 
in which the whole digest was electrophoresed on a 0. 7% low melting point agarose 
gel and the DNA fragment of interest excised. The DNA was then extracted from the 
agarose by either cold phenol (section 2.2.6.2) or Geneclean™ (section 2.2.6.1). This 
approach was used to maximise the chances of obtaining subclones, since the number 
of pGEM7Z molecules available for the formation of circular recombinants should be 
greater if phage arms are not present in the ligations. 
107 
4.4 SUBCLONING RESULTS : GROUP A 
Ligations were carried out as detailed in section 2.4.3.3 and transformation of 
competent JMl 09 cells performed as in section 2.4.4. Table 4.1 shows the results 
obtained from the first successful experiment using the shotgun approach. No 
colonies were seen on plate 1, indicating that competent JMI 09 do not contain any 
antibiotic resistant contaminants. On plate 2 (undigested pGEM7Z) a number of white 
colonies, I;IOth of the total colonies, were present. These represent false positives, 
since no insert DNA was present in the plasmid. The number of blue colonies seen for 
the unligated, Eco RI digested pGEM7Z (plate 3, 27 blues) represents liisth of the 
number seen on the plate with undigested pGEM7Z (plate 2, 400 blues). This implies 
that most of the pGEM7Z DNA was digested by the restriction enzyme. The blue 
colonies on plate 3 represent spontaneous religation of the digested plasmid. The 
number of blue colonies seen on plate 4 (ligated Eco RI digested pGEM7Z) is the 
same as plate 2. This indicates that the T4 DNA ligase was working efficiently. The 
number of white colonies seen on this plate, again represent false positives, since no 
insert DNA is present, and they are of the same order of magnitude seen for the 
undigested plasmid. 
The white colonies seen on plates 5-7 represent recombinant ｾＭｧ｡ｬﾷ＠ clones ie. those 
plasmids with insert DNA ligated into the multiple cloning site. The molar ratio of 
1:1, vector to insert (plates Sa and b), seems to have given the most white colonies 
and a similar number of blue colonies as compared to the control plate (plate 2). The 
molar ratio of 1 :3 (plates 6a and b) gave only two whites and a dramatic reduction in 
the number of blue colonies (1120th as compared to plate 2) indicating that the amount 
of insert DNA present is affecting the religation and hence very few pGEM7Z 
molecules are religating and hence cell death on ampicilin plates. The molar ratio of 
3: 1 (plates 7 a and b) gave a higher number of white recombinants than the molar ratio 
1 :3 (plates 6a and b) but tess than the 1:1 (plates Sa and b) and also less· blue colonies 
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PLATE DNA ENZYME MOLAR WHITE BLUE 
RATIO COLONIES COLONIES 
I * NoDNA .. - - -
2 * pGEM7Z (20ng) .. 
-
40 400 
3 * pGEM7Z (20ng) EcoRI - - 27 
4 pGEM7Z (20ng) EcoRI 
-
20 400 
Sa pGEM7Z (20ng) + grp A EcoR1 1:1 (V:I) 32 300 
Sb pGEM7Z (20ng) + grp A EcoR1 1:1 (V:I) 37 300 
6a pGEM7Z (20ng) + grp A EcoR1 1:3 (V:I) 1 20 
6b pGEM7Z (20ng) + grp A EcoR1 1:3 (V:I) 1 30 
7a pGEM7Z (20ng) + grp A EcoRI 3:1 (V:I) 13 70 
7b pGEM7Z (20ng) + grp A EcoR1 3:1 (V:I) 19 150 
Table 4.1 Cloning strategy and results of shotgun subcloning of the 
reco1nbinant phage group A (AL2) inserts into pGEM7Z. 
Plates 1-4 were plated at one dilution (1 OOJ.tl) 
Plates 5-7 were plated at two dilutions (a= 1 OOJ.tl, b = 200J.tl) 
*=no ligase added 
Eco RI = indicates that the plasmid had been linearised before ligation 
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than the I: 1. However the number of whites on each test plate (5-7) are only in the 
same order of magnitude as the false positives on the control plates 2 and 4 and 
therefore could represent false positives. 
It was decided to screen the white colonies from plate Sa and 7b (38 in total) for 
inserted DNA using the cracking method (section 2.4.4.3). Figure 4.1 shows an 
example of an ethidium bromide stained cracking gel. Lane al shows the supercoiled 
pGEM7Z which was used as a marker. DNA in lanes a2, 5 to 13 and b11 and b12 can 
be seen to migrate for the same distance as the marker and therefore represent plasmid 
DNA without insert (false positives). Lanes a3 and a4 show a supercoiling pattern 
different to that of the marker and represent recombinant plasmid DNA migrating 
more slowly through the gel. The ten colonies containing recombinant DNA identified 
in this manner were picked into IOml of LB media containing ampicillin (150f.!g/ml) 
and incubated overnight at 37°C. DNA was prepared by the STET method (section 
2.4 .I) using I.4ml of each of the ten overnight cultures. The final DNA preparations 
were disolved in 30f.ll of distilled water and 1 Oj..tl of each were digested with the 
enzyme Eco RI and electrophoresed on a 1% agarose gel. As can be seen from Figure 
4.2 all ten colonies contain an insert of a larger size than the pGEM7Z plasmid band. 
The recombinant clones in lanes 2, 4, 5, 12 and 13 contain a 7Kb insert, those in lanes 
3, 6, 7 and I 1 a 4. 7Kb insert and the one in lane I 0 contains a 5. 7Kb insert. From the 
Eco RI digestion pattern of the original group A phage DNA, only two different size 
inserts of 8. 5Kb and 7. OKb were expected (Figure 3.11 A), however, it is necessary to 
run the digested recombinant phage alongside the digested recombinant plasmids to 
make a true comparison of size. The origin of the 5. 7Kb insert is unknown. 
4.4.1 Characterisation of Group A Recombinant Subclones 
A Qiagen plasmid DNA preparation was performed on the subclones containing the 
three different sized inserts (section 2.4.2.2). 1j.lg of DNA of each subclone was 
digested with Eco RI along with Sf.lg of phage DNA and electrophoresed on a 1% 
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 
a 
marker-
b 
marker-
Figure 4.1 Screening of recombinant group A plasmid DNA by 
supercoiling pattern 
LANE 
Lane a 1: supercoiled pGEM7Z 
2: A: 7/2/15 
3: A: 7/2/14 
4: A: 7/2/13 
5: A: 7/2/11 
6: A: 7/2/10 
7: A: 7/2/8 
8: A: 7/2/7 
9: A: 7/2/6 
10: A: 7/2/4 
11: A: 7/2/3 
12: A: 7/2/2 
13: A: 7/2/1 
Lane b1:-
2: -
3: -
4:-
5: -
6: -
7:-
8:-
9: -
10: supercoiled pGEM7Z 
11: A: 7/2/19 
12: A: 7/2/18 
13: J... Hind HI marker 
14: A Hind III marker (sizes shown in Fig.4.2) 14: -
2 3 4 56 7 8 9 10 11 12 13 14 
SIZE (Kb) 
-23 
9 ·4 
- 6 ·5 
---4·4 
-2·3 2 ·0 
Figure 4.2 Digestion of recombinant group A plasmid DNA with Eco 
RI. Plasmid DNA prepared by the STET method was digested overnight with the 
resuiction enzyme indicated and then separated on a 1% agarose gel. 
Lane 1, 8, 9 and 14: J... Hind III marker 
2: A: 5/1/11 7: A: 5/1/2 
3: A: 5/1/8 10: A: 7/2/14 
4: A: 5/1/6 11: A: 7/2/13 
5: A: 5/1/5 12: A: 5/1/23 
6: A: 5/1/4 13: A: 5/1/19 
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agarose gel (Figure 4.3 (A)). From the Eco RI digestion pattern of the original group 
A phage DNA (lane 5) only two different sized inserts of 4.7Kb and 7.0Kb were 
expected in the recombinant pGEM7Z subclones, and these were obtained (lanes 2 and 
4 respectively). 
The DNA from the gel shown in Figure 4.3 (A) was transferred to Hybond NTM nylon 
filter by the method of Southern (section 2.6.1), and subsequently hybridised to the rat 
600bp eDNA CYP4Al probe. The filter was washed under moderately stringent 
conditions: two 20min washes in 2 X sse I 0.1% (w/v) SDS at room temperature, two 
30min washes in 0.1 X sse I 0.1% (w/v) SDS at 55°C and a final rinse in 5 X sse at 
room temperature. After autoradiography the filter was stripped to remove the 
radiolabelled probe (section 2.6.5), re-probed with the rat full length 2.1Kb eDNA 
CYP4AJ and washed using the same conditions as before. Figure 4.3 (B) shows the 
two autoradiographs obtained. No hybridisation signal was seen in the group A 
recombinant phage, lane 5, for either the 2.1Kb or 600bp probe. A positive signal had 
been obtained previously (figure 3.11 b and c, lane 7). The hybridisation experiment 
indicated that there was a problem with the probe. Both probes however, did 
hybridise to the pGEM7Z 3. OKb band indicating that they were slightly contaminated 
with some of the vector DNA. Whilst this was annoying, it did provide a positive 
control for the subsequent hybridisation experiments in which these batches of probes 
were used. 
4.4.2 Sequencing of Group A Subclones 
Since the Ero RI restriction pattern of the group A recombinant phage bore no 
resemblance to the published maps of CYP4AJ or CYP4A2, it was decided to obtain 
some sequence data for each subclone to see if similarity existed to any of the other 
published sequences. 
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A • 
800--. ＲﾷＱｾｾｾ＠
- 7 ·0 
- 4 ·7 
- 3 ·0 
123456 123456 123456 
Figure 4.3 (A) Digestion of recombinant group A phage and plasmid 
DNA with the restriction enzyme Eco RI. (B) Southern blot of group A 
DNA hybridised to rat CYP4Al 600bp and full length 2.1Kb eDNA 
probes. 
Lane 1 and 6 : A. Hind ill molecular weight markes 
2: A: 5/1/2 : pGEMA4.7 
3: A: 7/2/14: pGEMA5.7 
4: A: 5/1/5 : pGEMA7.0 
5: Recombinant phage group A (AL2) 
NB The hybridisation signal seen at 3.0kb, represents probe homology to the plasmid 
pGEM7Z (refer to section 4.4.1). 
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6J..Lg of the recombinant plasmids pGEMA7.0 and pGEMA4.7 were denatured by 
alkali (section 2.7.2) and sequenced using Sequenase™ version 2.0 (section 2.7). 
The T7 and SP6 polymerase promoters flanking the pGEM7Z plasmid multiple 
cloning site (Figure 2.2) were used as convenient specific priming sites to sequence 
each recombinant plasmid in the 5'-3' and 3'-5' direction respectively. After 24hr 
exposure to X-ray film, an autoradiograph was obtained (Figure 4.4). As shown, 
approximately 200 nucleotides could be read. 
The sequence data obtained was analysed using the Micro genie ™ software. 
Comparison of these sequences with those previously published, namely the genomic 
sequences CYP4A 1 and CYP4A2, revealed no sequence identity. The sequences were 
then compared to the other published sequences for the CYP4A eDNA's. Again no 
homology was identified, but since the four recombinant sequences might contain 
intronic sequences they would not necessarily align to any published eDNA. 
The sequences were compared with the database held in the Microgenie software. A 
91-96% match was found for pGEMA4.7 and pGEMA7.0 sequences, respectively, 
with that of bacteriophage lambda (Figure 4.5). The results from the sequencing were 
confirmed when the filter obtained from the gel in Figure 4.3 (A) was probed with a. 
32PdCTP labelled lambda DNA. Figure 4.6 shows the autoradiograph from this 
experiment. Lane 5 quite clearly shows that the inserts in the recombinant phage are 
homologous to the "A probe as are the insert bands in the recombinant plasmids 
pGEMA7.0 (lane 4) and pGEMA4.7 (lane 2). 
The rat genomic library used in this study was made in the late 1970's and had been 
obtained by this laboratory in 1986. The first libraries made, such as those made in the 
late 1970's, seem to suffer from the problem of lambda DNA re-packaging into the 
phage arms. It was not realised that this was going to prove such a problem until I 
discovered that group A recombinant phage contained lambda DNA. Subsequently, as 
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pG EMA7 .0 
SP6 T7 
ATCGATCG SP6 T7 ATCGATCG 
Figure 4.4 An autoradiograph of the sequencing gel from the sequencing 
of recombinant plasmids pGEMA 7.0 ｾ､＠ pGEMA4.7. 
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(I) 95.5% identity in 178 bp over1ap 
10 20 30 
pGEMA7.0 (A7.0) ACCTTTATTGGCCTCG-AACCACCGAGCCGGA 
II I I I I I I I I I I I I I I I I I I I I I I I I I I 
GACTTTA-TGGCCTCGAAACCACCGAGCCGGA Lambda 
31580 31590 31600 
40 50 60 70 80 90 
(A7.0) AC-TCATGAAATCCCGGAGGTAAAACGGGCATTTCAGTTCAAGGCCGTTGCCGTCACTGC 
II 11111111111111 I 11111111111111111111111111111111111111 
Lambda ACTTCATGAAATCCCGGGAGGTAAACGGGCATTTCAGTTCAAGGCCGTTGCCGTCACTGC 
31610 31620 31630 31640 31650 31660 
100 110 120 130 140 150 
(A7.0) ATAAACCATCGGGAGAGCAGGCGGTACGCATAGTTTCGTCGCGATAGATGATCGGGGATT 
11111111111111111111111111111111 111111111111111111111111111 
Lambda ATAAACCATCGGGAGAGCAGGCGGTACGCATACTTTCGTCGCGATAGATGATCGGGGATT 
31670 31680 31690 31700 31710 31720 
160 170 
(A7.0) CAGTAACATTCACGCCGGAAGTGAATTC 
1111111111111111111111111111 
Lambda CAGTAACATTCACGCCGGAAGTGAATTC 
31730 31740 31750 
(II) 91.9% identity in 185 bp overlap 
1 10 20 
pGEMA4.7 (A4.7) GATCCGGGAGGCGGAAGAAACAAAAAAAAG 
111111111111111111111111111111 
GATCCGGGAGGCGGAAGAAACAAAAAAAAG Lambda 
22350 22360 22370 
30 40 50 60 70 80 
(A4.7) CCTGATGCAGGTAGCCAGTGAGCATATTGCNNNGCTTCAGGATGCTGCAGATCTGGAAAT 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I : : : I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Lambda CCTGATGCAGGTAGCCAGTGAGCATATTGCGCCGCTTCAGGATGCTGCAGATCTGGAAAT 
22380 22390 22400 22410 22420 22430 
90 100 110 120 130 140 
(A4.7) TGCAACNGAGGAAGAAACCTCGTTNCTGG-ANNCTGGAAGAAGTATCGNGTNTTNCTGAA 
111111: 1111111111111111:1111 1::111111111111111:11:11:11111 
Lambda TGCAACGAAGGAAGAAACCTCGTTGCTGGAAGCCTGGAAGAAGTATCGGGTGTTGCTGAA 
22440 22450 22460 22470 22480 22490 
150 160 170 180 
(A4.7) CCGTNTTGAGACATCAACTGCNCCTGATATTGAGT 
1111:1111 11111111111:1111111111111 
Lambda CCGTGTTGATACATCAACTGCACCTGATATTGAGT 
22500 22510 22520 22530 
Figure 4.5 Sequence alignment of recombinant plasmids (I) pGEMA 7. 0 
(sequenced with the T7 primer) and (II) pGEMA4.7 (sequenced with the 
SP6 primer) to that of bacteriophage lambda. 
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LANE 1 2 3 4 5 6 
Sl ZE (Kb) 
23 
9·4 
6·5 
4 ·4 
2·3 2·0 
Figure 4.6 Autoradiograph of Southern Blot obtained from the gel in 
figure 4.3 (A), hybridised to radiolabelled bacteriophage lambda DNA. 
Lane 1 and 6 : A. Hind ill molecular weight markes 
2: A: 5/1/2 : pGEMA4.7 
3: A: 7/2/14: pGEMA5.7 
4: A: 5/1/5 : pGEMA7.0 
5: Recombinant phage group A (AL2) 
NB The hybridisation signal seen at 3.0kb, represents probe homology to the plasmid 
pGEM7Z (refer to section 4.4.1). 
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a matter of routine, Southern blots of the remaining groups were probed with a A, 
probe. 
4.5 SUBCLONING RESULTS: GROUP B 
Ligations were carried out as detailed in section 2.4.3 .3 and transformation of 
competent JMI 09 cells performed as described in section 2.4.4. Table 4.2 shows the 
results obtained from the first attempt at subcloning the insert fragments using the 
shotgun approach. The control ligation plates (plates 1-4) were very similar to those 
obtained previously for the subcloning of group A (Table 4.1), indicating that the 
stored cells were still competent, that the pGEM7Z had been linearized and that the 
T4 DNA ligase was working efficiently. Of the 97 white colonies (from plates 5,6 and 
7), 48 still remained white after re-streaking on fresh indicator plates, and these were 
further screened using the cracking procedure (section 2.4.4.3). From this screen, 32 
colonies were identified as possibly containing insert DNA and to confirm this, DNA 
was prepared by the STET method (section 2.4.1), digested with the Eco RI and 
electrophoresed on a 1 °/o agarose gel. Out of the 32 DNA preparations 18 were 
shown to contain inserts: three contained a 5.5Kb insert, one a 4.0Kb insert, four a 
2.5Kb insert, three a 2.3Kb insert, three a 1.8Kb insert and four contained a 1.0Kb 
insert (data not shown). 
The 8. SI<b fragment was not subcloned using the shotgun approach and therefore an 
attempt to subclone this fragment by electrophoresing Eco RI digested group B phage 
DNA (AL4) on a 1% agarose gel and cutting out the 8.5Kb band was made. The 
DNA was extracted from the agarose with phenol/chloroform (section 2.2.1). 
Ligations and transformations were carried out as before and the results can be seen in 
Table 4.3. Once again the control plates, 1-4, indicate that the JM109 cells were still 
competent, that the pGEM7Z had been linearized and that the T4 DNA was working. 
The total number of white colonies after re-streaking onto fresh indicator plates was 
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PLATE DNA ENZYME MOLAR WHITE BLUE 
RATIO COLONIES COLONIES 
1 * NoDNA 
- - - -
2 * pGEM7Z (20ng) 
- -
10 600 
3 * pGEM7Z (20ng) EcoR1 
-
1 7 
4 pGEM7Z (20ng) EcoR1 
-
7 200 
Sa pGEM7Z (20ng) + grp B EcoR1 1:1 (V:I) 37 200 
Sb pGEM7Z (20ng) + grp B EcoR1 1:1 (V:I) 15 100 
6a pGEM7Z (20ng) + grp B EcoR1 1:3 (V:I) - 25 
6b pGEM7Z (20ng) + grp B EcoR1 1:3 (V:I) - 12 
7a pGEM7Z (20ng) + grp B EcoR1 3:1 (V:I) 16 300 
7b pGEM7Z (20ng) + grp B EcoR1 3:1 (V:I) 29 400 
Table 4.2 Cloning strategy and results of shotgun subcloning of the 
recotnbinant phage group B (AL4) inserts into pGEM7Z. 
Plates 1-4 were plated at one dilution (1 OOJJ.l) 
Plates 5-7 were plated at two dilutions (a= 100JJ.l, b = 200JJ.l) 
* = no ligase added 
Eco RI = indicates that the plasmid had been linearised before ligation 
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PLATE DNA ENZYME MOLAR WHITE BLUE 
RATIO colonies colonies 
I *No DNA 
- - - -
2 *pGEM7Z (20ng) - - 5 400 
3 *pGEM7Z (20ng) EcoR1 
- -
4 
4 PGEM7Z (20ng)+8.5Kb EcoR1 - 10 200 
Sa pGEM7Z (20ng)+8.5Kb EcoR1 1:1 (V:I) 4 300 
Sb pGEM7Z (20ng)+8.5Kb EcoR1 1:1 (V:I} 14 500 
6a pGEM7Z (20ng}+8.5Kb EcoRl 1:3 (V:I) 6 200 
6b pGEM7Z (20ng}+8.5Kb EcoR1 1:3 (V:I) 14 400 
7a pGEM7Z (20ng}+8.5Kb EcoR1 3:1 (V:I) 18 200 
7b pGEM7Z (20ng)+8.5Kb EcoR1 3:1(V:I) 10 500 
Table 4.3 Cloning strategy and results of subcloning of the 8.5Kb Eco RI 
insert fragment frotn recombinant phage group B (AL4) into pGEM7Z. 
Plates 1-4 were plated at one dilution (1 OOJ.!l) 
Plates 5-7 were plated at two dilutions (a = 1 OOJ.!l, b = 200J.!l) 
* = no ligase added 
Eco RI = indicates that the plasmid had been linearised before ligation 
120 
reduced from 65 to 25. The cracking procedure was performed on these 25 colonies 
and the results indicated that a possible 7 contained inserts. DNA was prepared from 
the 7 colonies using the STET method (section 2.4.1) and digested with Eco RI. Four 
out of the seven colonies were found to contain inserts: two contained a 5.5Kb insert, 
one a 2.3Kb insert and one contained a 1.8Kb insert. It was obvious that the 8.5Kb 
fragment had not been subcloned. One further attempt was made to subclone this 
fragment. Again the group B phage DNA was digested with Eco RI, which was 
subsequently electrophoresed on a 1% agarose gel. The 8.5Kb band was excised from 
the gel and the DNA purified using Geneclean TM (section 2.2.6.1). Ligations and 
transformations were performed as before and once again no recombinant pGEM7Z 
clone containing an 8.5Kb insert was isolated. Sometimes, for no apparent reason, 
DNA fragments can be difficult to subclone. In this case the 8.5kb insert should have 
been digested with another enzyme and subcloned in two fragments, but this was not 
attempted. 
4.5.1 Characterisation of Group B Subclones 
A Qiagen plasmid DNA preparation (section 2.4.2.2) was performed on the subclones 
containing the six different sized inserts. 1 Jlg of DNA of each subclone was digested 
with Eco RI along with Ｕｾｌｧ＠ of phage DNA and electrophoresed on a 1% agarose gel 
(Figure 4. 7 A). The 5.5Kb and 2.3Kb fragments of the original phage have been 
ligated successfully into pGEM7Z (lanes 8 and 4 respectively). The origin of the other 
four inserts is unknown. The gel in Figure 4. 7 A was Southern blotted and probed 
with radiolabelled lambda phage DNA. The only bands to show homology to the 
probe were the A. Hind III markers and the right and left phage arms of the group B 
Eco RI digested phage DNA as expected (data not shown). 
The filter was then stripped of its probe (section 2.6.5) and re-probed with the rat 
600bp eDNA CYP4Al probe radiolabelled with a.32PdCTP (section 2.6.4.1). The 
filter was washed under stringent conditions: two 20min washes in 2 X sse I 0.1% 
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A 8 
- 23kb 
- 9-4 
- 8·5 
- 4•4 
-····· 
-····· 
-····· 
-····· 
1 2 3 4 s e 7 a 9 10 12345878810 1234 5 878 810 
Figure 4. 7 (A) Digestion of recombinant group B phage and plasmid 
DNA with the restriction enzyme Eco RI. (B) Southern blot of group B 
DNA hybridised to rat CYP4Al 600bp and full length 2.1Kb eDNA 
probes. 
Lane 1: A Hind III molecular weight markers 
2: pGEMBl.O 7: pGEMB1.8/4.0 
3: pGEMB1.8 8: pGEMB5.5 
4: pGEMB2.3 9: pGEMB2.9 
5: pGEMB2.5 10: Recombinant phage group B (AL4) 
6: -
NB The hybridisation signal seen at 3.0kb, represents probe homology to the plasmid 
pGEM7Z (refer to section 4.4.1). 
122 
(w/v) SDS at room temperature, two 30min washes in 0.1 x SSC I 0.1% (w/v) SDS at 
55°C and a final rinse in 5 X SSC at room temperature. After autoradiography the 
filter was washed once more to remove the radiolabelled probe, re-probed with the rat 
2. I Kb full length eDNA CYP4A 1 and washed under the same stringent conditions. 
Figure 4.7B shows the two autoradiographs obtained. It can be seen that the 8.5Kb 
and 2.3Kb band from the recombinant phage (lane 1 0) gave a positive hybridisation 
signal, as expected, to the 2.1Kb eDNA probe (although very weak), and that the 
recombinant plasmid pGEMB2.3 (lane 4) also gave a positive signal confirming that it 
contains the 2.3Kb phage insert . 
4.5.2 Sequencing of Group B Subclones 
6 J..tg of the recombinant plasmids pGEMB5.5 and pGEMB2.3 were denatured by 
alkali (section 2.7.2) and sequenced (section 2.7) using the T7 and SP6 primers. After 
24hr exposure to X-ray film an autoradiograph was obtained and the sequence read . 
The sequences were analysed using the Micro genie TM software and a comparison was 
made to the published sequences for the CYP4A family. 
The sequence of pGEMB2.3 was analysed by performing a nucleotide matrix 
comparison to the published sequences of the CYP4A family. 
Where significant similarity exists between one sequence and another, a 
series of dots is generated, totally similar sequences will show a continuous line from 
the upper left corner to the lower right corner. This type of analysis (data not shown) 
revealed that the sequence ofpGEMB2.3 aligned to CYP4A2 at positions 11,046bp to 
13,222bp (Figure 4.8). This result was somewhat surprising, since the preliminary 
restriction map of group B (Figure 3.12) suggested that it was not the genomic 
sequence of CYP4A2. At the nucleotide level, CYP4A2 and CYP4A3 share 97% 
sequence sim!larity (Kimura et a!., 1989a). These results indicate that the group B 
recombinant phage may represent the genomic sequence of CYP4A3. The sequence of 
pGEI\1B2.3 as compared to the CYP4A3 eDNA can be seen in Figure 4.9 . . The 5' end 
of this clone, which was sequenced with the T7 primer is obviously intronic sequence, 
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i) 94.4% identity in 284 bp overlap 
10 20 
pGEMB2.3/T7 primer (B2.3) GAATTC--CTC-GTTAATTCAAATG-AAAA 
111111 Ill 111111111111 1111 
CYP4A2 (4A2) GAATTCAACTCTATTAATTCAAATGAAAAA 
11050 11060 11070 
30 40 50 60 70 80 
(B2.3) GAATTTTAAAAATGTA---TTTTTCTGCCACGTTCCTTGCTGAGACAGGAGAATGTAGCC 
1111111111111111 11111111111111111111111111111111111111111 
(4A2) GAATTTTAAAAATGTACTTTTTTTCTGCCACGTTCCTTGCTGAGACAGGAGAATGTAGCC 
11080 11090 11100 11110 11120 11130 
90 100 110 120 130 140 
(B2.3) AATTACTTATACCTGATGCAGCCATCATTCCTTCTTCCNGCCTTAGACTCATGTGTCCCT 
Ill llllllllllllllllllllllllllllllll 1:1111111 1111111111111 
(4A2) AATCACTTATACCTGATGCAGCCATCATTCCTTCTTTCTGCCTTAGCCTCATGTGTCCCT 
11140 11150 11160 11170 11180 11190 
150 160 170 180 190 200 
(B2.3) CACTGACATCTTATGAAAAGTTACACACTCCTTGCTG-CCTATAGCCTGAAGTGTGGTGG 
1111111111111111111111111111111111111 1111111111111111111111 
(4A2) CACTGACATCTTATGAAAAGTTACACACTCCTTGCTGCCCTATAGCCTGAAGTGTGGTGG 
11200 11210 11220 11230 11240 11250 
210 220 230 240 250 260 
(B2.3) GTCCTTGAGTAAAGCACCTTAGCTACCTTAGAGTCCAGGAGGAGGTGAATG-CACAGAGG 
111111111111111111 I 111111111111111111111111111111 11111111 
(4A2) GTCCTTGAGTAAAGCACCCTTGCTACCTTAGAGTCCAGGAGGAGGTGAATGCCACAGAGG 
11260 11270 11280 11290 11300 11310 
270 
(B2.3) ATAGGGAGCTGGCT 
I II I I I I I II I I I I 
(4A2) ATAGGGAGCTGGCTG 
11320 11330 
ii) 97.6% identity in 206 bp overlap 
pGEMB2.3/SP6 primer (B2.3) GGTAGAGAGAAATGAATAGGTTTTTGCTACT 
IIIII 11111111111 111111 IIIII 
CY.P4A2 TCTATGAAATAATAGTACTGATGCAGAACAGTAGATAGAAATGAATA-GTTTTTACTACT 
12990 13000 13010 13020 13030 13040 
40 50 60 70 80 90 
(B2.3) TTGGGCCAAACTGTAAATAAATCCATTTCACTTCATTAATTTCTGTTTCATATTTTTATT 
111111111111111111111111111111111111111111111111111111111111 
CY.P4A2 TTGGGCCAAACTGTAAATAAATCCATTTCACTTCATTAATTTCTGTTTCATATTTTTATT 
13050 13060 13070 13080 13090 13100 
100 110 120 130 140 150 
(B2.3) TAAGATACAGAAATCTACTCAGCATGAACCTATGCTCCCTGAAGCACTTTT-GCAAGCCA 
111111111111111111111111111111111111111111111111111 IIIII II 
CY.P4A2 TAAGATACAGAAATCTACTCAGCATGAACCTATGCTCCCTGAAGCACTTTTGGCAAGTCA 
13110 13120 13130 13140 13150 13160 
160 170 180 190 200 
(B2.3) GCCATCAGAGAAGCCTGTTGCCATCTGCTCCCCACTGTTAGAATGGGGTAGAATTC 
11111111111111111111111111111111111111111111111111111111/ 
CY.P4A2 GCCATCAGAGAAGCCTGTTGCCATCTGCTCCCCACTGTTAGAATGGGGTAGAATTC 
13170 13180 13190 13200 13210 13220 
Figure 4.8 Sequence alignment of pGEMB2.3 to the genomic 
sequence of CYP4A2. i) pGEMB2.3 sequenced with the T7 primer, ii) 
pGE:MB2.3 sequenced with the SP6 primer. 
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i) 75.0% identity in 24 bp overlap 
170 180 190 200 210 220 
B2.3T7 ATGGCTGCATCAGGTATAAGTAATTGGCTACATTCTCCTGTCTCAGCAAGGAACGTGGCA 
I I I II I I I I I I I I I I I I I 
CY.P4A3 ATTCTCCTCGCCATAGCCATGCTTATCTGCCATTCT-CAGGAGGAGCAAGGAACTGCATT 
1320 1330 1340 1350 1360 1370 
230 240 250 260 270 
B2.3T7 GAAAAATACATTTTTAAAATTCTTTTCATTTGAATTAACGAGGAATTC 
CY.P4A3 GGGAAACAGTTTGCCATGAATGAGCTGAAGGTGGCTGTGGCCCTGACCCTGCTTCGCTTT 
1380 1390 1400 1410 1420 1430 
ii) 98.4% identity in 64 bp overlap 
10 20 30 
B2.3Sl?6 GGTAGAGAGAAATGAATAGGTTTTTGCTACT 
I I I I Ill I I I I I I I I I I I I I I I I II I II I 
CY.P4A3 TCTATGAAATAATAATTCTGATACAGAACAGTAGAGAGAAATGAATA-GTTTTTGCTACT 
2050 2060 2070 2080 2090 2100 
40 50 60 70 80 90 
B2.3 TTGGGCCAAACTGTAAATAAATCCATTTCACTTCATTAATTTCTGTTTCATATTTTTATT 
1111111111111111111111111111111111 
CY.P4A3 TTGGGCCAAACTGTAAATAAATCCATTTCACTTC 
2110 2120 2130 2140 
100 110 120 130 140 150 
B2.3 TAAGATACAGAAATCTACTCAGCATGAACCTATGCTCCCTGAAGCACTTTTGCAAGCCAG 
Figure 4.9 Sequence alignment of pGEMB2.3 to the eDNA sequence 
of CYP4A3. i) pGEMB2.3 sequenced with the T7 primer, ii) pGE:MB2.3 
sequenced with the SP6 primer. 
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as little homology exists between the clone and the CYP4A3 eDNA. The 3' end of 
pGE:MB2.3 aligns to CYP4A3 at positions 2078bp to 2140bp (Figure 4.9, ii.) and 
exhibits 98.4% sequence similarity. 
The recombinant plasmid pGEMBS. 5 was also sequenced with both the T7 and SP6 
primers, however no sequence identity was observed with either CYP4A2 or CYP4A3. 
This is perhaps not surprising since the results presented in Figure 3 .liB and C and 
Figure 4. 7B and C demonstrate that no homology to either the 600bp or 2.1kb probe 
exists. The pGErvffi5.5 sequence was then used to scan the GenEivfBL data base 
using the program FAST A to look for sequences sharing identity with it. This scan 
revealed nothing of significance (data not shown). 
4.6 SUBCLONING RESULTS: GROUP C 
Ligations were carried out as detailed in section 2.4.3.3 and transformation of 
competent JM109 cells performed as described in section 2.4.4. Table 4.4 shows the 
results obtained from the first attempt at subcloning the insert fragment, using the 
shotgun approach. Out of the 66 white colonies obtained on the test ligation plates 
(plates 5-7), 57 remained white after re-streaking on fresh indicator plates and these 
were further screened using the cracking procedure (section 2.4.4.3). From this 
screen, 28 colonies were identified as possibly containing insert DNA and to confirm 
this, DNA was prepared by the STET method (section 2.4.1). Of the 28 DNA 
preparations, eleven were shown to contain a 2.0Kb insert, six a 6.7Kb insert and 
eleven of the DNA preparations gave one single band at 3.0Kb. Since pGEM7Z is 
3. OKb in size and an insert of approximately the same size was being looked for, these 
3 .OKb clones isolated had to be investigated further. If group C represented the 
genomic sequence of CYP4A2, then according to the restriction map of the published 
sequence, the 5' end 3.0Kb Eco RI fragment would not have a Bgl I site. Bgl I cuts 
twice within the pGEM7Z sequence, therefore if a double digest using Eco RI and Bgl 
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PLATE DNA ENZYME MOLAR WHITE BLUE 
RATIO colonies colonies 
1 *No DNA - - .. -
2 *pGEM7Z (20ng) 
- -
2 300 
3 *pGEM7Z (20ng) EcoRl 
-
.. 18 
4 pGEM7Z (20ng)+grp C EcoRI .. 7 300 
Sa pGEM7Z (20ng)+grp C EcoRI 1:1 (V:I) 31 200 
Sb pGEM7Z (20ng)+grp C EcoR1 1:1 (V:I) 6 100 
6a pGEM7Z (20ng)+grp C EcoRl 1:3 (V:I) 10 100 
6b pGEM7Z (20ng)+grp C EcoRI 1:3 (V:I) 5 100 
7a pGEM7Z (20ng)+grp C EcoR1 3:1 (V:I) 8 150 
7b pGEM7Z (20ng)+8.5Kb EcoRI 3:1 (V:I) 6 100 
Table 4.4 Cloning strategy and results of shotgun subcloning of the 
recombinant phage group C (AL7) inserts into pGEM7Z. 
Plates 1-4 were plated at one dilution (IOOJ.Ll) 
Plates 5-7 were plated at two dilutions (a = 1 OOfll, b = 200J.ll) 
*=no ligase added 
Eco RI = indicates that the plasmid had been linearised before ligation 
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I was performed on one of these clones then the expected banding pattern (if it does 
contain a 3.0Kb insert) would be: 3.0Kb, 1.5Kb, 1.3Kb and O.lKb. Figure 4.10 shows 
the ethidium bromide stained gel of one of these clones digested with Eco RI and Bgl I 
(lane 3). It shows the banding pattern that was expected, indicating that this clone 
does indeed contain a 3. OKb insert. 
4.6.1 Characterisation of Group C Subclones 
A Qiagen plasmid DNA preparation (section 2.4.2.2) was performed on the subclones 
containing the six different sized inserts. 1 J..lg of DNA of each subclone was digested 
with Eco RI along with 5 ｾｴｧ＠ of phage DNA and electrophoresed on a 1% agarose gel 
(Figure 4.11 A). As can be seen, the three Eco RI fragments from the original phage 
(lane 5) have been successfully ligated into pGEM7Z (lanes 2, 3 and 4). This gel was 
then southern blotted (section 2.6.1) and hybridised to the rat 600bp eDNA CYP4Al 
probe (section 2.6.2). The nylon filter was washed under stringent conditions: two 
20min washes in 2 X sse I O.l% (wlv) SDS at room temperature, two 30min washes 
in 0. I X sse I O.l% (wlv) SDS at ssoe and a final rinse in 5 X sse at room 
temperature. After autoradiography, the filter was washed to remove the radiolabelled 
probe (section 2.6.5), re-probed with the rat full length 2.1Kb eDNA CYP4Al and 
washed under similar stringent conditions. Figure 4.11 B shows the two 
autoradiographs obtained. The fragments sharing homology to the 600bp probe in the 
recombinant phage (lane 5) are the 6.7Kb and the 3.0Kb bands. The recombinant 
plasmids pGEMe6.7 and pGEMC3 .0 (lanes 2 and 4 respectively) also show homology 
to the 600bp probe as expected. When probed with the 2.1I<b probe the 6. 7Kb and 
2.0Kb fragments lit up in the recombinant phage (lane 5) gave a positive hybridisation 
signal along '.vith pGEMe6.7 and pGEMe2.0 (lanes 4 and 2 respectively). These 
results confirm the earlier findings and the preliminary restriction map (Figure 3.12). 
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Ｍ ＭＭ ｾ ＭＭｾｾｾｾ ＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭＭ
3 2 1 
23Kb 
9·4 
6 ·5 
4·4 
2·3 
2·0 
Figure 4.10 Digestion of recombinant plasmid pGEMC3.0 with the 
restriction enzymes Eco RI and Bgll. 
Lane 1: A. Hind ill molecular weight markers 
2: pGEMC3.0 Eco RI 
3: pGEMC3.0 Eco RI!Bgl I digested 
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A 
123456 
- 23kb 
- 9·4 
"·5 
- 4·4 
2·3 
- 2·0 
B 
60 0 bp 2- 1 kb 
3·0kl 
- 2· ku 
1 2 3 4 56 1 2 3 4 5 6 
Figure 4.11 (A) Digestion of recombinant group C phage and plasmid 
DNA with the restriction enzyme Eco RI. (B) Southern blot of group C 
DNA hybridised to the rat CYP4Al 600bp and full length 2.1Kb eDNA 
probes. 
Lane 1 and 6: A. Hind ill molecular weight markers 
2:pGEMC2.0 
3:pGEMC3.0 
4:pGEMC6.7 
5: recombinant phage group C (AL 7) 
NB The hybridisation signal seen at 3.0kb, represents probe homology to the 
plasmid pGEM7Z (refer to section 4.4.1). 
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4.6.2 Sequencing of Group C Subclones 
In order to confirm that group C is in fact the genomic sequence of CYP4A2 as 
suspected, it was necessary to obtain some sequence data from the three recombinant 
plasmids pGI:MC6.7, pGEMC3.0 and pGEMC2.0. 6j.Lg of each recombinant plasmid 
was denatured by alkali (section 2.7.2) and sequenced (section 2.7) using the T7 and 
SP6 primers. After 24hr exposure to X-ray film an autoradiograph was obtained and 
the sequence read. The sequences were analysed using the MicrogenieTM software and 
a matrix comparison to the published sequence of CYP4A2 was made (data not 
shown). This revealed sequence identity between the subclones and CYP4A2, and 
indicated the relative position of each subclone as compared to CYP4A2 (Figure 4.12). 
The subclones were found to be almost identical to the published sequence of CYP4A2 
(Kimura et.al., 1989), pGEMC3.0 being similar to bases -1829/+1234, pGEMC7.0 
being similar to bases + 1877 /+8593 and pGEMC2.0 similar to bases +8593/+ 10,770. 
It was concluded that group Cis in fact CYP4A2 and contains -1829bp of 5' flanking 
sequence whtch could be investigated further. 
4.7 SUBCLONING RESULTS: GROUP D 
Ligations were carried out as detailed in section 2.4.3.3 and transformation of 
competent JM I 09 cells performed as described in section 2.4 .4. Table 4. 5 shows the 
results obtained from the first attempt at subcloning the insert fragments using the 
shotgun approach. Although the competency of the cells was reduced (plates 1-4) a 
number of white colonies was obtained and these were screened further using the 
cracking prot:;edure (section 2.4.4.3). Out of 34 colonies screened 18 appeared to 
contain inserts, five containing a 0.92Kb insert, two a I.OKb insert, three a 2.5Kb 
insert, two a 7.2Kb insert and two containing an 11.5Kb insert. The 4.8Kb, 3.4Kb and 
1. 75Kb fragments present in the original phage, were not subcloned using the shotgun 
approach therefore an attempt to subclone these fragments by excising the individual 
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i) pGEMC3.0 sequenced with the T7 primer (top), compared to CY.P4A2 
(bottom sequence), 95.6% similarity. 
1 .............•.......•. GAATTCTTTCAGGGATTTTTGTCATTC 27 
I I I I I I I I I I I I I II I I I I I I I II I I 
600 AACTGTTTGATTGTGTTTTCCTGGAATTCTTTCAGGGATTTTTGTGATTC 649 
28 CTCTCTGTAGGCTTCTACTTGTTTATTTATGTTTTGCCGTTTTTCTACTN 77 
11111111111111111111111111111111111 I 11111111 
650 CTCTCTGTAGGCTTCTACTTGTTTATTTATGTTTTCCTGTTTTTCT •. CT 697 
78 CGGGGCGTTCTTCATGTCTTTCTTGAAGTCCTCCAGCATCATGATCAAAT 127 
Ill 11111111111111111111111111111111111111111111 
698 ACGGGGGTTCTTCATGTCTTTCTTGAAGTCCTCCAGCATCATGATCAAAT 747 
128 ATGATTTTNAAACTAGATCTTCCTTTTCTGGTGTGTTTGGATATTCCGTG 177 
I I I I I I I I : I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
748 ATGATTTTGAAACTAGATCTTGCTTTTCTGGTGTGTTTGGATATTCCGTG 797 
17 8 TTTGCTT. . . . . . . . . . • . . • . . • . . • . . . . . . . . . • . . . . . . . . . . . . . 184 
I I II I I I 
798 TTTGCTTTGGTGGGAGAATTGGGCTCCGATGATGCCATGTAGTCTTGGTT 847 
ii) pGEMC3.0 sequenced with the SP6 primer(top) compared to CY.P4A2 
(bottom sequence), 99.3% similarity. 
304 ................... TTACACACTTAGCCACATTTAAGAATATTAA 274 
1111111111111111111111111111111 
3350 AGAGGCACTCAGTGTGGGATTACACACTTAGCCACATTTAAGAATATTAA 3399 
273 ACTCAGAGCTCTTTCCCCAGTAGC.TCTCTAAGAAGCCTTAGCTTCATCT 225 
111111111111111111111111 1111111111111111111111111 
3400 ACTCAGAGCTCTTTCCCCAGTAGCTTCTCTAAGAAGCCTTAGCTTCATCT 3449 
224 AACAAGGGNCCAGGATCTGGCTAGGGCAAATCCGTGGACATAGCAATGGC 175 
I I I I I I I I : I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
3450 AACAAGGGTCCAGGATCTGGCTAGGGCAAATCCGTGGACATAGCAATGGC 3499 
174 CTAGATGGAAGGNAC.AAAAGGACAGATCATCAAGCCAACTCAAATTTCT 126 
I I I I I I I I I I I I : I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
3500 CTAGATGGAAGGGACAAAAAGGACAGATCATCAAGCCAACTCAAATTTCT 3549 
125 ACCTTTTCCTGAACATTCTGAGCAATGCTCCTGTGGTGGTCCTGCATCTC 76 
11111111111111111111111111111111111111111111111111 
3550 ACCTTTTCCTGAACATTCTGAGCAATGCTCCTGTGGTGGTCCTGCATCTC 3599 
75 CCAT.CCACACAAAGCACTAGATGTCAAAGAACATCTTTATGAATTTATC 27 
1111 111111111111111111111111111111111111111111 II 
3600 CCATACCACACAAAGCACTAGATGTCAAAGAACATCTTTATGAATTTGTC 3649 
26 TTTTCTTTGATGTATGTTCCCAAAGG ........................ 1 
1111111111111 111111111111 
3650 TTTTCTTTGATGTCTGTTCCCAAAGGACAGAGAATTCCAGCAGGTTCTTA 3699 
132 
. ·------------------------------------------------------------
iii) pGEMC6.7 sequenced with the T7 primer (top) compared to CY.P4A2 
(bottom sequence), 99% similarity. 
1 ............................. GAATTCAGTGGGAGGAATGAA 21 
111111111111111111111 
4300 TGTTGAGCTCTGAAACCCACATTGAATTCGAATTCAGTGGGAGGAATGAA 4349 
. . 
22 CTAACTCCACAGAGTTGTCTTCTGAACTCTACACAGACACTGTAGCAGGT 71 
11111111111111111111111111111111111111111111111111 
4350 CTAACTCCACAGAGTTGTCTTCTGAACTCTACACAGACACTGTAGCAGGT 4399 
72 GCACCACAAATAATAATTTTTAAAATTCTGAAAAATCGAAAGAAAAAGCT 121 
111111111111111111111111111111111111 1111111111111 
4400 GCACCACAAATAATAATTTTTAAAATTCTGAAAAAT.GAAAGAAAAAGCT 4448 
122 TGTAGTTTTGAACACCATCCTCCTATCTCNTCCTCAAGATCTGTCTTACT 171 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I : I I I I I I I I I I I I I I I I I I I I 
4449 TGTAGTTTTGAACACCATCCTCCTATCTGGTCCTCAAGATCTGTCTTACT 4498 
172 TTTCAGATCCAAAGCCTTATCAATCCCTTGCTCCCTGGATTGGTAAGTAT 221 
11111111111111111111111111111111111111111111111111 
4499 TTTCAGATCCAAAGCCTTATCAATCCCTTGCTCCCTGGATTGGTAAGTAT 4548 
222 ATTAAAATAAGGAGTGTGTTTTCTTCACTACTCTCTGGCTAATGGAGAA. 270 
1111111111111111111111111111111111111111111111111 
4549 ATTAAAATAAGGAGTGTGTTTTCTTCACTACTCTCTGGCTAATGGAGAAG 4598 
iv) pGEM6.7 sequenced with the ｓｾＶ＠ ｰｲｾｲ＠ (top) compared to CY.P4A2 
(bottom sequence), 95.7% similarity. 
1 ................ GTATTCCAATTCTGTG.AACTTAAAGCTGTGGAT 33 
I I 11111111111 11111111111111111 
10800 GTAAGCATTTCTTCTGATTTACCAATTCTGTGAAACTTAAAGCTGTGGAT 10849 
34 TAGCTNCCCACAGACAGGCTTCAGATGTGGCATTTTACTGGAAGACATAT 83 
IIIII: II 1111111111111111111111111111111111111 
10850 TAGCTCCCACAGAACAGGCTTCAGATGTGGCATTTTACTGGAAGACATAT 10899 
84 GACACAGTTTATCCCATAGTGAAGAATGTCATCTTAACCAGCTAAAAGCA 133 
11111111111111111111111111111111111111111111111111 
10900 GACACAGTTTATCCCATAGTGAAGAATGTCATCTTAACCAGCTAAAAGCA 10949 
134 TACTGCAGCCATTGGAGGATAGGANAGTCGCAGGTTGTCAAGTTCCTAGC 183 
I I I I I I I I I I I I I I I I I I I I I I I I : I I I I I I I I I I I I I I I I I I I I I I I I I 
10950 TACTGCAGCCATTGGAGGATAGGAGAGTCGCAGGTTGTCAAGTTCCTAGC 10999 
184 TTAAAT.................................... . . . . . . . . 189 
I II I I I 
11000 TTAAATATCCTTATCCTCTATGCATATTATTGTGTTTTTAGAATTCGAAT 11049 
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v) pGEMC2.0 sequenced with the SP6 primer (top) compared to CY.P4A2 
(bottom sequence), 99.8% similarity. Unfortunately, no sequence was 
obtained with the T7 primer. 
99 ....................... ACTCAGCATGAA.CTATGCTCCCTGAA 74 
111111111111 11111111111111 
13100 TTTTATTTAAGATACAGAAATCTACTCAGCATGAACCTATGCTCCCTGAA 13149 
73 GCACTTTTGGCAAGTCAGCCATCAGAGAAGCCTGTTGCCATCTGCTCCCC 24 
11111111111111111111111111111111111111111111111111 
13150 GCACTTTTGGCAAGTCAGCCATCAGAGAAGCCTGTTGCCATCTGCTCCCC 13199 
23 ACTGTTAGAATGGGGTAGAATTC 1 
11111111111111111111111 
13200 ACTGTTAGAATGGGGTAGAATTC 13222 
vi) Sequencing strategy of Group C recombinant plasmid clones, and 
comparison to the genomic Eco RI restriction map of CY.P4A2. The 
arrows represent the direction of each sequencing reaction. 
Eco Rl EcoRI EcoRI EcoRI 
I I I I I CYP4A2 
T7 (184bp) T7 {270bp) 
--7 ---7 
ｾｾ＠ ___ P_G_E_Mc_3_.o __ ｾＺＺｊｾｉ＠ ｾＭＭＭＭＭＭＭＭＭｰｇ｟ｅ｟ｍ｟｣｟･｟ＮＷＭＭＭＭＭＭＭＭＭＭｾＺＺｊｾｾｰｇ｟ｅ｟ｍ｟｣｟Ｒ｟ＮｯｾＺｊｾ＠
SP6 (304bp) SP6 (189bp) SP6 (99bp) 
Figure 4.12 i-v) Sequence alignment of Group C recombinant 
plasmid clones to the genomic sequence of CYP4A2. vi) diagram of 
the sequencing strategy and relative position of each recombinant 
plasmid clone as compared to CYP4A2. 
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PLATE DNA ENZYME MOLAR WIDTE BLUE 
RATIO colonies colonies 
I . *NoDNA 
- - - -
2 *pGEM7Z (20ng) - - - 50 
3 *pGEM7Z (20ng) EcoRI 
- -
4 
4 pGEM7Z (20ng) EcoRI - 2 50 
Sa pGEM7Z (20ng)+ grp D EcoR1 1:1 (V:I) - 14 
5b pGEM7Z (20ng)+ grp D EcoR1 1:1(V:I) 1 27 
6a pGEM7Z (20ng)+ grp D EcoRI 1:3 (V:I) 1 22 
6b pGEM7Z (20ng)+ grp D EcoRI 1:3 (V:I} 13 60 
7a pGEM7Z (20ng)+ grp D EcoRI 3:1 (V:I) 3 60 
7b pGEM7Z (20ng)+ grp D EcoRI 3:1 (V:I) 26 100 
Table 4.5 Cloning strategy and results of shotgun subcloning of the 
recombinant phage group D (AR4) inserts into pGEM7Z. 
Plates 1-4 were plated at one-dilution (IOOJ..I.l) 
Plates 5-7 were plated at two dilutions (a= IOOJ..I.l, b = 200J..1.l) 
* = no ligase added 
Eco RI = indicates that the plasmid had been linearised before ligation 
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bands from a 1% agarose gel and extracting the DNA using Geneclean ™ was made. 
Several attempts were made with no success (data not shown). 
4.7.1 Characterisation of Group D Subclones 
A Qiagen plasmid DNA preparation (section 2.4.2.2) was performed on the subclones 
containing the five different sized inserts. 1 J..lg of DNA of each subclone was digested 
with Eco RI along with 5 J..lg of phage DNA and electrophoresed on a 1% agarose gel 
(Figure 4.13 A). Lanes 3 and 4 indicate that the l.OKb and the 2.5Kb bands 
respectively, from the phage, have been successfully ligated into pGEM7Z. The origin 
ofthe 0.92Kb, 7.2Kb and the 11.5Kb inserts are unknown. It was thought that maybe 
lambda DNA had been subcloned again, therefore the gel was southern blotted anq 
probed with radiolabelled lambda DNA. The only bands to show homology to the 
probe were the AHind III markers and the right and left phage arms of the group D 
Eco RI digested phage DNA as expected (data not shown). 
The filter was then stripped of its probe (section 2.6.5) and re-probed with the rat 
600bp eDNA CYP4A 1 probe radio labelled with a.32PdeTP (section 2.6.4.1 ). The 
filter was washed under stringent conditions: two 20min washes in 2 X sse I 0.1% 
(wlv) SDS at room temperature, two 30min washes in 0.1 x SSC I 0.1% (w/v) SDS at 
55°e and a final rinse in 5 X SSe at room temperature. After autoradiography the 
filter was washed once more to remove the radiolabelled probe, re-probed with the rat 
2.1 Kb full length eDNA and washed under similar stringent conditions. Figure 4.13 B 
shows the two autoradiographs obtained. It can be seen that the 4.8Kb and 3.0Kb 
bands from the original phage (lane 7) gave a positive signal when hybridised to the 
2.1Kb eDNA probe, confirming the previous result seen in Figure 3.11 e, lane 4. 
However, when the same southern was hybridised to the 600bp probe, no bands 
shared any homology. This is in agreement with Figure 3.11 B, lane 4, but still in 
disagreement with the result seen in Figure 3.6 B, gel 1, lane 4. It was decided to 
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A 
12345678 
23kb 
- S·4 
- 8·5 
- 4 ·4 
2·3 
- 2·0 
II 
12345678 
ＲﾷＱｾｾﾷ＠
- 11·5 
- 7·2 
- 4·8 
- 3·0 
- 2·5 
- 1 ·0 
- O·S 
12345678 
Figure 4.13 (A) Digestion of recombinant group D phage and plasmid 
DNA with the restriction enzyme Eco RI. (B) Southern blot of group D 
DNA hybridised to the rat CYP4Al 600bp and full length 2.1Kb eDNA 
probes. 
Lanes 1 and 8: A. Hind ill molecular weight markers 
2: pGEMD0.92 5: pGEMD7.2 
3: pGEMDl.O 6: pGEMD11.5 
4: pGEMD2.5 7: ·recombinant phage group D (AR4) 
NB The hybridisation signal seen at 3.0kb, represents probe homology to the 
plasmid pGEM7Z (refer to section 4.4.1) 
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sequence the I. OKb insert to establish if it shared any sequence similarity to the 
CYP4A family and also to sequence the 2.5Kb insert. 
4. 7.2 Sequencing of Group D Subclones 
Ｖｾｴｧ＠ of the recombinant plasmids pGE:rvtD2.5 and pGE:rvtDl.O were denatured by 
alkali (section 2.7.2) and sequenced (section 2.7) using the T7 and SP6 primers. The 
sequences were analysed using Microgenie™ software and a comparison to the 
published sequences for the CYP4A family made. 
The sequence obtained from recombinant plasmid pGE:rvtD2.5 revealed no sequence 
similarity with the published members of the CYP4A family. This was not surprising 
since no homology to either the 2.1 kb or 600bp probe was obtained (Figure 4.13, lane 
4). This sequence was then used to scan the GenE.MBL data base using the program 
FAST A, however this revealed nothing of significance (data not shown). 
The sequence obtained from pGE:rvtDl.O (Figure 4.14) was found to have no similarity 
to the published members of the CYP4A family indicating that the last two 600bp 
hybridisations were the true result, ie negative. The sequence obtained using the T7 
primer (Figure 4.14 i) ) contained 15bp repetitive DNA sequence stretching for at least 
112bp (Figure 4. 14, ii) ) . This repetitive 15bp sequence along with the sequence for 
pGE:rviD I. 0 was used to scan the GenEMBL data base using the program FAST A. 
This revealed no significant homology to the sequences in the data base. The 
significance of the repetitive element is unknown, but probably ｩｮ､ｩｾ｡ｴ･ｳ＠ the position 
of pGEMD 1. 0 to be non-coding. 
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i) pGEMDl.O sequenced using the T7 primer. The sequence 
underlined represents the beginning of a 15bp repetitive 
element. 
1 GAATTCTTCA CTTTGCTCAA GGTGTACTTA ACAGCGATGT GGTTCTATAC 
51 GGTACAAGAA GCAGTCCCCT GCCTGCCCCT CCCAGAGCCA AATCTACAGA 
101 CTCCCCAGAA GTAACTCTGT TCAACCTTCC AACAATGTAC ACGTGGGGCT 
151 CTTCGTGCAC GCTCCTAGTC TGTGGCTCTG CTTCTGTCTC TTGTCCTCAT 
201 CACCCTCATG AGGAACCAGC ACTGGGACAG CCAGCACTGG GACAGCCAGC 
251 ACTGGGACAG CCAGCACTGG GACGGCCAGC ACTGGGACAG CCAGCACTGG 
301 GACAGCCAAC ACTGAGATGG CCAGCACT 
ii) Consensus sequence of 15bp repeat element. 
5' CCAGCACTGG GACAG 3' 
iii) pGEMDl.O sequenced with the SP6 primer 
1 TAGGCCTAGC CAAACCCTCG CTCAAGTCTG AGAGAGCAGA CGGAAGGTCT 
51 GTGGACAGGC CCAGTGCTAA CACTGTCACC TCCCACACAG CCTCTCCAGG 
101 AGATTTCAAC AAAGAGAAAG TGGAGCTAAA CAAGGGAATA AAACAAAGGC 
151 ATTTGTTAGG ATGGTGGCAA AGAAAAATCT CAGGTCCAAC AGTCAGCTGG 
201 AAGAAGATCA GTGACGATGA GGGACTTTAT GCTAGCGGGT GTGCAACCCT 
251 AGAAAACTCA AATGGAGACG TTCTGGACAA AGAAGCTGTG ACTGCTCTGA 
301 CAGTCAAAXC AGTATACGAA XXTGAAT 
Figure 4.14 
pGEMDl.O 
Sequence obtained from recombinant plasmid 
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4.8 SUBCLONING RESULTS: GROUP E 
Ligations were carried out as detailed in section 2.4.3.3 and transformation of 
competent JM1 09 cells performed as described in section 2.4.4. Table 4.6 shows the 
results obtained from the first attempt at subcloning the insert fragments using the 
shotgun approach. Out of the 49 white colonies (plates 5-7), 22 still remained white 
after re-streaking on fresh indicator plates and these were further screened using the 
cracking procedure (section 2.4.4.3). From this screen, 9 colonies were identified as 
possibly containing insert DNA and to confirm this, DNA was prepared by the STET 
method (section 2.4.1 ), digested with the restriction enzyme Eco RI and 
electrophoresed on a 1% agarose gel. Out of the 9 colonies, eight were found to 
contain a 6. 7Kb insert and one to contain a 6.2Kb insert. The expected 7.8Kb 
fragment from the original phage was not subcloned and further attempts to do so by 
extracting the band from a gel and purifying the DNA failed (data not shown). 
4.8.1 Characterisation of GroupE Subclones 
A Qiagen plasmid DNA preparation (section 2.4.2.2) was performed on the subclones 
containing the two different sized inserts. 1 ｾｬｧ＠ of DNA of each subclone was digested 
with Eco RI along with Spg of phage DNA and electrophoresed on a 1% agarose gel 
(Figure 4.15 A). As can be seen only the 6. 7Kb fragment of the original phage (lane 
4) has been successfully ligated into pGEM7Z (lane 3). The origin of the 6.2Kb insert 
is unknown. The DNA from the gel shown in Figure 4.15 A was transferred to 
Hybond N™ nylon filter by the method of Southern (section 2.6.1), hybridised to the 
rat 600bp eDNA CYP4A 1 probe and subsequently to the rat 2.1Kb full length eDNA 
probe after the filter had been stripped of the first probe (section 2.6.5). The filter was 
washed under the same stringent conditions after each probe: two 20min washes in 2 x 
sse I 0.1% (wlv) SDS at room temperature, two 30min washes in 0.1 X sse I O.l% 
(wlv) SDS at ssoe and a final rinse in 5 X sse at room temperature. Figure 4.15 B 
shows the two autoradiographs obtained. The fragment sharing homology with the 
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PLATE DNA ENZYME MOLAR WHITES BLUES 
RATIO 
1 *No DNA 
- - - -
2 *pGEM7Z (20ng) 
- - -
1000 
3 *pGEM7Z (20ng) EcoR1 
- -
10 
4 pGEM7Z {20ng) EcoR1 - 3 400 
Sa pGEM7Z (20ng)+ grp E EcoR1 1:1 (V:I) 7 280 
Sb pGEM7Z (20ng}+ grp E EcoRl 1:1 (V:I) 12 520 
6a pGEM7Z (20ng)+ grp E EcoR1 1:3 (V:I) 9 200 
6b pGEM7Z (20ng)+ grp E EcoR1 1:3 (V:I) 14 600 
7a pGEM7Z (20ng)+ grp E EcoRI 3:1 (V:I) 2 160 
7b pGEM7Z (20ng}+ grp E EcoR1 3:1(V:I) 5 400 
Table 4.6 Cloning strategy and results of shotgun subcloning of the 
recombinant phage groupE (RG4) inserts into pGEM7Z. 
Plates 1-4 were plated at one dilution {lOOJll) 
Plates 5-7 were plated at two dilutions (a= lOOJ.ll, b = 200J.1l) 
* = no ligase added 
Eco RI = indicates that the plasmid had been linearised before ligation 
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A B 
600 bp 2·1 kb 
- 23kb 
-- 9·4 
-8·5 - 7·8Kb 
- 4 ·4 - 8·7 
- 3·0 
- 2·3 
- 2·0 
0·6 
1 2 3 4 5 
1 2 34 5 1 2 34 5 
Figure 4.15 (A) Digestion of recombinant groupE phage and plasmid 
DNA with the restriction enzyme Eco RI. (B) Southern blot of group E 
DNA hybridised to the rat CYP4Al 600bp and full length 2.1kb eDNA 
probes. 
Lanes 1 and 5: A. Hind m molecular weight markers 
2:pGEME6.2 
3:pGEME6.7 
4: Recombinant phage group E (RG4) 
NB The hybridisation signal seen at 3.0kb, represents probe homology to the 
plasmid pGEM7Z (refer to section 4.4.1). 
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600bp probe in the recombinant phage (lane 4) is the 6. 7Kb insert. This 6. 7Kb sized 
insert in recombinant plasmid pGEME6.7 (lane 3) also shares homology to the 600bp 
probe as expected. These inserts both share homology with the 2.1Kb probe as well. 
The 7. 8Kb insert in the recombinant phage (lane 4) does not share homology with 
either the 600bp or the 2.1Kb probe. 
4.8.2 Sequencing of Group E Subclones 
Ｖｾｴｧ＠ of the recombinant plasmids pGEME6. 7 and pGEME6.2 were sequenced as 
described in section 2. 7. The four sequences were analysed using the Micro genie ™ 
software. Matrix homology comparisons of these sequences with those previously 
published identified pGEME6. 7 as being identical to CYP4A2 at position 
+1877/+8593 (Figure 4.16 (i)), however pGEME6.2 showed no homology to any of 
the CYP4A sequences or any sequences contained in the Microgenie data bank or the 
GenENBL data base. Figure 4.16 (i) shows the alignment ofthe pGEME6.7 sequence 
with that of CYP4A2. However, if group E was the genomic sequence of CYP4A2, 
then its Eco RI restriction pattern would be one of 3.0, 0.6, 6.7 and 2.2kb rather than 
the 7.6 and 6.7Kb seen (Figure 4.15 A, lane 4). It was thought that perhaps groupE 
represented the genomic sequence of CYP4A3, since this eDNA shares 97% 
nucleotide sequence homology with CYP4A2 (Kimura et al., 1989b). The pGEME6.7 
sequence was looked at more closely and it was recognised that it had been sequenced 
through exon 3, which is a short exon made up of 36bp. Figure 4.16 (ii) is a sequence 
comparison between exon 3 of CYP4A2 and CYP4A3. It can be seen there are a 
number of sequence differences resulting in 5 amino acid changes. Figure 4.16 (ii) 
shows that pGEME6. 7 is I 00% identical to CYP4A2 in the region of exon 3 
(underlined sequence) indicating that it is CYP4A2. 
In order to try to determine the origin of the 7.8Kb fragment the filter obtained from a 
Southern blot of the gel in Figure 4.15 A was re-probed with a.32PdCTP labelled 
lambda DNA. The autoradiograph from this experiment indicated that the 7.8Kb 
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i) pGEME6.7 sequenced using the T7 primer (top), compared to CYP4A2 
(bottom sequence), 100°/o similarity. The sequence underlined represents exon 3. 
1 ......... GAATTCAGTGGGAGGAATGAACTAACTCCACAGAGTTGTCT 41 
11111111111111111111111111111111111111111 
4320 ATTGAATTCGAATTCAGTGGGAGGAATGAACTAACTCCACAGAGTTGTCT 4369 
42 TCTGAACTCTACACAGACACTGTAGCAGGTGCACCACAAATAATAATTTT 91 
11111111111111111111111111111111111111111111111111 
4370 TCTGAACTCTACACAGACACTGTAGCAGGTGCACCACAAATAATAATTTT 4419 
92 TAAAATTCTGAAAAATGAAAGAAAAAGCTTGTAGTTTTGAACACCATCCT 141 
11111111111111111111111111111111111111111111111111 
4420 TAAAATTCTGAAAAATGAAAGAAAAAGCTTGTAGTTTTGAACACCATCCT 4469 
142 CCTATCTGGTCCTCAAGATCTGTCTTACTTTTCAGATCCAAbGCCTTATC 191 
11111111111111111111111111111111111111111111111111 
4470 CCTATCTGGTCCTCAAGATCTGTCTTACTTTTCAGATCCAAAGCCTTATC 4519 
192 bATCCCTTGCTCCCTGGATTGGTAAGTATATTAAAATAAGGAGTGTGTTT 241 
11111111111111111111111111111111111111111111111111 
4520 aATCCCTTGCTCCCTGGATTGGTAAGTATATTAAAATAAGGAGTGTGTTT 4569 
242 TCTTCACTACTCTCTGGCTAATGGAGAAGAACGGGTGACTGGTCACAGTA 291 
11111111111111111111111111111111111111111111111111 
4570 TCTTCACTACTCTCTGGCTAATGGAGAAGAACGGGTGACTGGTCACAGTA 4619 
292 TCATGATCCATTCCTAAATCAAGCATTA .....•................ 319 
1111111111111111111111111111 
4620 TCATGATCCATTCCTAAATCAAGCATTATTTCTCTTCTCCTAATCAGTCC 4669 
ii) Sequence comparison of exon 3 (underlined) from CYP4A2 (top) compared to 
CYP4A3 (bottom sequence). 
4501 TCAGATCCA8AGCC ......... TTATCAbTCCCTTGCTCCCTGGATTGG 4541 
111111111111 I 11111111 111111111111111111 
337 TCAGATCCAAAGGCTTCTGGAATTTATCAATTCCTTGCTCCCTGGATTGG 386 
Figure 4.16 (i) Sequence alignment of recombinant plasmid 
pGEME6.7 to the genomic sequence of CYP4A2. (ii) Sequence 
comparison of exon 3 from CYP4A2 to CYP4A3. 
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insert in the recombinant phage was homologous to the probe as were the right and 
left phage arms and the A.Hind III markers. The recombinant plasmid pGEJ\.1E6.2 did 
not show any homology to the lambda probe and its origin remains unknown (data not 
shown). 
4.9 SUBCLONING RESULTS: GROUP F 
Ligations were carried out as described in section 2.4.3.3 and transformation of 
competent JM109 cells performed as described in section 2.4.4. Table 4.7 shows the 
results obtained from the first attempt at subcloning the insert fragments using the 
shotgun approach. Out of the 113 white colonies (plates 5-7), 4 7 were further 
screened using the cracking procedure (section 2.4.4.3). This identified 28 colonies as 
possibly containing inserts and to confirm this DNA was prepared by the STET 
method (section 2.4 .1 ), digested with the restriction enzyme Eco RI and 
electrophoresed on a 1% agarose gel. Out of the 28 DNA preparations, 25 were 
found to contain inserts: eleven contained a 2.1Kb insert, nine a 3.8Kb insert and five 
contained a 6. 7Kb insert (data not shown). 
4.9.1 Characterisation of Group F Subclones 
A Qiagen plasmid DNA preparation (section 2.4.2.2} was performed on the subclones 
containing the three different sized inserts. 1 J..lg of DNA of each subclone was 
digested with Eco R1 along with 5 ｾｴｧ＠ of phage DNA and electrophoresed on a 1% 
agarose gel (Figure 4.17 A). As can be seen the three Eco RI fragments from the 
original phage DNA (lane 5) have been successfully ligated into pGEM7Z (lanes 2, 3 
and 4). The DNA from this gel was transferred to a nylon filter by the method of 
Southern (section 2.6.1), which was hybridised to the rat 600bp eDNA CYP4Al 
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PLATE DNA ENZYME MOLAR WHITE BLUE 
RATIO colonies colonies 
I *No DNA 
- - - -
2 *pGEM7Z (20ng) 
- - 4 150 
3 *pGEM7Z (20ng) EcoRl 
- -
6 
4 pGEM7Z (20ng) EcoRl 
-
2 50 
Sa pGEM7Z (20ng)+ grp F EcoR1 1:1 (V:I) 8 30 
5b pGEM7Z (20ng)+ grp F EcoR1 1:I (V:I) 36 80 
6a pGEM7Z (20ng)+ grp F EcoR1 1:3 (V:I) 10 12 
6b pGEM7Z (20ng)+ grp F EcoRI 1:3 (V:I) 34 50 
7a pGEM7Z (20ng)+ grp F EcoR1 3:1 (V:I) 5 10 
7b pGEM7Z (20ng)+ grp F EcoRl 3:1 (V:I) 20 70 
Table 4. 7 Cloning strategy and results of shotgun subcloning of the 
recombinant phage group F (RGll) inserts into pGEM7Z. 
Plates I-4 were plated at one dilution (I OOJ.Ll) 
Plates 5-7 were plated at two dilutions (a = I OOJ.!l, b = 200j..tl) 
* = no ligase added 
Eco RI = indicates that the plasmid had been linearised before ligation 
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A 
123456 
23kb 
- 8·4 
- 8·5 
4·4 
2-3 
- 2.0 
8 
600 bp 2·1 kb 
- 8·7 
- 3·8 
- 3·0 
- 2·1 
123456 123456 
Figure 4.17 (A) Digestion of recombinant group F phage and plasmid 
DNA with the restriction enzyme Eco RI. (B) Southern blot of group F 
DNA hybridised to the rat CYP4Al 600bp and full length 2.1kb eDNA 
probes. 
Lanes 1 and 6: A Hind Ill molecular weight markers 
2: pGEl\1F2.1 
3: pGEl\1F3.8 
4: pGEl\1F6. 7 
5: Recombinant phage group F (ROll) 
NB The hybridisation signal seen at 3.0kb, represents probe homology to the 
plasmid pGEM7Z (refer to section 4.4.1). 
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probe and subsequently to the rat 2.1Kb full length eDNA probe after the filter had 
been stripped of the first probe (section 2.6.5). The filter was washed under the same 
stringent conditions after each probe: two 20min washes in 2 X sse I O.l% (w/v) SDS 
at room temperature, two 30min washes in 0.1 X sse I 0.1% (wlv) SDS at 55°C and a 
final rinse in 5 x S SC at room temperature. Figure 4.17 B shows the two 
autoradiographs obtained. The fragment in the recombinant phage (lane 5) sharing 
homology to the 600bp probe was the 6. 7Kb insert. The recombinant plasmid 
pGEivfF6.7 also shared homology to the 600bp probe as expected. The fragments 
sharing homology to the 2.1Kb probe were the 6.7Kb and the 2.1Kb inserts in the 
recombinant phage (lane 5) and the recombinant plasmids pGEMF6.7 (lane 4) and 
pGEivfF2.1 (lane 2). The 3.8Kb insert in the recombinant phage and the recombinant 
plasmid pGEMF3.8 (Jane 3) did not share any sequence identity to either probe and 
therfore must lie outside of the coding region either to the 5' end or the 3'end of the 
gene as can be seen in the preliminary restriction map (Figure 3.12). 
4.9.2 Sequencing of Group F Subclones 
Ｖｾｴｧ＠ of the recombinant plasmids pGEivfF6.7, pGEMF3.8 and pGEMF2.1 were 
sequenced as described in section 2. 7. The six sequences obtained were analysed 
using the Micro genie ™ software and matrix comparisons were performed against 
sequences previously published for members of the CYP4A family. The sequences for 
pGEivfF6. 7 and pGEivfF2.1 were found to be homologous to CYP4A2 (Figure 4.18 i-
iv) in positions +1877/+8593 and +8593/+10770 respectively and Figure 4.18 vii 
shows the alignment of the sequences to CYP4A2. However pGEivfF3.8 showed no 
sequence homology to CYP4A2 or any of the other published sequences, indicating 
that it almost certainly lies to the 3' end ofpGEMF2.1 and not as first thought to the 5' 
end ofpGEivfF6.7. 
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i) pGEMF6.7 sequenced using the T7 primer (top), compared to CYP4A2 
(bottom sequence), 99% similarity. 
1 GAATTCAGTGGGAGGAATGAACTAACTCCACAGAGTTGTCTTCTGAACTC 50 
11111111111111111111111111111111111111111111111111 
4329 GAATTCAGTGGGAGGAATGAACTAACTCCACAGAGTTGTCTTCTGAACTC 4378 
51 TACACAGACACTGTAGCAGGTGCACCACAAATAATAATTTTTAAAATTCT 100 
11111111111111111111111111111111111111111111111111 
4379 TACACAGACACTGTAGCAGGTGCACCACAAATAATAATTTTTAAAATTCT 4428 
101 GAAAAATGAAAGAAAAAGCTTGTAGTTTTTGAACACCATCCTCCTATCTG 150 
1111111111111111111111111 111111111111111111111111 
4429 GAAAAATGAAAGAAAAAGCTTGTAG.TTTTGAACACCATCCTCCTATCTG 4477 
151 GT.CTCAAGATCTGTCTTACTTTTCAGATCCAAAGCCTTATCAAT.CCTT 198 
II 111111111111111111111111111111111111111111 1111 
4478 GTCCTCAAGATCTGTCTTACTTTTCAGATCCAAAGCCTTATCAATCCCTT 4527 
199 GCT.CCTGGATTGGT.AGTATATTAAA •. TAGGAGTGTGTGTT 237 
Ill 11111111111 11111111111 1111111111 II 
4528 GCTCCCTGGATTGGTAAGTATATTAAAATAAGGAGTGTGTTTT 4570 
ii) pGEMF6. 7 sequenced using the SP6 primer (top), compared to CYP4A2 
(bottom sequence), 100% similarity. 
154 AGACATATGACACAGTTTATCCCATAGTGAAGAATGTCATCTTAACCAGC 105 
11111111111111111111111111111111111111111111111111 
10892 AGACATATGACACAGTTTATCCCATAGTGAAGAATGTCATCTTAACCAGC 10941 
104 TAAAAGCATACTGCAGCCATTGGAGGATAGGAGAGTCGCAGGTTGTCAAG 55 
11111111111111111111111111111111111111111111111111 
10942 TAAAAGCATACTGCAGCCATTGGAGGATAGGAGAGTCGCAGGTTGTCAAG 10991 
54 TTCCTAGCTTAAATATCCTTATCCTCTATGCATATTATTGTGTTTTTAGA 5 
11111111111111111111111111111111111111111111111111 
10992 TTCCTAGCTTAAATATCCTTATCCTCTATGCATATTATTGTGTTTTTAGA 11041 
4 ATTC 1 
I II I 
11042 ATTC 11045 
iii) pGEMF2.1 sequenced using the T7 primer (top), compared to CYP4A2 
(bottom sequence, 98% similarity. 
1 GAATTCAACTCTATTAATTCAAATGAAAAAGAATTTTAAAAATGTACTTT 50 
11111111111111111111111111111111111111111111111111 
11046 GAATTCAACTCTATTAATTCAAATGAAAAAGAATTTTAAAAATGTACTTT 11095 
51 TTTTCTGCCACGTTCCTTGCTGAGACAGGAGAATGTAGCCAATCACTTAT 100 
11111111111111111111111111111111111111111111111111 
11096 TTTTCTGCCACGTTCCTTGCTGAGACAGGAGAATGTAGCCAATCACTTAT 11145 
101 ACCTGATGCAGCCATCATTCCTTCTTTCTGCCTTAGCCTCATGTGT.CCT 149 
1111111111111111111111111111111111111111111111 Ill 
11146 ACCTGATGCAGCCATCATTCCTTCTTTCTGCCTTAGCCTCATGTGTCCCT 11195 
150 CACTGACA .. CTATGAAA .. GTACACACTCCTT 178 
11111111 1111111 111111111111 
11196 CACTGACATCTTATGAAAAGTTACACACTCCTT 11228 
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iv) pGEMF2.1 sequenced using the SP6 primer (top), compared to CYP4A2 
(bottom sequence), 99.8% similarity. 
141 ATTAATTTCTGTTTCATATTTTTATTTAAGATACAGAAATCTACTCAGCA 92 
lllllllllllllllllllllllllllllllllllllllllllll 1_1111 
13081 ATTAATTTCTGTTTCATATTTTTATTTAAGATACAGAAATCTACTCAGCA 13130 
. 
91 TGAACCTATGCTCCCTG.AGCACTTTTGGCAAGTCAGCCATCAGAGAAGC 43 
11111111111111111 11111111111111111111111 I Ill I I Ill 
13131 TGAACCTATGCTCCCTGAAGCACTTTTGGCAAGTCAGCCATCAGAGAAGC 13180 
42 CTGTTGCCATCTGCTCCCCACTGTTAGAATGGGGTAGAATTC 1 
111111111111111111111111111111111111111111 
13181 CTGTTGCCATCTGCTCCCCACTGTTAGAATGGGGTAGAATTC 13222 
v) pGEMF3.8 sequenced using the T7 primer. 
1 GAATTCTGTT TAGATATGTA CACCATTATT TTTCACTGAG TTGTCGTTTT 
51 TTAATGTCTA GGTTTGTGTG TGTGTGTGTG TGTGTGTGTG TGTGTGTGTG 
101 TGTGTGTATG TGTTTGTATG TGTATATATG CGTGTGTATG TGTGTGTGTA 
151 CTTTTGGGTA TGTGTGTGTA TATGTGTATG TGTATATGTG TGTATGTGTG 
201 TGCATGTGTG TGTAC 
vi) pGEMF3.8 sequenced using the SP6 primer. 
1 GAATTCTCAG CTCCTGAGAG GTTGTACTTG GATTGTTGAC TTCTGGGCTG 
51 GTTTATACAA ATGTAGGTTT GTGATTTTGT GGAGCTAAAG AGTTTTCTGA 
101 TTTTACCCTG GCCTGATTTG GTCAGAGTGC TCTGAATATC AGTTTAGTGA 
151 TTGAGAT 
vii) Sequencing strategy of Group F recombinant plasmid clones, and 
comparison to the genomic Eco RI restriction map of CYP4A2. The arrows 
represent the direction of each sequencing reaction. 
IEco Rl Eco Rl IEco Rl Eco Rl 
-t-1-1--+--11 ----t--1 --tl CYP4A2 
T7 (244bp) 
--7 
pGEMF6.7 
SP6 (158bp) 
T7 <)84bp) T7 ｾＲＱＵ｢ｰＩ＠
I pGEMF2.1 I pGEMF3.8 ｾ＠
SP6 (146bp) SP6 (157bp) 
Figure 4.18 i-iv) Sequence alignment of group F recombinant plasmid 
clones to the genomic sequence of CYP4A2. v-vi) Sequence obtained 
from pGEMF3.8 using the T7 and SP6 primers. vii) Diagram of the 
sequence strategy and relative position of each recombinant plasmid 
clone as compared to CYP4A2 and proposed position of pGEMF3.8. 
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4.10 DISCUSSION 
The publishing of the genomic sequences for CYP4Al and CYP4A2 (Kimura et al., 
1989a}, enabled me to ascertain the identity of some of the clones that I had isolated. 
Figure 4.19 indicates the Eco RI restriction map of the rat CYP4Al and CYP4A2 
genes. Comparing these maps to the preliminary restriction maps in Figure 3 .12, it can 
be seen that group C is the only one that appears to have a similar Eco Rl digestion 
pattern. Although if group C represented CYP4A2 then a 0.6Kb fragment was 
missing from the recombinant phage. This 0.6Kb fragment may have been missed on 
the gel (ie electrophoresed off the bottom), but repeated Eco RI digests of group C 
recombinant phage DNA showed it not to be present. The Eco RI restriction pattern 
of group · F recombinant phage DNA, identified it as possibly being CYP4A2, an 
overlapping clone of group C with 3.8Kb of previously unpublished 3' flanking 
sequence. Sequence analysis (Figures 18) gave strong support to this suggestion. 
The recombinant phage in group B produced an interesting Eco RI restriction pattern 
made more so by the fact that when pGEMB2.3 was sequenced it appeared to be part 
of the CYP4A2 gene (Figure 4.8). However, the Eco RI restriction pattern was not 
that of CYP4A 2 (Figure 4.19). Since the eDNA of CYP4A3 and the coding sequence 
of CYP4A2 are 97% homologous at the nucleotide level (Kimura et al., 1989b), it 
was thought that group B recombinant phage may represent the genomic sequence of 
CYP4A3. However, it was impossible to tell just by comparing the sequence of 
subclone pGEl\1B2.3 with that of CYP4A3 (Figure 4.9). 
The identity of the recombinant phage in group D remains unknown. The Eco RI 
restriction pattern is completely dissimilar to that of CYP4Al and CYP4A2 and the 
sequences obtained from pGE:rviD2.5 and pGE:rviDI.O (Figure 4.14) share no 
homology with the other published CYP4A eDNA sequences. This is perhaps not 
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surprising since pGEl\1D2.5 and pGEl\IDI.O do not hybridise to either the rat 600bp 
or 2.1Kb probe (Figure 4.13 B) and therefore represent non-coding sequences. The 
recombinant phage in group D may represent a new member of the rat CYP4A family. 
The recombinant phage in groups E and A both proved to contain bacteriophage 
lambda DNA fragments. Figure 4.16 indicated that the recombinant plasmid 
pGEl\1E6. 7 was homologous to CYP4A2, however, as discussed previously, it did not 
have the correct Eco Rl restriction pattern to be CYP4A2, and therefore it was 
thought that it might represent the genomic sequence of CYP4A3. The sequence 
around exon 3 in CYP4A2 and CYP4A3 was known to contain several basepair 
differences. Figure 4.16 showed that the sequence for pGEME6. 7 spanned exon 3 and 
was 100% identical to CYP4A2 in this region. The origin of the 7.8Kb fragment in 
the group E recombinant phage DNA was confirmed when this fragment hybridised to 
a32PdCTP labelled bacteriophage lambda DNA. 
The two Eco RI fragments in the group A recombinant phage DNA were also positive 
when hybridised to radiolabelled bacteriophage lambda DNA (Figure 4.6) confirming 
the sequencing of the subclones, recombinant plasmids pGEMA7.0 and pGEMA4.7 
(Figure 4.5). How then was this clone originally isolated? In the original phage there 
was probably a CYP4A2 Eco RI fragment, size 6. 7Kb, that when digested with Eco 
RI was electrophoresed to the same position as the bacteriophage lambda piece of 
DNA isolated in recombinant plasmid pGEMA7.0. Hence when the library was 
originally screened with the 2.1Kb CYP4Al eDNA probe this clone would have been 
positive and therefore isolated. However when the Eco Rl fragments were subcloned 
into pGEM only the bacteriophage lambda sequences were subcloned and not the 
CYP4A2 6. 7Kb sequence. Figure 3.11, lane 7, would confirm this hypothesis since a 
positive signal is seen for both the 600bp and 2.1 Kb probes and this fragment is the 
same size as those positive signals seen for group C (lane 5), group E (lane 3) and 
group F (lane 2), all containing a CYP4A2 6. 7Kb sequence. 
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The re-packaging of bacteriophage lambda back into the A.Ch4A arms seems to be a 
common event in the fact that 5 out of 16 of the total number of recombinant phage 
clones isolated, (::::33%), contain lambda DNA as an insert. This is known to be a 
common problem of libraries made in the late 1970's, early 1980's. The method of 
Benton and Davis (1977) for screening phage genomic libraries is efficient and has 
been extensively used in many laboratories. However, a large number of clones need 
to be screened in order to isolate single copy genes. Clarke and Carbon, (1976), 
derived a formula which relates the probability of including any one DNA sequence in 
a random library of genomic recombinants with the number of recombinant phage as 
follows: 
N =In ( 1-P) 
In ( 1- f) 
Where N = number of recombinants, 
P = probability of isolating the gene, 
f= the fractional proportion of the genome in a single 
recombinant, ie fragment size (bp) 
genome size (bp) 
From this formula, with an average size of recombinant insert of 20Kb (such as that 
produced by random fragment insertion into A.Ch4A), 6.5 x 105 phage need to be 
screened in order to have a 99% chance of isolating a single copy gene. Thus it was 
gratifying that as described in Chapter 3 when approximately 2 x 1 o6 phage were 
screened (only a factor of 3 greater than the predicted number needed) a number of 
recombinants which hybridised to the rat CYP4A1 eDNA were isolated, eleven of 
which appear to contain some CYP4A2 sequences. However, it was surprising that no 
CYP4A1 sequences had been isolated. Kimura eta/., (1989a), isolated an 18Kb Bam 
HI fragment containing the coding sequences for CYP4A 1 by screening an unamplified 
partial genomic library, hybridised to the rat CYP4A1 eDNA, previous attempts at 
screening amplified libraries having failed. This may then be a reason why the genomic 
sequence for CYP4A 1 was not isolated from the screening of the amplified genomic 
library in A.CH4A. 
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There were a number of inserts subcloned into pGEM7Z that were not present in the 
original phage. The origin of these inserts remains unknown, although it is possible 
that due to the method used to subclone the recombinant phage inserts that bacterial 
DNA was subcloned instead. In order to establish which group might represent the 
genomic sequence for CYP4A3 as opposed to CYP4A2, it was decided to characterise 
groups B, C and F further. 
The sequences presented in this chapter cannot be taken as I 00% accurate since the 
reaction was only performed in one direction. To be absolutely certain of the 
sequence, both strands of the DNA must be sequenced at least twice. This was not 
pursued as only an indication as to the clones identity was required. 
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CHAPTERS 
GENE-SPECIFIC ANALYSIS OF CYP4A SEQUENCES USING 
OLGONUCLEOTIDES 
5.1 INTRODUCTION 
Since the eDNA of CYP4A3 shares 97% nucleotide sequence similarity to CYP4A2 
(Kimura et a/., 1989b) it was necessary to develop a method which would distinguish 
between the two groups thought to represent the genomic sequence of CYP4A2 
(groups C and F) and CYP4A3 (group B). Two gene-specific oligonucleotide probes 
were used, made to the 3' end of the genes. The P450 4A2 and 4A3 oligonucleotides 
are homologous to the corresponding regions of the CYP4A2 gene (nucleotides 
+10,127/+10,146) and CYP4A3 cDNA(nucJeotides 1691-1710), respectively, and are 
based on Kimura eta/. (1989b ). 
In 1990 Issemann and Green reported cloning and characterisation of a member of the 
nuclear hormone receptor family that can be activated by peroxisome proliferators 
(PP AR). These studies showed that a chimeric receptor constructed using the DNA 
binding domain of the oestrogen receptor and the putative ligand binding domain of 
PP AR was able to activate an oestrogen-responsive gene in the presence of 
peroxisome proliferators. A comparison of primary amino acid sequences within the 
steroid hormone receptor family revealed considerable identity between the DNA 
recognition helix of the DNA binding domain ofPPAR and the other nuclear hormone 
receptors that bind to the sequence TGACCT (Schwabe et al., 1990; Umensono and 
Evans, 1989; Smith eta/., 1991). Issemann and Green (1990) therefore predicted 
that PP AR would recognize a similar motif and on the basis of this the 
oligonucleotide GTOX285 was synthesised (at ICI) and used as a probe (by myself) 
to identify possible sites of transcriptional regulation within the genes that I had 
isolated. 
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5.2 USE OF CYTOCHROME P450 4A2 AND 4A3 
OLIGONUCLEOTIDES IN SOUTHERN BLOT ANALYSIS 
The two specific oligonucleotides are shown below. It can be seen that they differ by 
only four nucleotides (indicated in bold), but this is sufficient to descriminate between 
CYP4A2 and CYP4A3 sequences by using the appropriate washing conditions. 
5'-ACTCCAGACACCTTCCCAGC-3' 4A2 
5'-CCTCCAGACTCCATCCCAGT-3' 4A3 
15pmol of each oligonucleotide were labelled with 50J..LCi ofy-32p ATP using 10 units 
ofT4 polynucleotide kinase (section 2.6.4.2). The nylon filters obtained from the gels 
seen in Figure 4. 7 A (group B), Figure 4.11 A (group C) and Figure 4.17 A (group F) 
were prehybridised in 40ml of hybridisation solution (section 2.6.3) for five hours at 
50°C and hybridised in 1 Oml of fresh hybridisation solution overnight at the same 
temperature. The washing conditions used were those described by Kimura eta/., 
namely an initial 5min wash in 3 X sse I 0.5% (w/v) SDS at 50°C followed by two 
20min washes in 3 X sse I 0.5% (w/v) SDS at 55°C. The filters were 
autoradiographed for 2 and 18 hours at -70°C (section 2.2.5) and then stripped ofthe 
first probe as detailed in section 2.6.5. 
Figure 5 .I shows the autoradiographs obtained at 2 and 18 hours after hybridisation 
to the 4A2 specific oligonucleotide. It can clearly be seen that the 2.1Kb fragment in 
the recombinant plasmid pGEMC2.0 (lane 2) and pGEl\1F2.1 (lane 2) and the 
corresponding fragment in their respective phage DNA (lane 5) hybridised to the 4A2 
oligonucleotide as expected. The recombinant plasmid pGEl\1B2.3 in lane 4 showed 
no hybridisation signal, even after an 18 hour exposure. 
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Figure 5.1 Autoradiograph of Southern blots obtained from recombinant DNA in group B, group C and group F (gels seen 
in Figure 4.7 A, 4.11 A and 4.17 A respectively. Details for each gel can be found in the appropriate Figure legend), 
hybridised to radio labelled CYP 4A2 oligonucleotide. 
Figure 5.2 shows the autoradiographs obtained after hybridising to the 4A3 specific 
oligonucleotide. After a 2hr exposure the group B film shows a band at 2. 1Kb in lane 
4 representing the recombinant plasmid pGEMB2.3. The corresponding band in the 
group B phage DNA can be seen in lane 10, although it is very faint. Both bands are 
more clearly visualised after an 18hr exposure. The group C and group F 
recombinant plasmids pGEMC2.0 and pGEMF2. 1, as for the 4A2 oligonucleotide, 
hybridised to the 4A3 oligonucleotide (lane 2 respectively). This result was 
unexpected since I was certain group C was in fact CYP4A2 and therefore implied 
the hybridisation and washing conditions were not correct to achieve total specificity 
for each oligonucleotide probe. However, the fact that pGE:rvtB2.3 only showed 
homology to the 4A3 oligonucleotide and not the 4A2 oligonucleotide under the same 
conditions, was a good indication that this was in fact CYP4A3. It was decided to use 
the 4A2 and 4A3 oligonucleotides as specific primers in a sequencing reaction using 
pGEMB2.3, pGEMC2.0 and pGE:MF2.1 as templates to confirm these findings . 
5.3 USE OF CYTOCHROME P450 
OLIGONUCLEOTIDES AS SPECIFIC 
SEQUENCING 
4A2 AND 4A3 
PRIMERS FOR 
Ｖｾｌｧ＠ of the recombinant plasmids ｰｇｅｾＲＮＳＬ＠ pGEMC2.0 and pGEivlF2.1 were 
denatured by alkali (section 2.7.2) and sequenced, using the P450 4A2 and 4A3 
oligonucleotides, according to section 2.7, except that the amount of primer used for 
each reaction was lpmol. ｰｇｅｾＲＮＳ＠ only sequenced with the P450 4A3 
oligonucleotide and this sequence aligned to the CYP4A3 eDNA in positions 
1761/1889 (Figure 5.3 (i)). This sequence was also compared to CYP4A2 (Figure 5.3 
(ii)) which demonstrated 5bp differences that had not been seen in Figure 5.3 (i). The 
plasmid pGEMB2.3 had been sequenced twice with the P450 4A3 oligonucleotide, 
indicating that these 5bp differences were not due to sequencing error. 
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Figure 5.2 Autoradiograph of Southern blots obtained from recombinant DNA in group B, group C and group F (gels seen 
in Figure 4.7 A, 4.11 A and 4.17 A respectively. Details for each gel can be found in the appropriate Figure legend), 
hybridised to radio labelled CYP 4A3 oligonucleotide. 
i) pGEMB2.3 sequenced (nucleotides 1 to 140) using the P450 4A3 specific oligo 
(underlined sequence) aligned to the CYP4A3 sequence 
1791 CCTCCAGACTCCATCCCAGTTTGTGCGTGGACCCATTTCCCATCTGTTT 1739 
12 ••..•.......•..•...•• ACTTGCCGCCAGCAGCCTGTCCTCCAGCC 40 
11111111111111111111111111111 
1740 TCACCTCTGACCAGCCACTGAACTTGCCGCCAGCAGCCTGTCCTCCAGCC 1789 
41 TGCTTACCCCTCATTATCATTGGACTAACAGAGAAAGATGTATTTTAGAG 90 
11111111111111111111111111111111111111111111111111 
1790 TGCTTACCCCTCATTATCATTGGACTAACAGAGAAAGATGTATTTTAGAG 1839 
91 GGAAACTCTTGCACTTTATCTCTCTTCAGTTCTCAGAGTCTTGGGACAAT 140 
11111111111111111111111111111111111111111111111111 
1840 GGAAACTCTTGCACTTTATCTCTCTTCAGTTCTCAGAGTCTTGGGACAAT 1889 
ii) pGEMB2.3 sequenced (nucleotides 1 to 140) using the P450 4A3 specific 
oligonucleotide (the position of the P450 4A2 specific oligonucleotide is 
underlined), aligned to the CYP4A2 sequence. The differences between the two 
sequences are highlighted in bold. 
ACTCCAGACACCTTCCCAGC 12650 
12651 TTGTGCGTGGACCCATTTCGCATCTGGTTTCACCTCTGACCAGCCACTGA 12700 
12 ACTTGCCGCCAGCAGCCTGTCCTCCAGCCTGCTTACCCCTCATTATCATT 61 
II 11111111111111 11111111111111111111 1111 111111 
12701 ａｃｃｔｇｃｃｇｃｃａｇｃａｇｃｃｃｇｔｃｃｔｃｃａｇｃｃｔｇｃｔｔａｃｃｾｔｃａｔｃａｔｃａｔｔ＠ 12750 
62 GGACTAACAGAGAAAGATGTATTTTAGAGGGAAACTCTTGCACTTTATCT 111 
IIIII 111111111111111111111111111111111111111111111 
12751 GGACTAACAGAGAAAGATGTATTTTAGAGGGAAACTCTTGCACTTTATCT 12800 
112 CTCTTCAGTTCTCAGAGTCTTGGGACAAT 140 
I 111111111111111111111111111 
12801 CCCTTCAGTTCTCAGAGTCTTGGGACAAT 12829 
Figure 5.3 Sequence obtained from group B recombinant plasmid 
pGEMB2.3 using a P450 4A3 specific oligonucleotide, compared to i) 
CYP4A3 and ii) CYP4A2. 
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The sequences obtained for pGEMC2.0 and pGE:MF2.1 with the 4A2 oligonucleotide 
were IOOo/o identical to CYP4A2 (data not shown). These plasmids only sequenced 
with the 4A2 oligonucleotide and taken together with the data presented in Chapter 4, 
indicate that these are overlapping genomic clones of CYP4A2. 
5.4 USE OF A PPRE-SPECIFIC OLIGONUCLEOTIDE IN 
SOUTHERN BLOT ANALYSIS 
In an attempt to elucidate whether the genomic DNA inserts from any of the 
recombinant groups contained a binding sequence for the recently discovered PP AR, 
an oligonucleotide (GTOX285) was synthesised (section 2. 7.5) which can be seen 
below. The letters in bold represent the direct repeat of a hexanucleotide sequence 
thought to represent the PPAR DNA binding site (known as the PPRE, the 
peroxisome proliferator response element). 
5'-AGCTTGACCTcTGACCTG-3' GTOX285 
The first approach used was one of spotting lOJ.tl of phage stock (section 2.5.1) from 
each group onto a freshly prepared growing lawn of LE392 cells on an LB agarose 
plate. The plate was left to harden for I hr at room temperature and then incubated at 
3 7°C overnight to allow the phage to lyse the bacterial cells. Filter lifts were 
performed as described in section 2.3 .4 in duplicate and then prehybridised at 42°C 
for 8hrs. 15pmol of GTOX285 was labelled with SOJJ.Ci of y-32p ATP using 10 units 
of T4 polynucleotide kinase (section 2.6.4.2) and added to lOml of hybridisation 
buffer (section 2.6.3). Hybridisation was performed at 67°C for the first 40min and 
then at 28°C overnight. The filters were washed at low stringency for 2 x 20min in 
6 X SSC I 0.1% (w/v) SDS at room temperature and then autoradiographed for 2hr 
at -70°C. 
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Figure 5. 4 shows the autoradiograph obtained. The area of lysis from the 
bacteriophage of each group are outlined and each group clearly marked. Group A 
was present as a negative control, since this was known to contain a lambda DNA 
insert and therefore should not have hybridised to the probe GTOX285. As a positive 
control, phage containing some 20Kb of 5' CYP4Al sequence with a putative PPAR 
response element known to be positive to the GTOX285 probe, was used {T. Aldrich, 
ICI, unpublished). As can be seen in Figure 5.4 no clear hybridisation signal was 
obtained from any of the groups and more importantly none could be seen for the 
positive control. A second attempt was made using the Southern blots prepared 
previously for each group (Chapter 4), and as a positive control a Southern blot, of 
the 5' end of CYP4A 1 DNA, described above was used. The filters were hybridised to 
GTOX285 under the same conditions as above and autoradiographed for 24hr at 
-70°C. The positive control showed a single band, although it was very weak in 
intensity. No bands could be seen on any of the other filters (data not shown). 
5.5 DISCUSSION 
Kimura et a!., (1989b), investigated the regulation of CYP4Al, CYP4A2 and 
CYP4A3 by the use of gene specific oligonucleotide probes. Using the same gene 
specific oligonucleotides for CYP4A2 and CYP4A3, under the same hybridisation 
conditions, I was able to identify the recombinant phage in group B as probably the 
genomic clone representing CYP4A3 (Figure 5.2, group B recombinant phage and 
plasmid DNA, lanes 4 and 10 respectively). However this same CYP4A3 
oligonucleotide probe also hybridised to the 2.1Kb fragment in group C and group F 
(recombinant phage and plasmid, lanes 2 and 5 respectively), which indicated that the 
conditions of hybridisation used were not totally specific. Taken together with the 
fact that the CYP4A2 oligonucleotide did not hybridise to the recombinant plasmid 
pGEMB2.3 and the corresponding size fragment in the group B recombinant phage 
(Figure 5.1, lanes 4 and 10, respectively), indicated that group B probabily 
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Figure 5.4 Autoradiograph of filter from recombinant phage spot plate, 
hybridised to radio labelled oligonucleotide GTOX285. 
Group A (AL2) Group B (AL4) Group C (AL7) 
Group D (AR4) GroupE (RG4) Group F (RG 11) 
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represented part of the genomic sequence of CYP4A3. This was confirmed by using 
the 4 A3 specific oligonucleotide as a sequencing primer as only the recombinant 
plasmid pGEMB2.3 produced any sequence. Figure 5.3 shows the sequence 
compared to that ofCYP4A2 and CYP4A3. It suggests that the group B recombinant 
phage represents the genomic sequence ofCYP4A3. 
The use of the putative PP AR binding site as an oligonucleotide probe, proved to be 
inconclusive. It appeared from the results obtained that no such site was present in 
the recombinant phage clones that I had isolated, however the probe seemed to bind 
non-specifically to high molecular weight DNA (data not shown). Further to the 
work of Issemann and Green (1990), Tugwood et a/. (1992), identified a PPAR 
response element (PPRE) in the 5' flanking region of the rat acyl Co A oxidase gene. 
This response element, located 570bp upstream of the acyl CoA oxidase gene, 
contains a direct repeat of the sequence motifs TGACCT and TGTCCT and binds 
PP AR. More recently, Muerhoff et a/. (1992a) identified a PPRE in the 5' flanking 
region of the rabbit CYP4A6 gene. A comparison of these two response elements to 
the GTOX285 oligonucleotide can be seen below: 
5'-ACGTGACCTTTGTCCTGG-3' 
5'-cccTGGCCTTTGTCCTAc-3' 
5'-AGCTTGACCTcTGACCTG-3' 
ACO PPRE (-572/-555bp) 
CYP4A6 PPRE ( -724/-741 bp) 
GTOX285 
The number of base pair differences from the actual PPRE's to the putative 
GTOX285 oligonucleotide PPRE used and the actual hybridisation conditions may 
account for the lack of a hybridisation signal. Alternatively no PPRE site exists in the 
CYP4A genomic DNA sequences that I have isolated. · 
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CHAPTER6 
CYP4A PROMOTER ASSAYS USING AN IN VITRO DNA 
TRANSFECTION METHOD 
6.1 INTRODUCTION 
Since expression of the rat CYP4A2 gene had not been examined in relation to 
PPAR regulation, my CYP4A clones were used to investigate this aspect. Despite the 
fact that the 2Kb of upstream sequence isolated in the group C recombinant plasmid 
had already been sequenced (Kimura et a/., 1989a) and found not to contain a 
recognisable PPRE sequence, it was decided that this would provide a good starting 
point in a transfection system. 
In order to study the effects of putative promoters or enhancers in vitro , these 
sequences must first be linked to a reporter gene and transfected into eukaryotic cells. 
Such reporter gene systems are able to provide quantitation of transcription in whole 
cells in response to transcriptional activators. The reporter gene system used in this 
chapter is the CAT (chloramphenicol acetyltransferase) gene. Since CAT is a 
bacterial gene, levels of CAT enzyme can be easily assayed with little or no 
background from endogenous cellular gene activity. 
The transfection level measured for a reporter gene is highly dependent on the 
efficiency of transfection obtained with the target cell and therefore it is necessary to 
include an internal control in each transfection reaction so that results can be 
compared from experiment to experiment. The plasmid pCHll 0 (Stratagene) is 
designed for this purpose. It contains a functional/acZ gene which is expressed from 
the SV 40 early promoter producing P-galactosidase which can then be easily assayed. 
A number of methods have been devised to introduce foreign DNA into eukaryotic 
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cells, the most commonly used being DNA/calcium phosphate co-precipitation or 
methods based on the use of high molecular weight polycations such as DEAE-
dextran. Although extensively used for cell-line transfection, these methods suffer 
from high variability of efficiency or of cell survival and need to be adapted to each 
cell line. The transfection method used in this work is based on compacted cationic 
lipid-coated plasmid DNA (Feigner et a/., 1987). The reagent used, N-[1-(2,3-
dioleyloxy)propyl]-N,N,N-trimethylammonium chloride (DOTMA), forms positively 
charged liposomes which complex with the nucleic acids. The lipid-nucleic acid 
complex, when applied to cultured cells, fuses with plasma membranes and transfers 
the nucleic acid into the cells. This technique is highly efficient and also lacks any 
detectable toxic side effects at the concentration used. 
6.2 EVALUATION OF THE TRANSFECTION SYSTEM USING 
STRUCTUALLY 
PROLIFERA TORS 
DIFFERENT PEROXISOME 
In order to investigate the promoter/enhancer activity of the 5' flanking sequences 
isolated it was necessary to set up the cell culture facilities in the laboratory and to re-
create the transfection system used by Tugwood eta/. (1992). To this end the mouse 
Hepal cl c7 cells, carrier plasmid pBluescript, expression vector pSGS, the PP AR 
expression vector pSGS .PP AR, the P-galactosidase expression plasmid pCHll 0 and 
the reporter vectors pG.CAT and pAC0(-1273/-471)G.CAT were all kindly donated 
by S. Green, ICI. 
Qiagen plasmid DNA preparations (section 2.4.2.2) were performed on the above 
plasmids and diluted to a concentration of lJ.lg/J.ll. The reporter plasmid pACO(-
1273/-471)G.CAT was transfected into the mouse hepatoma cell line Hepal (section 
2.1 0) in the presence or absence of the PP AR expression vector (pSGS.PP AR) that 
contained the complete coding sequence of the mouse receptor, and in the presence 
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or absence of the potent peroxisome proliferator Wy 14643 and the structually 
dissimilar peroxisome proliferator perfluorodecanoic acid (PFDA), as indicated in 
Table 6.1. The cells were harvested from each plate and cytosol extracted by three 
rounds of freeze thaw cycles. Extracts were normalized for f3-galactosidase activity 
as described in section 2.10.1 and a CAT assay performed as described in section 
2.10.2. 
The autoradiograph of the TLC plate can be seen in Figure 6.1 and the results from 
the TLC scanner in Table 6.1. Figure 6.1 shows the parent I4c chloramphenicol at 
the bottom of the autoradiograph and the two acetylated products, that have migrated 
at slightly different rates, further up the autoradiograph. It can be seen that there is an 
increase in intensity of the top metabolite as there is an increase in Wy 14643 (Figure 
6.1 A) concentration and this is reflected in the graph of Figure 6.2. The graph 
indicates that the maximal induction of the CAT enzyme is seen at a Wy 14643 
concentration of 1 o-sM and that this response plateaus at 1o-4M. In fact 
concentrations ofWy 14643 greater than 10-4M were found to be toxic, as indicated 
by cell detachment. Figure 6.2 also indicates that PFDA does not activate PP AR to 
increase the amount of CAT enzyme produced. When PP AR was not co-transfected 
with pAC0(-1273/-471)G.CAT in the absence of inducer (Wy 14643), the percent of 
acetylated chloramphenicol was 4.6. This is probably due to the rabbit J3-globin 
promoter driving some CAT production. When PP AR was co-transfected with the 
reporter plasmid still in the absence of inducer, the percent of acetylated 
chloramphenicol was 21.5. This value was thought to be extremely high, since the 
percent of acetylated chloramphenicol in the presence of PP AR and Wy 14643 at 1 o-
5M was 45 ± 1.2, representing only a 2 fold induction. A lower value for the absence 
of inducer along with a 4 fold induction was expected (Tugwood et al., 1992). 
It was thought that perhaps because the Wy 14643 solutions were made in plastic 
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PLATE LIGAND PLASMIDS (J.Lg) MEAN% AcCh:I:SEM 
pBiuescrlpt pSGS pSGSPPAR pCHllO pACOGCAT (% total 14C) 
1/2 DMSO 10 - - - - . 
3/4 DMSO 5 1 - 3 1 4.6 
5/6 DMSO 5 - 1 3 1 21.5 
718/9 WY to-7M 5 - 1 3 1 20.8 ± 1.7 
10/11/12 WY 10-6M 5 - 1 3 1 28.6 ± 1.0 
13/14/15 WY w-5M 5 - 1 3 1 45 ± 2.9 
16/17118 WY 10-4M 5 - 1 3 1 44 ± 1.2 
19/20/21 WY to-3M 5 - 1 3 1 cell death 
22/23/24 PF w-7M 5 - 1 3 1 14.9 ± 2.4 
25/26/27 PF 10-6M 5 - 1 3 1 12.1 ± 1.0 
28/29/30 PF w-5M 5 - 1 3 1 14.7±0.1 
31/32/33 PF 10-4M 5 - 1 3 1 21.9 ± 1.8 
34/35/36 PF to-3M 5 - 1 3 1 cell death 
Table 6.1 Transfection strategy and results of CAT assay. Wy indicates 
peroxisome proliferator Wy 14643, PF indicates peroxisome proliferator PFDA, AcCh 
indicates acetylated 14c chloramphenicol and SEM indicates standard error of the 
mean .. 
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Figure 6.2 Dose response of pAC0(-1273/-47l)G.CAT stimulation 
using the peroxisome proliferators Wy 14643 (Wy) and PFDA (PF). 
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eppendorfs that the DMSO used to dissolve the inducer may have caused the leaching 
of some phthalate esters from the tubes giving rise to an increase in activation of the 
PP AR. To test this theory, an experiment was set up using just DMSO, in plastic or 
glass, to activate the PP AR (Table 6.2). The results indicate that there is no 
significant difference in CAT activity when using DMSO (ACS or Analar grade) 
stored in either glass or plastic. In fact it can be said that the DMSO is not affecting 
CAT activity since CAT activity was within the same range when sterile Milli 
Q water was used instead. The value of CAT activity in the absence of PPAR 
receptor (3.6% ± 0.3) was similar to that observed before (Table 6.1, 4.6% ± 0. 7). 
The values obtained in the presence of PPAR (6.2 to 8.3% acetylated 
chloramphenicol) were at least half the value of that observed before (Table 6.1, 
21. So/o ), however, this result was obtained from two plates only. Taken together 
these results indicate that there is slight variation between experiments, despite the 
fact that each experiment has an internal control (the pCH11 0 vector). 
The transfection of pAC0(-1273/-471) with or without PPAR in the presence of 
increasing concentrations of Wy 14643 was repeated again, with controls, all 
performed in triplicate, as described above. The mean values of % acetylated 
chloramphenicol are given in Table 6.3. The co-transfection of pAC0(-1273/-
471)G.CAT with PPAR in the absence of Wy 14643 gave a percent of acetylated 
chloramphenicol of 12.12 ± 1.67 which is very similar to the values seen in Table 6.2 
for the same experiment. Once again, an increase in CAT activity is seen with an 
increase in Wy 14643 concentration. 
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PLATE DMSO PLASMIDS (J.lg) MEAN °/o 
AcCh :l:SEM 
pBiuescript pSGS pSGSPPAR pCHUO pACOGCAT (% totat 14Cl 
1 ACS, Glass 10 - - - - -
2/3/4 ACS Glass 5 1 
-
3 1 3.6± 0.3 
5/6/7 ACS, Glass 5 - 1 3 1 8.3 ± 0.6 
8/9/10 Analar, 5 
-
1 3 1 6.2 ± 0.2 
Glass 
11112/13 Analar, 5 - 1 3 1 8.3 ± 1.3 
Plastic 
14/15/16 H20 5 - 1 3 1 9.8 ± 2.5 
Table 6.2 Transfection strategy for looking at the effect of two 
different DMSO's and results of the CAT assay performed. ACS 
indicates ACS grade from Sigma, Analar indicates analar grade from Fisons, stored in 
either glass or plastic. AcCh = acetylated 14c chloramphenicol and SEM indicates 
standard error of the mean. 
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PLATE LIGAND PLASMIDS (J.Lg) MEAN% AcCh:i:SEM 
pBiuescript pSGS pSGSPPAR pCHllO pACOGCAT (% totat 14C) 
1/2 DMSO 10 - - - -
-
3/4/5 DMSO 5 1 - 3 1 2.46 ± 0.21 
6/718 DMSO 5 - 1 3 1 12.12 ± 1.67 
9/10/11 WY Io-8M 5 - 1 3 1 12.44 ± 2.26 
12/13/14 WY w-7M 5 - 1 3 1 8.08 ± 1.92 
15/16/17 WY 10-6M 5 - 1 3 1 16.9 ± 2.12 
18/19/20 WY to-SM 5 - 1 3 1 33.66 ± 2.31 
Table 6.3 Transfection strategy and results of CAT assay. Wy indicates 
peroxisome proliferator Wy 14643, AcCh indicates acetylated 14c chloraphenicol and 
SEM indicates standard error of the mean. 
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6.3 SUBCLONING OF RAT CYP4A2 5' FLANKING SEQUENCE 
6.3.1 PCR Amplification of 5' CYP4A2 Sequence 
Oligonucleotides were synthesised (section 2. 7.5) based on the published sequence of 
the rat CYP4A2 gene promoter (Kimura eta/., 1989a) and used to amplify a region 
corresponding to positions -1871 to +20 (containing the gene start site), and positions 
-1871 to -100 (gene start site absent), from the recombinant plasmid pGEMC3.0 
using the polymerase chain reaction (PCR). The three oligonucleotides used and their 
position within the 5' flanking sequence of CYP4A2 can be seen in Figure 6.3. To aid 
the subcloning of the PCR fragments into the expression vector pG.CAT, a Sph I 
enzyme restriction site was incorporated into the middle of each oligonucleotide 
(indicated in bold letters in Figure 6.3). The annealing temperature in the thermal 
cycle and the number of cycles were modified in order to reduce non-specific 
amplification and to produce the best yield of the specific DNA product required 
(data not shown). PCR was performed for both primer sets as described in section 
2. 8 and electrophoresed on a 1% agarose gel. Figure 6.4 shows the ethidium bromide 
stained gel. Lanes 1 and 2 represent the negative control for each primer set and the 
lack of bands in these two lanes indicate that no contaminating DNA was present 
since none had been amplified. It can be seen that there is more than one band 
present in each lane indicating that the 5' primer is not specific. The 1. 9Kb bands 
(lanes 3-5) representing DNA amplified from primers Sl/S2 and the 1.8I(b bands 
(lanes 6-9) representing DNA amplified from primers S l/S3 were excised from the 
gel and purified by the Geneclean method (section 2.2.6.1). 
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I pGEMC3.0 I 
Eco Rl Eco Rl Eco Rl Eco Rl 
ｾｾＭＮＮＮＮｊＭＭＭＱＮＭｾ＠ 1-----11------11 CYP4A2 
I -
-
-
-I S1 (-1871bp) ---
-
-ｉｾ＠
ｾ＠
S2 (+20bp) 
f-
S3 (-100bp) 
Sl 5' GAATTCTTTCAGGGAGCATGCTTTTTGTGATTCCTC 3' 
S2 5' ACCCATGGTTAATGGGCATGCCTTCTGGATCACTAG 3' 
S3 5' AGTGACCTCAGACTCGCATGCCAAAGTTTATTACTC 3' 
Figure 6.3 PCR oligonucleotides Sl, 82 and 83. Their position in 
relation to the 5' flanking sequence of CYP4A2 is indicated and the Sph I 
restriction endonuclease site incorporated into the oligonucleotides can be 
seen in bold. 
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Lane 
Figure 6.4 Amplification of 5' flanking sequence of the rat CYP4A2. 
Lane 1: no template DNA+ primer set S 1/S2 
2: no template DNA+ primer set Sl/S3 
3: pGEMC3.0 (template)+ primer set S1/S2 
4: pGEMC3 .0 (template)+ primer set Sl/82 
5: pGEMC3 . 0 (template) + primer set S l/S2 
6: pGEMC3.0 (template)+ primer set Sl/83 
7: pGEMC3 .0 (template)+ primer set 81/83 
8: pGEMC3 .0 (template)+ primer set Sl/S3 
9: pGEMC3.0 (template)+ primer set Sl/S3 
10: A Hind III molecular weight markers 
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6.3.2 Ligation of Amplified 5' CYP4A2 
Expression Vector pG.CAT 
Sequences into the 
SJ.lg ofQiagen prepared pG.CAT DNA was digested with the restriction enzyme Sph 
I ( 12 units) at 3 7°C overnight and then dephosphorylated with calf intestinal alkaline 
phosphatase as described in section 2.2. 7.2, and then purified by phenol/chloroform 
extraction (section 2.2.1 ). The DNA was recovered by ethanol precipitation (section 
2.2.2, method B) and dissolved in water to a final concentration of approximately 
100ng/J.ll. 
The purified PCR products were digested with the restriction enzyme Sph I (12 units) 
at 37°C overnight and then purified by phenol/chloroform extraction (section 2.2.1). 
The DNA was recovered by ethanol precipitation (section 2.2.2, method A) and 
dissolved in water to a final concentration of approximately SOng/J.ll. 
Ligations were carried out as detailed in section 2.4.3.3 and transformation of 
competent TBI cells performed as described in section 2.4.4. The expression vector 
pG.CAT does not contain the lac a-peptide and hence recombinant DNA-plasmid 
colonies cannot be selected by blue/white colour screening. Instead they are selected 
for by their ability to resist the antibiotic ampicillin, the colonies appearing white on 
the selective plate. However, since antibiotic resistance is conferred to the bacterial 
host cell by the plasmid and not just by the recombinant plasmid, a number of false 
positives are undoubtedly formed. Table 6.4 shows the results obtained from the 
subcloning of the PCR products into the expression vector pG.CAT. It can be seen 
that the TB 1 cells are extremely confluent (plate 2) in that the whole plate was 
covered with white colonies. The number of white colonies was reduced when the 
plasmid had been digested with the restriction endonuclease Sph I (plate 3 ), however 
due to the presence of the plasmids compatable ends this number of colonies was still 
quite large (the white colonies representing self religations as no T4 DNA ligase was 
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PLATE DNA ENZYME ClAP MOLAR WHITE 
RATIO colonies 
1 *No DNA 
- - - -
2 •pG.CAT (lOng) 
- - -
NO 
3 *pG.CAT (20ng) Sphl 
- -
1360 
4 *pG.CAT (20ng) Sph! ClAP 
-
45 
5 pG.CAT (20ng) Sphi 
-
1:1 (V:I) 3200 
6 pG.CAT (20ng) Sphi ClAP 1:1 (V:I) 80 
7 pG.CAT (20ng) + SIIS2 Sphi ClAP 1:1 (V:I) 64 
8 pG.CAT (20ng) + SI/S2 Sphl ClAP 1:3 (V:I) 38 
9 pG.CAT (20ng) + Sl/S2 Sphl ClAP 1:6 (V:I) 15 
10 pG.CAT (20ng) + SI/S3 Sph! ClAP 1:1 (V:I) 65 
11 pG.CAT (20ng) + SIIS3 Sphl ClAP 1:3 (V:I) 52 
12 pG.CAT (20ng) + Sl/S3 Sphl ClAP 1:6 (V:I) 49 
Table 6.4 Cloning strategy and results of subcloning of the PCR products 
from the two primer sets, S 1/S2 and S l/S3 into the expression vector 
pG.CAT. 
* indicates no ligase included 
Sph I indicates the plasmid had been linearised before ligation 
ClAP indicates the plasmid had been dephosphorylated with calf intestinal 
alkaline phosphatase before ligation 
ND indicates that there were too many colonies to count 
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present). These self religations were further reduced by dephosphorylating the 
plasmid (plate 4) preventing the plasmid from religating. The T4 DNA ligase was 
seen to be working since the number of whites doubled on plates 5 and 6 as compared 
to plates 3 and 4 respectively. The greatest number of colonies for both primer sets 
appeared to be at the 1: 1 vector: insert molar ratio (plates 7 and 1 0). 64 colonies were 
picked at random from plates 7, 8 and 9 and another 64 from plates 10, 11 and 12 and 
screened further using the cracking procedure (section 2.4.4.3). This screen identified 
11 colonies as possibly containing insert DNA and these were further investigated by 
preparing DNA by the STET method (section 2.4.1). The DNA from these 11 
colonies were digested with the restriction enzyme Sph I and electrophoresed on a 
1% agarose gel. Only a linearised plasmid of 5. 5Kb size was produced, characteristic 
ofpG.CAT without an insert (data not shown). Further attempts to subclone the two 
PCR fragments using differing molar ratios of 0. 5: 1. 0 and 1 :2 (vector: insert) also 
failed (data not shown). 
6.3.3 Ligation of pGEMC3.0 Insert DNA into Expression Vector 
pG.CAT 
A second approach taken was to try to subclone the 5' flanking sequence of CYP4A2 
by taking the entire 3. OKb of insert DNA from recombinant plasmid pGEMC3. 0 and 
subcloning it into the expression vector pG. CAT. The vector was treated in the 
following way. 5Jlg of Qiagen prepared pG.CAT (section 2.4.2.2) was digested with 
the restriction endonuclease Xba I ( 1 0 units) at 3 7°C for four hours after which time 
the 3' recessed ends created, were filled using the Klenow fragment of DNA 
polymerase as described in section 2.2. 7.3. The DNA was then purified by 
phenoVchloroform extraction (section 2.2.1) followed by ethanol precipitation 
(section 2.2.2, method A) and resuspended in water to a final concentration of 
40ng/J.ll. 
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5J.!g of the recombinant plasmid pGEMC3.0 was digested with the restriction 
enzymes Eco RI and Bgl I as described in section 4.6 and electrophoresed on a 1% 
agarose gel. The 3. OKb band was excised from the gel and the DNA purified using 
Geneclean (section 2.2.6.1). The 3' recessed ends created from the Eco RI digestion 
were filled using the Klenow fragment of DNA polymerase (section 2.2.7.3) and then 
treated with T4 polynucleotide kinase (section 2.2.7.4) to phosphorylate the DNA. 
The DNA was then purified by phenol/chloroform extraction (section 2.2.1) followed 
by ethanol precipitation (section 2.2.2, method A) and resuspended in water to a final 
concentration of 40ng/J.d. 
Blunt end ligations were carried out as detailed in section 2.4.3.3 and transformation 
of competent TB1 cells performed as described in section 2.4.4. Table 6.5 shows the 
results obtained. Digesting the plasmid DNA with Xba I and treating with Klenow 
(plate 3) produced only a few white colonies, 14, representing self ligation. When 
compared to plate 3 in table 6.3 (1360 whites) it could be seen that the filling of the 3' 
recess had been successful. Plate 4 (Table 6.5) indicated that blunt end religation of 
the plasmid had taken place and hence that the T4 DNA ligase was active. The 
greatest number of colonies was produced on plate 5 by a vector to insert molar ratio 
of 1:0.5. One hundred of these colonies were picked at random and screened further 
using the cracking procedure (section 2.4.4.3), however none were found to contain 
insert DNA (data not shown). Unfortunately, time restraints prevented furtherance of 
this work. 
6.4 PROMOTER ACTIVITY OF HUMAN CYP4A 5' FLANKING 
SEQUENCES 
In parallel to my work using the rat genomic library other members of the laboratory, 
(S. Hood and C. McGeogh), screened a human genomic DNA library with the same 
CYP 4A 1 probe and isolated positive hybridising recombinant phage clones. One 
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PLATE DNA ENZYME KLENOW MOLAR WHITE 
(K) RATIO colonies 
1 *No DNA 
-
.. 
- -
2 *pG.CAT (lOng) 
- - - ND 
3 *pG.CAT (20ng) Xbal K - 14 
4 pG.CAT (20ng) Xbal K 
-
1000 
5 pG.CAT (20ng) + 3.0kb Xbal K 1:0.5 (V:I) 1600 
6 pG.CAT (20ng) + 3.0kb Xbal K 1:1 (V:l) 1000 
7 pG.CAT (20ng) + 3.0kb Xbal K 1:3 (V:I) 1000 
Table 6.5 Cloning strategy and results of subcloning of the 3.0Kb insert 
from the vector pGEMC3. 0 into the expression vector pG. CAT. 
* indicates no ligase included 
Xba I indicates the plasmid has been linearised before ligation 
Klenow indicates the 3' overhangs of the plasmid has been filled before ligation 
ND indicates that there were too many colonies to count 
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clone, when characterised, was found to contain the 3' end of a human CYP4A gene. 
This DNA fragment was used to screen a second human genomic DNA library, from 
which two positive hybridising recombinant phage clones were isolated. The two 
clones were overlapping and the larger of the two (designated AB 1) was found to 
contain a complete human CYP4A gene and 9.0Kb of 5' flanking sequence. The 
restriction map ofABI can be seen in Figure 6.5. The DNA sequence ofAB1 shows 
extensive homology with the recently described CYP4AJJ eDNA (Palmer et al., 
1993). The Xba I and Xba I/Xho I fragment, indicated in Figure 6.5, were subcloned 
into the plasmid pGEM7Z and characterised by DNA sequencing. In order to 
investigate promoter activity in response to PP AR I subcloned the 5' flanking 
sequence (present in recombinant plasmids HG22 and HG23) of this human CYP4A 
gene into the expression vector pG.CAT. 
6.4.1 Subcloning of Human CYP4All Gene 5' Flanking Sequence 
5j...tg ofQiagen prepared pG.CAT DNA was digested with the restriction enzyme Xba 
I ( 1 0 units) at 3 7°C overnight, dephosphorylated with calf intestinal alkaline 
phosphatase as described in section 2.2.7.2, and purified by phenoVchloroform 
extraction (section 2.2.1). The DNA was recovered by ethanol precipitation (section 
2.2.2, method B) and dissolved in water to a final concentration of approximately 
100ng/j...tl. 
5j...tg of Qiagen prepared recombinant plasmids HG22 and HG23 were digested with 
the restriction enzyme .xba I (10 units) at 37°C overnight and then electrophoresed 
on a 1% agarose gel. The 4Kb and 2.4Kb inserts were excised from the agarose gel 
and the DNA extracted by the Geneclean™ method (section 2.2.6.1). 
Ligations were carried out as detailed in section 2.4.3.3 and transformation of 
competent XLI-blue cells performed as described in section 2.4.4. Table 6.6 shows 
the results from this subcloning experiment. It can be seen that plates 7 and 8 
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PLATE DNA ENZYME ClAP MOLAR WHITE 
RATIO colonies 
1 *No DNA - - - -
2 *pG.CAT (20ng) 
- - -
800 
3 *pG.CAT (20ng) Xbai - .. 90 
4 *pG.CAT (20ng) Xbai ClAP 
-
15 
5 pG.CAT (20ng) Xbal - - 500 
6 pG.CAT (20ng) Xbal ClAP 
-
50 
7 pG.CAT (20ng) + HG22 Xba I ClAP 1:2 (V:I) 200 
8 pG.CAT (20ng) + HG23 Xbai ClAP 1:2 (V:I) 150 
Table 6.6 Cloning strategy and results of subcloning of the human 
CYP4A 5' flanking sequences into the expression vector pG.CAT. 
* indicates no ligase included 
Xba I indicates the plasmid had been linearised before ligation 
ClAP indicates the plasmid had been dephosphorylated with calf intestinal 
alkaline phosphatase before ligation 
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produced, respectively, four and three times as many colonies as the control plate 
(plate 6). 5 colonies from each test plate were screened further. The five colonies 
from plates 7 and 8 were picked at random and DNA prepared by the STET method 
(section 2.4.1). The DNA was digested with the restriction enzyme Xba I along with 
the recombinant plasmids HG22 and HG23, which were used as appropriate size 
markers, and electrophoresed on a 0.7'% agarose gel (Figure 6.6). Two bands can be 
seen in lane 1, the 5.5l(b band representing the plasmid pG.CAT and the 4l(b band 
representing the HG23 insert. Lane 2 contained the recombinant plasnlid HG23 
digested with Xba I, which gave rise to a band the same size as that seen in lane 1, 
namely the 4Kb HG23 insert, and also produced a 3Kb band representing the plasmid 
pGEM7Z. Lane 3 shows an insert of size 2.4Kb equivalent to that seen when the 
recombinant plasmid HG22 is digested with Xba I (lane 4 ). Sequencing, using the -40 
universal primer, confirmed that the inserts in the recombinant plasmids 
pHG22G.CAT and pHG23G.CAT were the human genomic fragments from the 
recombinant phage AB 1 (data not shown). 
6.4.2 Activity of Reporter Plasmids Containing Human CYP4All 5' 
Flanking Sequences in Response to the Peroxisome Proliferator 
Wy 14643 
DNA from the recombinant plasmids pHG22G.CAT and pHG23G.CATwas prepared 
as described in section 2.4.2.2 and diluted to a concentration of lJlg/Jll. These two 
reporter plasmids were transfected into the mouse hepatoma cell line Hepa I, using the 
procedure described in section 2.1 0, in the presence or absence of PP AR and in the 
presence or absence of the peroxisome proliferator Wy 14643. A concentration of 
I o-5M, which was previously determined to give maximal induction of the CAT 
enzyme, was used (Table 6.7). The reporter plasmid pAC0(-1273/-471)G.CAT was 
also co-transfected with PP AR, since this was known to contain a PPRE, and 
therefore served as a positive control. The cells were harvested from each plate and 
cytosol extracted by three rounds of freeze/thaw cycles. Extracts were normalized for 
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lane 
Figure 6.6 Digestion of recombinant plasmids pHG22.GEM and 
pHG23.GEM along with recombinant human CYP4A pG.CAT clones, 
with the restriction enzyme Xba I. 
Lane 1: clone 16a: pHG23G.CAT 
2: pHG23.GEM 
3: clone 14d: pHG22G.CAT 
4: pHG22.GEM 
5: A Hind III molecular weight markers 
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P-galactosidase as described in section 2.10.1 and a CAT assay performed as 
described in section 2.10.2. 
The autoradiograph of the TLC plate can be seen in Figure 6. 7 and the results from 
the TLC scanner in Table 6.7. As expected, the reporter plasmid pAC0(-1273/-
471)G.CAT was stimulated when co-transfected with the p8GS.PPAR expression 
plasmid in the presence of Wy 14643 (Figure 6.7, lanes 3 and 4). However, the 
potent peroxisome proliferator Wy 14643 was unable to stimulate CAT activity in the 
human CYP4All 5' flanking sequence CAT constructs (Figure 6.7, lanes 8-10 and 
14-16). 
6.5 DISCUSSION 
Unfortunately, subcloning of the rat CYP4A2 5' flanking sequence was unsuccessful. 
Numerous attempts were made to subclone the 5' flanking PCR fragments shown in 
Figure 6.4, using various molar ratios of vector to insert DNA (Table 6.4) none of 
which yielded a recombinant clone. However only 55% and 38% of the total number 
of colonies of the ligation of the PCR products from the primer sets 8 1/82 and 81/83 
respectively, into the expression vector pG.CAT, were screened. It is possible that a 
recombinant clone existed in the colonies that were not screened. An approach to 
consider in the future for subcloning the PCR fragments would be to use a specially 
designed PCR cloning vector such as that produced by Invitrogen Corporation or 
Promega. Both vectors are provided as a linearised plasmid modified to contain dT 
overhangs and cloning of PCR products takes advantage of the single dA added to 
the 3' end of double-stranded DNA molecules by thermostable polymerases. Since I 
had already managed to subclone the 3.0Kb Eco RI fragment of CYP4A2 into the 
vector pGEM7Z, an attempt was made to subclone this fragment into the expression 
vector pG.CAT. The vector pG.CAT, however, did not contain an Eco RI site in its 
multiple cloning site, therefore it was necessary to perform a blunt end ligation. The 
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results seen in Table 6.5 indicated that the ligation had been successful (plate 5 as 
compared to plate 4). However, a vast number of colonies were obtained, 
approximately 18,000 (plates 5, 6, and 7) ofwhich only 100 were screened, none of 
which contained a recombinant clone. If time had allowed then the transformation of 
competent TB 1 cells would have been performed with less DNA and plated at a lower 
density to give a more managable number of colonies to screen. 
The transient co-transfection assay was established in the laboratory with some 
success. Table 6.1 shows the results from the first experiment. The average percent 
acetylated chloramphenicol for the co-transfection ofPP AR with the reporter plasmid 
in the absence of an inducer (plates 5 and 6) was 21.5%. As stated previously, this 
was felt to be quite high, however this experiment was only performed in duplicate. 
In the subsequent experiments this value was reduced (Table 6.3) to 12.12% ± 1.67, a 
value comparable to that reported by Tugwood eta/., (1992). The results in Table 
6.1 demonstrate that some CAT activity is produced by the reporter vector alone 
(4.5%> acetylated chloramphenicol). This could be due to the rabbit f3-globin 
promoter driving CAT production, or it may represent the presence of PP AR in the 
cell. The fact that the cotransfection of pSG5 .PP AR stimulates the reporter plasmid 
(21. 5% acetylated chloramphenicol) in the absence of a peroxisome proliferator may 
indicate either that PP AR has some partial constitutive activity or that there are small 
levels of a natural PP AR ligand present either in the culture medium or endogenous to 
the cells. 
The results in Table 6.1 and 6.3 indicate that PP AR is activated by the peroxisome 
proliferator Wy 14643 (45 ± 2.9 % and 33.6 ± 2.3 % acetylated chloramphenicol. 
respectively, at 1o-5M concentration) and not at all by the peroxisome proliferator 
PFDA (21.9 ± 1.8% acetylated chloramphenicol at I0-4M concentration). PFDA is a 
perfluorocarbon that is used in the chemical industry. Generally, perfluorocarbons are 
considered metabolically inert and relatively non-toxic compounds (Sargent and Sefil, 
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1970). Recently, however, perfluorinated compounds such as perfluorodecanoic acid 
(PFDA) have been shown to be peroxisome proliferators (Ikeda et al., 1985, Borges 
eta/., 1992). The result obtained in the cotransfection assay may indicate that PFDA 
does not exert its peroxisome proliferator action via the PP AR, however this 
experiment needs to be repeated. It has been shown that PFDA administration to rats 
increases the plasma triglyceride levels while causing a decrease in plasma cholesterol 
levels. This finding was in contrast to that observed for other classical peroxisome 
proliferators, such as the hypolipidaemic agent, clofibrate, and has led to the 
classification of PFDA as a 11non-hypotriglyceridaemic" peroxisome proliferator 
(Borges eta!., I 990). 
Figure 6.7 demonstrates that the potent peroxisome proliferator Wy 14643, at a 
concentration of 1 o-sM, was unable to stimulate the human 5' CAT constructs in the 
absence or presence of co-transfected pSG5.PPAR (lanes 5-16). This is consistent 
with the lack of a PPRE in the sequence so far obtained (S. Hood, personal 
communication). However there are a number of possibilities as to why no response 
was seen: 
i) There is no PPRE present. 
ii) A PPRE may be present further upstream than that tested. 
iii) There may exist a negative cis regulatory region exerting an effect (as seen 
in the rat acyl CoA oxidase gene, Osumi et al., 1991). 
iv) An auxiliary factor maybe required such as RXR. 
The significance of these possibilities will be discussed in more detail in Chapter 7. 
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CHAPTER 7 
DISCUSSION 
The phenomenon of peroxisome proliferation has invariably been associated with 
induction ofmember(s) of the CYP4A subfamily enzymes. Regulation of the members 
of the rat CYP4A family has not been fully studied at the molecular level and despite 
publication of the rat CYP4A 1 and CYP4A2 genomic sequences (Kimura et al., 
1989a), no functional assays have been performed to determine the mechanism of their 
transcriptional activation by peroxisome proliferators. 
In this thesis I report on the isolation and sequencing of three different members of the 
rat CYP.fA family. With the recent discovery that mPP AR mediates the transcriptional 
activation of the rat acyl-CoA oxidase gene {Tugwood et al., 1992) and also the rabbit 
CYP4A6 gene (Muerhoff eta/., 1992b) by peroxisome proliferators, the presence of a 
PP AR response element (PPRE) in the 5' regulatory DNA sequences of the three 
different rat CYP4A genes isolated here was investigated. I also examined the effect of 
mPP AR on the transcriptional activation of the human CYP4All gene, the first such 
report. 
7.1 THE ISOLATION AND CHARACTERISATION OF THE RAT 
CYP4A GENES 
A rat genomic recombinant phage library in A.Ch4A was screened using the rat 
CYP4Al eDNA (Earnshaw et a!., 1988) as a probe and a total of 16 clones were 
isolated. These were segregated into 6 different groups according to their Eco RI 
restriction pattern (Figure 3.1 0). The library had been screened with medium 
stringency so as not to exclude the isolation of other isoforms of CYP4Al as it had 
been demonstrated by Southern blot, that at least two or three genes existed in the rat 
CYP4 family (Hardwick eta!., 1987). 
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The six different recombinant phage clones were characterised by Southern blot using 
a more 5' located 600bp of CYP4Al eDNA as a probe (representing the first 5 exons). 
The fragments were subcloned into the plasmid pGEM7 and partly sequenced. Figure 
3. 11 B demonstrated that all groups, except group D, exhibited hybridisation to the 32p 
labelled 600bp probe. Eco RI fragments hybridising only to the 600bp probe appeared 
to lie upstream to those Eco RI fragments showing homology to both the 600bp and 
full length CYP4A 1 eDNA and a preliminary restriction map was made based upon 
these results (Figure 3.12). 
From the sequence analysis presented in chapter 4, I concluded that group A and E 
dissappointingly, represented A. DNA sequences (Figure 4.5 and Figure 4.19) as well 
as containing a 6.7kb Eco RI fragment from CYP4A2 which seemed to be very well 
represented in this particular genomic library. I concluded that group B probably 
represented the genomic clone of CYP4A3. 
It is now known that a great deal of multiplicity exists within the CYP4A family (Table 
1.2) with four members in the rat family, four in the rabbit , two in the mouse, one in 
the guinea pig and two (?) in the human family identified to date. The relationship at 
the amino acid level of the individual members of the CYP4A family can be seen in 
Table 7.1. In view of the fact that the members of the CYP4A family are so closely 
related (ranging from 70-97% amino acid similarity), it was surprising that none of the 
six different recombinant phage isolated from the library screen, represented the rat 
CYP4A I genomic sequence (section 4.1 0). This must be a reflection of the quality of 
the recombinant library and not the conditions used to screen it. The quality of the 
library was also reflected by the number of recombinant phage clones isolated that 
contained lambda DNA as an insert (5 out of the original 16, Figure 4.6). 
The cytochrome P450s are thought to have evolved from a common ancestral gene 
some 3. 5 billion years ago. The diversity seen within the cytochrome P450 family is 
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thought to have arisen as the result of species specific gene duplication and conversion 
events which have conferred an evolutionary advantage on the animals concerned On 
the basis of this, Nebert (1990) has proposed that the oldest cytochrome P450 
enzymes may play an important role in maintaining the steady-state levels of 
endogenous ligands involved in ligand-modulated transcriptional regulation of genes 
effecting homeostasis, growth, differentiation and neuroendocrine function. So far the 
CYP4 genes have the highest number of introns among the eukaryotic P450 genes, 
from_IO in CYP4BJ (Yokotani eta/., 1990) to 12 in CYP4Al (Kimura eta/., 1989a). 
A hypothesis has been proposed that as genes evolved, intron loss occured (Gilbert et 
a/., 1986). Therefore the CYP4 genes may preserve the most "ancient" structure 
among known eukaryotic cytochrome P450 genes (Degtyarenko and Archakov, 1993). 
The multiplicity of genes seen in the CYP4A subfamily can be related to the multiplicity 
of their substrates (co-hydroxylation of fatty acids and prostaglandins), their tissue 
specificity (expressed in the liver, kidney, lung, small intestine and prostate), and their 
species specificity. These all relate to endogenous functions (reviewed in section 
1.2.2) which for the most part remain unknown. 
7.2 THE ROLE OF PPAR IN THE TRANSCRIPTIONAl 
REGULATION OF CYP4A GENES AND IN PEROXISOME 
PROLIFERATION 
The balance of evidence produced over the last four years indicates that the steroid 
hormone receptor PP AR (lssemann and Green, 1990), mediates some of the biological 
responses to peroxisome proliferators. Since the demonstration that PP AR recognises 
a response element (PPRE) present in the 5' upstream region of the rat peroxisomal 
acyl CoA oxidase gene causing an increase in its transcription (Tugwood et al., 1992), 
a number of other PPRE's have been identified. They have also been found in the 
genes for the rat peroxisomal bifunctional enzyme (Zhang et al., 1992a, Bardot et a!., 
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1993), the rat peroxisomal 3-ketothiolase gene (Kliewer et al., 1992b), CYP4A6, the 
major rabbit lauric acid 12-hydroxylase (Muerhoff et a/., 1992b), and rat liver fatty 
acid binding protein (Issemann eta/., 1992, Simonet a/., 1993). More recently it has 
also been demonstrated that PP AR activates these genes through heterodimer 
formation with the retinoid receptor RXR (Kliewer et a/., 1992b, Issemann et al., 
1993, Gearing eta/., 1993, Keller eta/., 1993, Bardot eta/., 1993). A scheme for the 
involvement of PP AR and RXR. in peroxisome proliferator dependent enzyme 
induction is shown in Figure 7.1. 
As can be seen in Figure 7. 1 a number of questions remain about the control of 
enzyme induction by PP AR, for instance; 
I) does a PPRE exist in the 5' upstream region of genes such as 
CYP4AJI4A214A314Al 1 and cell cycle regulatory genes such as c-myclc-fos? 
2) what is the natural ligand for PPAR? 
3) what is the function of the heterodimerisation with RXR? 
4) which other members of the steroid hormone receptor family can interact 
with PPAR? 
5) how do peroxisome proliferators activate PPAR? 
6) are all the pleiotropic effects of peroxisome proliferators mediated through 
PPAR? 
7) what is the role ofthe peroxisome proliferator dependent induction ofPPAR 
(Gebel eta/. 1992, McNae personal communication)? 
The identification that clofibrate-activated PP AR could bind to the regulatory 
sequence at position -727bp upstream of the CYP4A6 gene and stimulate 
transcriptional activity (Muerhoff et a!., 1992b ), strongly suggests that the induction 
by clofibrate of the closely related rat fatty acid ro-hydroxylases CYP4Al/4A214A3 
(Table 7.1) also involves PP AR. These peroxisome ｰｲｯｬｩｦ･ｲ｡ｴ･ｾ＠ inducible genes, 
including acyl Co A oxidase, do not contain a consensus TAT A box in their promoter 
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Figure 7.1 Schematic diagram indicating the role of PPAR and RXR in peroxisome proliferator dependent 
enzyme induction. Retinoid X receptor (RXR), peroxisome proliferator activated receptor (PPAR), heat shock protein (HSP}. 
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sequence (Kimura eta/., 1989a, Osumi eta/., 1991, Muerhoff eta/., 1992a), however 
several putative regulatory sequences have been identified in the 5' flanking regions of 
these genes. Two highly consetved sequences have been identified in the upstream 
regions of CYP4Al and CYP4A2. These are a 19bp sequence located 42 and 48bp 
upstream and a 6bp (GATTTA) sequence located 20 and 25bp upstream of the 
transcriptional start sites of CYP4Al and CYP4A2 respectively (Kimura eta/., 1989a). 
The function of these sequences are not yet known. A consensus GC rich sequence, 
the core binding site for the transcription factor Sp 1, has been identified in the 5' 
flanking regions of both CYP4Al and CYP4A6 (Kimura et al., 1989a, Muerhoff eta/., 
1992a). In addition an 11 bp sequence (the function of which is unknown) is strongly 
conserved between CYP4Al and CYP4A6 (Muerhoff eta/., 1992a). 
The CYP4A6 PPRE is present in a reverse orientation to that in the rat peroxisomal 
acyl CoA oxidase gene at position -558bp (Figure 7.1), indicating that the PPRE is an 
inducible enhancer element. The fact that enhancers can act at a considerable distance 
from the transcriptional start site might explain why a PPRE has not been identified in 
the -l.Okb and -2.5kb of upstream sequence of CYP4Al and CYP4A2 respectively 
(Kimura et a/., 1989a). It has been suggested that a PPRE is present at -5.0kb 
upstream of the CYP4Al (Green, personal communication), however, others have 
suggested that no PPRE exists up to -20kb of CYP4Al (Gonzalez, personal 
communication). 
It should not be assumed however that the transcriptional activation of rat CYP4A 
fatty acid co-hydroxylases, and acyl CoA oxidase is equally sensitive to PP AR 
otherwise results such as those of Milton et a/. (1990) cannot be explained. These 
workers observed a biphasic induction of the apoprotein content, catalytic activity and 
mRNA levels of CYP4Al after a single dose of clofibrate. The first and second peaks 
of induction were obsetved at about 30 minutes and 18 hours respectively. However, 
the mRNA levels of acyl CoA oxidase and palmitoyl CoA oxidase were induced in a 
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monophasic manner after clofibrate treatment with peaks at about 18 hours and 18 to 
24 hours post dose respectively (Milton et a/., 1990). In addition the clofibrate-
induced level of CYP4Al mRNA 24 hours after clofibrate treatment was not affected 
by co-treatment with tcycloheximide, but the induction of acyl CoA oxidase mRNA 
was abolished by cyclohexamide treatment. The results of this study suggest that the 
basal level of the PP AR is sufficient for the induction of CYP4A1 while the 
transcriptional induction of acyl CoA oxidase might require the de novo synthesis of 
additional regulatory factor(s). This second phase may be due to recycling of the 
PP AR and RXR. 
In the search for the endogenous ligand ofPPAR several workers have reported that 
long chain fatty acids can activate PPAR (Gottlicher et a/., 1992, Issemann et a!., 
1993) but the relative potency compared to activation by the peroxisome proliferators 
themselves was low. However, in contrast Keller et a/. (1993) demonstrated that 
polyunsaturated fatty acids activated the Xenopus laevis PP AR receptor as efficiently 
as the most potent peroxisome proliferator, Wy 14643. Ultimately, binding studies are 
required to determine whether fatty acids are the endogenous ligand of PP AR or 
whether a fatty acid metabolite, such as the co-hydroxy metabolite of arachidonic acid, 
could be the true ligand. 
It is possible that the increase in fatty acid co-hydroxylation, due to the early induction 
of CYP4A (Milton et a/., 1990), prior to the induction of peroxisomal P-oxidation 
results in the generation of the true ligand of PP AR. However, an inhibitor of 
CYP4Al, 1-aminobenzotriazole, did not inhibit PPAR activation by fatty acids in 
transfected hepatocytes (Gottlicher et a!., 1992). The substrate overload theory 
suggests that an accumulation of fatty acids occurs after administration of the 
peroxisome proliferator due to an inhibition of the mitochondrial P-oxidation which 
occurs at an early time point (Lock et a/., 1989). Therefore, CYP4A has access to 
excess fatty acid substrate which could then lead to production of the endogenous 
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ligand for PP AR, therby leading to induction of peroxisomal f3-oxidation. In support 
of this theory is the observation that induction of peroxisomal acyl CoA oxidase is 
dependent on an earlier phase of protein synthesis (Milton et a/., 1990). This early 
phase of protein synthesis might represent the synthesis of CYP4A1 since it has been 
shown that mechanism based inhibitors of CYP4Al can substantially inhibit 
peroxisome proliferation in vivo (Ortiz de Montellano, 1992). 
Another question raised above is how is RXR heterodimerisation involved in the 
regulation of PP AR responsive genes? It has been demonstrated that the DNA-
binding capacity of receptors such as the Drosophila ecdysone (EcR), the thyroid 
hormone receptor (TR), retinoic acid receptor (RAR) and the vitamin D3 receptor 
(VDR) with their target response elements is potentiated by the heterodimerisation of 
the receptor with the retinoid X receptor (RXR) (Yao et a/., 1992, Leid et a/., 1992, 
Zhang eta!., 1992b, Kliewer eta!., 1992a, Carlberg et al., 1993). More recently it has 
been shown that RXR can heterodimerise with PP AR, in the presence of 9-cis retinoic 
acid (the ligand for RXR) and peroxisome proliferators, to act synergistically in the 
induction of acyl Co A oxidase, 3-ketothiolase and bifunctional protein genes (Kliewer 
et al. , 1992b, Bardot et al., 1993). Presumably, the ability of RXR to contribute to 
transcriptional activation of the heterodimer will depend upon the context of the 
response element within the promoter, and also the cell type, thus providing fine tuning 
of the respor.se. As has been stated above, there are now a number of PPREs that 
have been identified, all with slight variations in the TGACCT direct repeat (Figure 
7.1 ). These slight differences may lead to differences in the affinity of PP ARIRXR 
binding, thus leading to differential induction of the relevant genes by the PP ARIRXR 
heterodimer. 
The interaction of PP AR with other steroid hormone receptors such as COUP-TF 
(Chicken Ovalbumin Upstream Promoter Transcription Factor) has not been 
investigated. It is known that COUP-TF can recognise a direct repeat separated by 
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either lbp (the same specificity exhibited by PPAR) or 2bp (Green, 1993). COUP-TF 
appears capable of exerting either a negative or positive effect on target gene 
transcription (O'Malley and Conneely, 1992) and may therefore represent another type 
of control over the peroxisome proliferator dependent induction of certain genes. 
The multiplicity ｯｦｾｐ＠ AR was discussed in Chapter 1 (section 1.6). It is known that as 
well as the mouse PPAR (Issemann and Green, 1990) there are 3 PPARs (a., {3, y) 
present in Xenopus laevis (Dreyer et a/., 1992), one in rat (Gottlicher et a/., 1992), 
one in human (Sher eta/., 1993) and a human PPAR-like receptor, Nuc-1 (Schmidt et 
a/., 1992). It is likely that there are more PPAR isoforms present in mouse, rat and 
human, especially as it is known 3 isoforms of RXR exist (a., {3, y) (Mangelsdorf et 
a!., 1990). The presence of these isoforms could also produce fine tuning of the 
response by each having different affinities for ligands and for DNA binding sites. 
It has been demonstrated that the human PPAR, when co-transfected into mouse 
Hepa 1 cells in the presence of peroxisome proliferators Wy 14643, nafenopin and 
clofibrate, has the ability to trans-activate the rat acyl CoA oxidase promoter and the 
rabbit CYP4A6 promoter, comparable to that of the mouse receptor (Sher et a/., 
1993). The existence of an active human PPAR would indicate the possible presence 
of PPREs upstream of the human genes orthologous to those shown in Figure 7.1. 
Although it has been demonstrated that the peroxisomal enzymes and {3-oxidation 
system do exist in human cells (Watkins eta!., 1991), unfortunately none of the human 
peroxisomal {3-oxidation genes have been isolated to determine the existence of a 
PPRE. The work presented in Chapter 6 is the first report of an investigation of the 
possible role of PPAR in the induction of a human gene, namely CYP4All . Two 
constructs were made, pHG23G.CAT (-3.2kb/-20bp of CYP4AJJ) and pHG22G.CAT 
(-5 .8kb/-3.2kb), both of which were co-transfected with the PPAR expression plasmid 
into the mouse hepatoma cell line, Hepa 1. In the presence of the peroxisome 
proliferator Wy 14643 (I o-SM), no CAT activity was observed (Figure 6. 7). This lack 
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of response, although consistent with the sequencing data so far obtained for this 
region (however, this is far from complete) could be due to a number of factors (some 
of which have already been discussed), for example; 
1) negative cis regulatory regions may exist which exert a dominant negative 
effect, such as that observed in the rat acyl CoA oxidase gene (Osumi eta/., 1991) and 
the rat bifunctional enzyme (Bardot eta/., 1993). The only way to test this hypothesis 
would be to sequentially delete the sequence from both the 5' and 3' end and place 
these truncated sequences upstream of the CAT reporter vector to see if a response to 
Wy 14643 could be elicited. 
2) an auxiliary factor such as RXR, may be required to elicit a full response. 
3) a PPRE exists, but further upstream than the -5 .8kb tested. 
4) no PPRE exists. 
The lack of a response of the CYP 4A 11 to PP AR is not totally unexpected when 
considering the species differences that exist in response to peroxisome proliferators. 
Peroxisome proliferation has not been clearly demonstrated in humans (Hanefeld et a/., 
1983). It may well be that the mechanism of regulation of the response element 
controlling the human CYP4A11 and perhaps other human genes (such as acyl CoA 
oxidase) induced by PP AR and its activators/ligands, fundamentally differs from that of 
rats or mice, resulting in low responsiveness to peroxisome proliferators. One 
possibility is that the human genes have lost the cis-acting regulatory elements found in 
rodent genes. It would be interesting to determine whether there is an inducible 
human acyl Co A oxidase response element which can be activated by human PP AR in 
the presence of a suitable activator, or whether some inhibition of the induction 
process can account for the low responsiveness of humans to peroxisome proliferators. 
The co-hydroxylated product of CYP4A metabolism requires further oxidation to the 
carboxylic acid before it can enter the f3-oxidation pathway, one of these oxidations 
being performed primarily by alcohol dehydrogenase. Oxidation of primary alcohols is 
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catalysed by a family of enzymes, the alcohol dehydrogenases, each with a different 
substrate specificity (Vallee and Bazzone, 1983 ). Alcohol dehydrogenase is known to 
catalyse the rate limiting step of the oxidation of retinol to retinoic acid. Examination 
of the 5' flanking regions of one of these alcohol dehydrogenases revealed the presence 
of a retinoic acid response element (RARE), suggesting that a positive feedback loop 
operates resulting in increased formation of retinoic acid (Harding and Duester, 1992). 
This RARE consists of a direct repeat, separated by 5bp and therefore represents a 
target for RAR/RXR heterodimers. Since the ligand for RXR, 9-cis retinoic acid, is a 
stereoisomer of retinoic acid, it is possible that this feedback loop also operates to 
increase 9-cis retinoic acid. It seems that alcohol dehydrogenase may be intimately 
involved in the mechanism of peroxisome proliferation, not only in oxidising co-
hydroxy fatty acids, but also by increasing the formation of retinoic acid from retinol 
(Figure 7.2). 
Retinoic acid is involved in cell differentiation and proliferation processes and 
therefore an increase in cellular concentration of this mediator and its involvement in 
peroxisome proliferation may indicate that a receptor-mediated mechanism of 
peroxisome proliferator-induced cell proliferation and hepatocarcinogenesis may exist. 
Genes containg PPRE or RARE sequences involved in cell proliferation undoubtably 
exist and await further investigation. For example c-myc and c-fos are known to be 
induced by peroxisome proliferators (Cherkaoui-Malki et a/., 1990, Bentley et a/., 
1988). 
Another question raised above is how do peroxisome proliferators activate PP AR? 
This could be achieved by a number of mechanisms. The peroxisome proliferator 
might bind directly to the PP AR inducing a conformational change in the PP AR 
molecule, although, to date, no evidence for this has been produced. However, recent 
ｩｮｶ･ｳｴｩｧ｡ｴｩｯｮｾ＠ with computer aided molecular modelling (D. Lewis, personal 
communication) have suggested that, although peroxisome proliferators have diverse 
207 
t-
.) 0 00
 
R
et
in
ol
 
ｾ＠
R
et
in
oi
c 
Ac
id
 (R
A)
 _
_
_
 ＮＮＮＮＬｾ＠
9-
ci
s 
R
et
in
oi
c 
Ac
id
 (9
-ci
sR
A)
 
Pe
ro
xi
so
m
e 
Pr
ol
ife
ra
to
r 
AD
H Qt 
!Q 
Is
om
er
as
e 
!Q 
ｾｑ＠
I 
R
AR
 
.
.
_
 
R
AR
-R
A 
{in
ac
tiv
e) 
{ac
tiv
e) 
RX
R 
.
.
_
 
RX
R-
9c
isR
A 
{in
ac
tiv
e) 
{ac
tiv
e) 
PP
AR
 .
_
 
PP
AR
 
(ac
tiv
e) 
(in
ac
tiv
e) 
I 
I 
I 
I 
.
Q 
I 
I 
I 
I 
I 
L
_
 _
_
 
ＭｴＺＭＭｾＭｾ＠
) 
I 
CY
P4
A 
ｸｾＯｾ＠
I 
-
-
-
-
ｾ＠
ｾＭＭＭＭ｟ｪ＠
r 
Q+
 
+G)?
 
Pe
ro
xi
so
m
al
 ｾＭｯｸｩ､｡ｴｩｯｮ＠
ge
ne
s 
AD
H 
AL
DH
 
ｴｾ＠
ro
-h
yd
ro
xy
la
te
d 
FA
 
.
.
.
.
 
F
A
-C
H
Q
--
FA
-C
OO
H 
Fa
tty
 A
ci
d 
(FA
) 
.
.
.
.
.
.
.
_
 
.
.
.
.
.
.
.
-
Fi
gu
re
 7
.2
 T
he
 ro
le
 o
f p
os
iti
ve
 fe
ed
ba
ck
 re
gu
la
tio
n 
in
 p
er
ox
is
om
e 
pr
ol
ife
ra
tio
n.
 R
et
ino
ic 
ac
id 
re
ce
pt
or
 (R
AR
), 
re
tin
oid
 X
 re
ce
pt
or
 (R
XR
), p
er
ox
iso
m
e 
pr
oli
fe
ra
to
r a
ct
iva
te
d 
re
ce
pt
or
 (P
PA
R)
, a
lco
ho
l d
eh
yd
ro
ge
na
se
(AD
H)
, a
lde
hy
de
 d
eh
yd
ro
ge
na
se
 
(AL
DH
) a
nd
 s
tim
ula
tio
n 
of
 a
ct
ivi
ty
(+)
. 
. - ··------- ·-- - -------------: 
chemical structures, many share some common structural features and functional 
groups and a putative ligand-binding site which can accomodate numerous peroxisome 
proliferators has been proposed (Lewis and Luke, 1993). Alternatively, 
conformational change in the PP AR molecule might be caused by an intermediate, 
peroxisome proliferator activated factor. 
It is known that the 70kD and 90kD heat shock proteins (HSP70 and HSP90 
respectively) are associated with the steroid hormone receptors and are vital in 
controlling receptor function (Landers and Spelsberg, 1992), for example, dissociation 
of HSP90 from the glucocorticoid receptor results in activation of the receptor without 
ligand binding (Daniel et a!., 1991 ). It has been demonstrated that peroxisome 
proliferators can bind to heat shock proteins in vitro (Alvares et al., 1990) and this 
may provide a mechanism of activation of PP AR, by peroxisome proliferators 
sequestering certain heat shock proteins. 
Phosphorylation provides another possible mechanism for the activation of PP AR by 
peroxisome proliferators. Many steroid hormone receptors have been found to be 
phosphorylated (Daniel et a/., 1991) and this affects the transcriptional efficiency of 
these receptors. It is interesting to note that peroxisome proliferators. can activate 
protein kinase C (PKC) via formation of their CoA-thioesters, which are rapidly 
formed by hepatocytes (Bronfinan et al., 1986, 1989). The PKC gene family codes for 
at least nine serine/threonine protein kinases (Nishizuka, 1992) that are present, in 
quiescent cells, as cytosolic inactive enzymes. Each isoform has specific requirements 
for diacylglycerol, phosphatidylserine and calcium. Some PKC isoforms are known to 
be the intracellular receptors for phorbol ester tumour promoters such as 12-o-
tetradecanoylphorbol-13 -acetate (Nishizuka, 1984), demonstrating a crucial role of 
these enzymes in cell growth and differentiation. Recently a functional link between 
the PKC and retinoid pathways has been established (Tahayato et a/., 1993). The 
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authors demonstrated that selective inhibition of PKC lead to the loss of ligand 
dependent transcription of a retinoic acid inducible promoter. 
7.3 SUGGESTIONS FOR FUTURE WORK 
In order to progress this work further, the following lines of investigation may be 
fruitful: 
1. To fully characterise the group B recombinant phage clone, establishing its identity 
as the genomic sequence of CYP4A3 by sequencing the exons, using exon specific 
primers, and to use PCR to establish intron length. Characterisation of the 5' flanking 
region could then be carried out and investigations into this genes inducibility by 
peroxisome proliferators (Kimura et a/., 1989b) and the differences in this inducibility 
observed between male and female (Sundseth and Waxman, 1992) performed. 
Control elements may also be present downstream of the promoter. 
2. Further fittempts to investigate the role of PP AR in the induction of CYP4A2 
should be made. Screening of a second library using the recombinant plasmid 
pGEMC3 . 0 as a probe should be performed to pull out further 5' sequence to the 
-2.5kb already published (Kimura eta/., 1989a). 
3. Investigations into the control of the basal level of transcription of CYP4A2 and 
CYP4A3 should be carried out by incubating the 5' ends of these genes with nuclear 
and cytosol extracts from liver and kidney from a control male and female rat. Using 
the techniques of gel retardation and footprinting any DNA/protein interactions could 
be established and characterised in regard to the site of DNA binding. Isolating these 
proteins would be more difficult. 
4. The results presented in Chapter 6 indicate that the peroxisome proliferator PFDA 
does not activate the PP AR, suggesting that not all peroxisome proliferators mediate 
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their response via the PP AR. This experiment should be repeated, using a variety of 
different peroxisome proliferators, (ranging in potency as regarding their ability to 
induce hepatocarcinogenesis in rodents), as well as PFDA, at different concentrations 
so that a full characterisation of the transfection system in our hands could be 
established. 
5. Further analysis ofthe human 5' flanking region ofCYP4All should be carried out 
as suggested in the previous discussion. In total, -9. Okb of upstream region has been 
isolated, but only -5.8kb has been tested. 
6. Analysis of the regulatory regions of other human genes such as acyl CoA oxidase 
would give a better understanding of the observed species differences in response to 
peroxisome proliferators. 
7. An attempt to establish whether the induction of CYP4Al, by peroxisome 
proliferators, is causal or casual in the ensuing peroxisome proliferation could be made 
by stably transfecting a cell line (whose response to peroxisome proliferators has been 
characterised) with an expression vector, such as the one shown below:-
S\140 Promoter Stop Sequence CYP4A1 ｓ｜ＱＴＰｾ＠
FLP Recombinase 
S\140 Promoter CYP.V..1 ｓ｜ＱＴＰｾ＠
The integration of the construct into the cells could be selected for using a neomycin 
resistance cassette. However, no CYP4Al would be produced from this vector as 
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there is a lengthy stop sequence placed inbetween the SV 40 promoter and the 
CYP4Al eDNA. This stop sequence is flanked by FLP recombinase recognition sites. 
Transient transfection of a FLP recombinase expression vector into these cells would 
flip out the stop sequence, thereby bringing the CYP4Al eDNA under control of the 
SV40 promoter switching on its expression. The effect of induction of CYP4Al on 
the rest of the cell could then be monitored. 
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